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ABSTRACT 
This thesis reports experiments I have done to investigate 
some of the immunobiological aspects of a naturally occurring 
squamous cell carcinoma in sheep . Methods were established for 
the successful cultivation of a number of pure populations of 
. tumour cells in vitro. The epithelial nature of the established 
cell lines was confirmed by electron microscopic studies . An 
ass ociation was found between the site at which the tumour grew 
on the host and the rate of success obtained in establishing the 
tumour in culture . Tumours growing on the muzzle were established 
in culture most easily followed by those on the ear and the vulva 
respectively. A similar correlation 'was observed between the site I 
of the primary tumour and its capacity to grow in nude mice. 
Studies on the tumour cell-lymphocyte interaction indicated 
that all tumour cell lines that were tested failed to stimulate a 
proliferative response in allogeneic lymphocytes when mixed 
together in vitro. This lack of stimulation was found to be due 
to an immunosuppressive capacity of the majority of the cell 
lines tested . This immunosuppressive capacity of the tumours, 
which was manifest in vitro~ was not seen in vivo~ since 
challenge of allogeneic normal sheep with tumour cells resulted 
in significant stimulation of the recipient~ irrrrnune system. 
The immune reactivity of tumour-bearing sheep to autochthonous 
tumour cells was investigated both in the lymph node regional to 
the tumour and in lymph nodes distant from the tumour site. This 
was done by cannulating both the afferent and the efferent 
lymphatics of the lymph nodes and measuring the immune responses 
that were produced,in the efferent lymph following challenge 
with autochthonous tumour cells . While the primary tumour 
remained present , no immune reactivity , as measured by cellular 
changes in the lymph from the regional nodes was detected 
whereas a significant response did occur in the lymph from a 
distant node when this was challenged directly with tumour cells. 
The response observed in the distant lymph node was associated 
with the production of antibodies which bound to the tumour cells 
but were not cytotoxic for them . Removal of the primary tumour 
and subsequent sensitization of the host thr ee weeks after the 
tumour was resected , resulted in the appearance of specific 
humoral and cellular cytotoxic mechanisms in the efferent lymph 
from distant nodes when these were challenged by autochthonous 
tumour cells . 
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CHAPTER 1 
INTRODUCTION 
Skin cancer is one of the most common cancers of man. The 
incidence of skin cancer in Australia is the highest of any 
country in the world and represents more than 50% of all the 
cancers diagnosed. There is a well established association 
between the incidence of skin cancer in man , and the degree to 
which the skin is exp osed to s unlight. Skin cancer in sheep is 
also common in Australia and this tumour, like the skin tumours 
in man, has b e en attributed to the effect of ultraviolet 
irradiation of the sun. Thus skin cancer in sheep provides an 
excellent model for studying the biology of a cancer which is of 
important medical significance(Ladd and Entwistle 1977). 
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Th e aim of th e work described in this thesis was to investigate 
some of the immunobiological aspects of this naturally occurring 
solid tumour of the skin of sheep . The introduction to the thesis 
consists of two parts; one part describes the histological 
structure of the skin, the alterations in the skin which are a 
prelude to the development of either basal or squamous cell 
carcinomata, and includes a discussion of the natural history 
of squamous cell carcinoma in s h eep . The othe r part revie ws 
the various type s of immune r e activitie s detected in natural and 
experimental tumours both i n vitro and &n V&VO. 
1 . 1 PATHOLOGY OF SKIN TUMOURS 
The s k i n consis t s of an oute r ep ide rmis and an inne r dermis. 
The epide rmi s is divided into four main layers; the basal layer 
consisting of a single row of columnar epithelial cells (stratum 
ge rminativum), a thi ck p rickle cell layer (stratum spinosum), a 
thin laye r of diamond-shaped c e lls filled with granules known as 
2 
keratohyalin (stratum granulosum) and , a surface -layer of dead 
keratinized cells (stratum corneum) . Cell proliferation in the 
epidermis occurs mainly in the basal layer . Newly-formed cells 
leave this layer and move outwards through the more superficial 
layers until they reach the surface and are shed . During this 
process of outward migration, the cells undergo a series of 
characteristic morphological changes in which they become 
progressively more keratinized. As the cells produce the 
insoluble protein keratin , they lose their nuclei and die . Thus, 
under normal conditions , the production of new cells in the 
basal layer is balanced against the death of cells through the 
process of keratinization and desquamation . In certain circum-
stances, for example . following prolonged exposure of the skin to 
UV-light , hyperplasia of the epidermis can occur (Blum l959; 
Blum et al . ~ 1975) . This hyperplastic condition of the skin may, 
with time
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revert to normal or become permanent . Two types of 
epidermal carcinomata may re~ult from alterations in the balance 
between cell proliferation and cell differentiation (keratinization), 
and these tumours are classified as basal cell and squamous cell 
carcinoma ta . 
1 . 1 . 1 Basal Cell Carcinoma 
Basal cell carcinoma accounts for over 75% of all skin 
cancers (Fitzpatrick and Pathak 1977). These carcinomata arise 
from the basal layer of the epidermis and the malignant cells 
show little tendency to undergo the usual differentiation into 
keratinized squamous cells (Belisario 1959 ; Klein et al.~ 1973). 
Although these tumours very rarely metastasise, they are locally 
invasive and, if neglected they will spread into underlying 
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structures including nerves , bone and brain. This cancer occurs 
mainly on the head and neck of man , classically distributed around 
the shade line of the hat . The typical basal cell carcinoma 
appears as a non ·-inflamed smooth , translucent waxy nodule, which 
has a variable amount of melanin pigment. Such nodules often 
ulcerate and a crust forms on their surface . Basal cell 
carcinomata may also take other forms, including more subtle 
infiltrating lesions that do not produce elevated nodules. 
Although there is no readily recognizable premalignant lesion that 
precedes a basal cell carcinoma , the cancer is normally seen in 
people who manifest symptoms of skin damage from sunlight or 
X-rays (Klein et al .~ 1973). 
1 . 1 . 2 Squamous Cell Carcinoma 
Squamous cell carcinoma also arises from the epidermis and 
the malignant cells show significant differentiation into squamous 
cells . This cancer is characterized histologically by the presence 
of accumulations of keratinized cells with a characteristically 
whorled arrangement described as keratin pearls (Klein et al . J 
1973; Fitzpatrick and Pathak , 1977) . This pattern is apparent in 
the e arly stages of the disease . Squamous cell carcinoma may also 
grow and infiltrate the deeper layers of the dermis and 
subcuticulum as does the basal cell carcinoma or it may grow to 
form a raised hyperplastic l es ion which may infiltrate the deeper 
tissue at a later stage . Squamous cell tumours tend to metastasise 
more readily than basal cell tumours, but the outcome depends on 
the size , location and the invasiveness of the tumour. 
Iri 
contrast to b a sal cell carcinomata, squamous cell carcinomata most 
commonly arise from a pre-existing actinic or solar keratosis. 
These premalignant keratoses are scaly, rough , red plaques that 
occur in chronically sun-damaged skin. Although very few of 
these keratoses progress to carcinomata , most squamous-cell 
carcinomason exposed skin do arise from these keratoses(Klein 
et al . ~ 1973; Scott and Starf 1977) . The type of squamata which 
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arise from keratotic lesions has a low frequency of metastases 
(below 2%,Fitzpatrick and Pathak 1977) . Squamous cell carcinomata 
which arise from mucous membranes , mucocutaneous junctions., burn 
scars or chronic ulcers have a greater tendency to metastasize 
(Klein et al . ~ 1973). In general however, the malignancy of 
squamous cell carcinomata is fairly low and metastases occur 
infrequently. When the tumours do spread, they do so principally 
through the lymphatic system although occasionally they do spread 
by way of the blood. Because of this metastases are seen most 
frequently in the lymph nodes regional to the tumour but they 
occur sometimes in the lungs. Secondary growths are rarely found 
outside these two sites. 
1 . 2 THE AETIOLOGY OF SKIN CANCER IN MAN 
1. 2. 1 Ultraviol et Irradiation 
It has been suspected for many years that the ultraviolet 
component of sunlight has carcinogenic activity (Blum 1948; 1964). 
Evidence to support this proposition is derived from both 
epidemiological and experimental studies. Epidemiological 
observations have shown that there is a close correlation between 
the extent of exposure of skin to sunlight and the incidence of 
skin cancer. Studies have shown that the incidence of skin cancer 
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in outdoor workers is much higher than in people who work indoors 
(Upton 1973; Urbach 1975) and that the lesions occur most commonly 
on those parts of the body which are most exposed to sunlight. 
The areas most commonly affected are the skin of the face, 
particularly the ear, lip and nose, the backs of the hands and 
the back of the neck (Silverstone and Gordon 1966; Urbach 1975). 
The · relationship between the exposure to sunlight and the prevalence 
of skin cancer is also highlighted by the high incidence of these 
tumours in persons living in the tropics (Upton 1973; Scott and 
Starf 1977). The fact that blonde races with little skin 
pigmentation are more susceptible to skin cancer than dark-
skinned people also suggests that UV-light is a causative agent 
of the disease. The highly susceptible people are those who have 
fair complexionsand who sunburn easily, severely and often 
(Silverstone et a l ., 1963; Silverstone and Searle 1970). 
Furthermore, people suffering from xeroderma pigmentosum (XP), an 
inherited disease characterized by extreme sensitivity of the skin 
to sunlight, show a significantly higher incidence of skin cancer 
than the normal population (Robbins et al ., 1974; Burnet 1978; 
Setlow 1978). Skin cancer has been produced experimentally in 
laboratory animals by exposing them to UV-irradiation and this 
finding supports the causal r e lationship between UV-light and 
skin cancer (Blum 1959; Kripke 1974). 
1. 2. 2 Photo en i li zati on 
Photosensitization is another factor which has been 
implicated in the causation of skin cancer (Weisburger 1973). 
Cutaneous photosensitivity is a general term used in referring to 
the abnormal reaction of the skin to light. The adverse response 
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manifested by the skin is usually the result of the exposure to 
certain chemical ag€nts coupled with sunlight. This can occur if the 
photosensitizing agents are present either in the interstitial 
fluid of the skin or in the epidermal cells themselves. Thus the 
sensitizing agent can arrive in the skin following absorption into 
the blood or following topical application. Photosensitivity 
reactions are characterized by an abnormal sunburn reaction, 
oedema of the skin and an acute eczematous reaction. This may be 
accompanied by desquamation and the subsequent hyperpigmentation 
of heal d lesions . 
Many substances which occur in nature (plants and certain 
oils) hav·e a photosensitizing potential. Many other substances 
which have been prepared synthetically for clinical and commercial 
purposes can also cause photosensitivity reactions when the skin 
i s exposed to sunlight. These include certain chemical agents 
such as tranquillizers, antibiotics and antimicrobial agents that 
are incorporated into soaps and other cosmetic products. These 
agents or drugs are generally innocuous to the skin in the absence 
of exposure to light. However, if the skin is subjected to a 
sufficient concentration of the agent together with the appropriate 
wavelength of light, photosensitivity reactions occur and the cells 
may be damaged or killed. 
There are experimental studies as well as clinical 
observations which suggest that photosensitization may play a role 
in carcinoge11esis. Photosensitizing substances reiult in skin 
damage and damaged skin seems to predispose to skin cancer (Klein 
et al .~ 1973; Weisburger 1973). Thus most squamous cell carcinomata 
arise from skin that has been damaged by sun or from pr~-cancerous 
l esions ; they rarely appear in areas which are completely 
normal (Willis 1948; Belisario 1959; Klein et al.~ 1973). 
Experimentally, Bungeler (1937) observed an increased incidence 
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of epithelioma in the skin of mice treated with chemical 
carcinogens following photose nsitization with eosin and 
haematoporphyrin . Thus it seems that contact with photosensitizing 
substances may provoke lesions of the skin; such lesions may 
become cancerous when exposed to other carcinogenic agents. 
Consequently, photosensitizing substances may play a role in 
cancer development by acting as co-carcinogens. 
1.3 OVINE SQUAMOUS CELL CARCINOMA 
1 . 3. 1 Introduction 
Epithelial skin tumours are common neoplasms affecting 
domestic animals and have been described in a variety of animal 
species such as cattle (Drabble 1929; Anderson et al.~ 1956; 
French 1959), dogs (Nielsen and Cole 1960), goats (Ramadan 1975), 
horses (Fe ldman 192~) and shee p (Dodd 1923; Davis and Shorten 
1952 ; Carter 1958; Lloyd 1961; Vandegraaff 1976; Ladd and 
Entwistle 1977). In all these species , as in man, the tumours 
are common on those parts of the body which lack protective 
pigmentation and are exposed to the greatest intensity of 
sunlight (Dodd 1923; French 1959; Lloyd 1961; Ladd and Entwistle 
1977) . ~his epidemiological finding supports the view that solar 
irradiation is a causative factor in skin cancer in animals as 
well as in man. 
The details of squamous cell carcinomata in sheep have 
been reported by several investigators (Dodd 1923; Carter 1958; 
Lloyd 1961; Vandegraaff 1976; Ladd and Entwistle 1977). 
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Extensive studies on this tumour were done by Lloyd (1961) and 
by Ladd and Entwistle (1977) . Lloyd (1961) studied a flock of 
7840 Merino sheep in which an increase in the incidence of the 
tumours was observed following a period of drought conditions. 
The overall incidence of the tumours in the flock was 1 . 75% 
compared with the usual incidence of approximately 0.2% . Ladd 
and Entwistle (1977) studied the disease over a period of 4 years 
in a flock of 8000 Merino sheep maintained at a research station 
in Queensland . 
In the studies of both Lloyd (1961) and Ladd and Entwistle 
(1977) a number of parameters associated with malignancy were 
investigated . These are discussed below. 
1 . 3. 2 Age and Sex Incidence of Ovine Squamous Cell Carcinoma 
Both studies showed an increased incidence of tumours in 
older sheep . The maximum age of sheep in the flock studied by 
Lloyd (1961) was 6 years . In this age group , the incidence of 
the tumour was 3 . 26%. No tumours were observed in sheep between 
1-3 years old. The age of the sheep investigated by Ladd and 
Entwistle extended up to 12 years. In the 12 year old 
sheep , the incidence of tumours was as high as 12% . The increased 
incidence of ovine squamous cell carcinoma in the oldest age group 
studied was significant and this finding was similar to the increased 
incidence of tunours with age in man (Silverstone et al .) 1963; 
Silversto11e and Searle 1970: M6ller and M6ller 1975). 
Ladd and Entwistle (1977) suggested that ewes were more susceptible 
to the disease than wethers. However, the unequal distribution of 
sexes within the flock studied could have influenced the interpre-
tation of results obtained . 
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1. 3. 3 Site of Lesions 
A total of 69 and 146 tumours were observed by Lloyd (1961) 
and Ladd and Entwistle (1977) respectively . In both studies it 
was found that the most common site for tumours was the ear, 
followed by the muzzle, the lower lip , perineal region and finally, 
the eye . When tumours were present on the ears , they were mainly 
located on the outer aspect of the auricle and on the distal part 
(Lloyd , 1961). The sites of the lesions were consistent with the 
idea that sunlight is an important factor in the aetiology of the 
disease , since the outer aspect of the auricle and t he distal 
part of the ear would be more exposed to sunlight than the inner 
aspect of the auricle and the proximal part. Lloyd (1961) has y 
pointed out that the lower incidence of the tumours on the muzzle 
as compared to the ears may be due to the fact that on hot days 
sheep move around with their heads down, and this reduces the 
extent to which the skin of the muzzle is exposed to sunlight. 
Moreover, the wool on the fronto-parietal region and the wool 
covering the cheeks seems to provide protection for the eye from 
sunlight and this may explain the low incidence of tumours in 
that region (Lloyd 1961). 
The perineal region of sheep is not usually exposed to much 
direct sunlight and the incidence of tumours in this region is 
low . It is a management practice in some flocks to perform the 
Mule ' s operation to remove skin wrinkles from each side of the 
vulva and across the tail so as to produce a woolless perineum 
which is stretched free of skin folds . This operation is 
performed to reduce the incidence of blow-fly strike . The 
removal of medial perineal skin folds during the Mulels operation 
leads to lateral contraction of the skin and partial opening of 
the lips of the vulva during the healing process. This results 
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in an increased exposure of this region to sunlight and as a 
resul~ up to 3% of 3 year old ewes may have tumours of the vulval 
region (Vandegraaff 1976). 
1. 3. 4 Frequency of Metastases 
Th frequency of metastases of skin tumours in sheep is 
approximately 11-12% (Lloyd 1961 ; Ladd and Entwistle 1977). The 
secondary tumours occur mainly in the regional lymph nodes 
particularly in the parotid, retropharyngeal , mandibular and 
prescapular lymph nodes. A single case was described in which 
the secondary lesion was found in the lung (Lloyd 1961). 
Lloyd (1961) suggested that the actual frequency of 
metastases in sheep might be higher than 12% since two factors 
would reduce the number of secondary tumours observed, the 
early death of the affected animals due to infection or fly 
strike , and early removal of lesions by the stockowner. These 
two factors make it difficult to obtain an accurate figure for 
the incidence of secondary tumours in sheep with skin cancer. 
1. 3. 5 Aetiology 
The re are probably several factors which are responsible 
for the aetiology of ovine squamous cell carcinoma; however as in 
man, squamous cell carcinoma in sheep has been mainly attributed 
to the effect of solar UV-irradiation (Dodd 1923; Lloyd 1961; 
Ladd and Entwistle 1977) although other contributing factors 
have been implicated. 
Carne et al . (1963) suggested that penetration 
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of the skin by grass seeds was closely associated with the 
development of skin cancer in sheep. Dodd (1923), examined 47 
skin tumours in sheep and observed that such neoplasms were often 
preceded by a long period of chronic irritation and inflammation. 
He postulated that chronic irritation and inflammation associated 
with ear marks may play a part in the development of skin cancer. 
Similar findings were reported by Ladd and Entwistle (1977) who 
observed that 39% of the tumours on the ear were associated with 
punch holes or ear marks. 
The possibility of a co-carcinogenic agent involved in the 
aetiology of the disease has been suggested by a number of 
investigators (Carter 1958; Lloyd 1961; Vandegraaff 1976). The 
increased incidence of tumours observed by Lloyd (1961) was 
associated with an outbreak of photosensitization following 
ingestion of certain plants growing in the grazing area. Similar 
observations were reported by Carter (1958) who claimed that 
acute photosensitization with dermatitis was common in 
flocks with a high incidence of skin cancer. Photosensitization 
due to topical application of organo-phosphate chemicals for 
the treatment of cutaneous myiasis of the perineum has been 
implicated in the development of skin cancer in that region 
(Vandegraaff 1976). 
Virological studies carried out on cultivated tumour 
material have so far revealed no evidence of viral involvement 
in the disedse (Ladd and Entwistle 1977). 
1.4 BOVINE OCULAR SQUAMOUS CELL CARCINOMA 
Bovine ocular squamous cell carcinoma is an example of 
another malignant disease which has been attributed to the effect of 
UV-irradiation from the sun. This disease has been reported to 
occur in a variety of animal species ; morbidity is much higher 
in cattle than in other species, and the tumour is widely 
recognized as a particular disease prob l em in certain breeds of 
cattle (Russell et al._, 1956) . 
The age incidence of this tumour shows a similar trend to 
that of skin cancer. in sheep . The disease occurs 
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infrequently in cattle less than 5 years of age (Anderson et al._, 
1957; Russell et al ._, 1976); the incidence increases with age 
up to a peak at 8 years . The rate of metastasis of this tumour 
seems to be higher than that of ovine squamous cell carcinoma 
but it, too , spreads primarily by way of the lymphatic system 
(Russell et al._, 1956). 
Many factors have been proposed as causes for eye cancer 
in cattle , but solar ·radiation has been postulated as being 
most important in the causation of the disease. Guilbert et al. 
(1948) have suggested that sunburn of nonpigmented orbital skin 
results in the development of ulcers and benign tumours, and 
malignant transformation follows with continued irritation. 
This is supported by the finding that "cancer eye " is particularly 
prevalent in areas where solar radiation is high and in cattle 
that lack eye pigmentation (Anderson et al._, 1956; French 1959; 
Anderson and Skinner 1961). 
In addition to solar radiation , an influence of 
hereditary fdctors on the occurrence of ocular squamous carcinoma 
has been inferred by many investigators. Thus, although the 
disease has been reported to occur in many different breeds of 
cattle, it has been frequently stated that the Hereford breed is 
especially susceptible to ocular squamous carcinoma, (Frank 1943; 
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Woodward and Knapp 1950). 
The possibility of viral involvement in the aetiology of 
bovine ocular carcinoma has been argue d by some investigators 
(Nair and Sastry 1954; Russell e t al .~ 1956). Evidence to support 
this comes from studies by Taylor and Hanks (1969) who isolated 
infectious bovine rhinotracheitis virus (IBR) from eye cancer 
material. 
Other factors have also been suspected to contribute to the 
disease. These include irritation caused by sand, insects, 
chemicals,· thorny plants and photose nsi tization (Russe1J_ et al.~ 
1956) . 
1 . 5 MECHANISMS OF CARCINOGENESIS 
1. 5. 1 Introduction 
It is thought that the carcinogenic action of UV-light and 
of other physical and chemical agents is due to interactions which 
produce damage in the DNA of the target cells. It is well 
established that structural defects can be produced in DNA by 
UV-irradiation and this causes disruption of the continuity of 
the molecule. Other UV damage interferes with replication and 
transcription of DNA by causing changes in the hydrogen bonding. 
Single-strand breaks and cross-links between the DNA strands are 
induced by UV-light, but they occur only at high doses and their 
biological significance is questionable (Setlow et al.) 1968). 
Modification of the DNA bases which results in the formation of 
pyrimidine dimers is the most frequent lesion formed in DNA by 
UV-irradiation but again the significance of these alterations in 
carcinogenesis is not known. 
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1. 5. 2 Mechanisms of DNA Repair 
Although a vari ety of agents can produce lesions in DNA, 
living plant and animal cells possess mechanisms which enable DNA 
damage to be corrected so as to re-establish the integrity of the 
molecule . Most of the early work on the mechanisms of DNA repair 
following UV-induced damage has been done using the bacterium 
Eschericia coli (E . coli) . In these cells three mechanisms of DNA 
repair have been identified; ( 1) Photoenzymatic repair, in whi_ch 
the damaged part of the molecule can be restored to a functional 
state in situ . This is accomplished by an enzymatic mechanism 
(Sutherland 1975). (2) Excision repair, which is a multi-enzymatic 
process in which the damaged part is removed and replaced by the 
insertion of the correct sequence of nucleotides necessary to 
restore the normal function of the original molecule (Cerutti 
1974; Regan and Setlow 1974). (3) Post replication repair, in 
which the damage may remain in the DNA which is then repaired after 
r ep lication by a complicated process which involves recombination 
of the damaged daughter DNA with paternal strands and de novo DNA 
synthesis (Rupp et al .~ 1971; Lehmann 1974). 
1. 5. 3 Faulty DNA Repair and Carcinogenesis 
Although UV-induced damage to DNA can be repaired by a variety 
of mechanisms , cell mutations caused by UV-light, still occur. 
One possible explanation is that such mutations originale from 
errors in thP repair process itself. Recently Witkin (1976), has 
shown that at least in E. coli~ most of the repair procedures are 
free of error . Evidence however, has been provided for the existence 
of an enzyme system which seems to be involved in error-prone 
repair processes . The synthesis and operation of such an enzyme 
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system is normally suppressed in undamaged E. coli cells. However, 
when the bacterium is severely damaged by UV-light, the synthesis 
of the enzyme system is induced . This system seems to be involved 
in error-prone forms of repair which lead to the insertion of 
incorrect nucleotides into the damaged DNA strand and subsequently 
to mutation. Support for the above view linking error-prone DNA 
repair , mutagenesis and carcinogenesis has come from studies by 
Latarjet (1977) , who found that the induction of skin cancer in 
mice by UV-light is s trongly inhibited by caffeine (a specific 
inhibitor of error-prone repair process) . 
Other evidence for the role of unrepaired DNA damag~ in 
mutagenesis and possibly cancer induction is derived from the work 
of Cleaver (1968; 1969) on the pathogenesis of xeroderma 
pigmentosum. One important clinical finding in patients with 
xeroderma pigmentosum is the accelerated appearance of epithelial 
tumours of the skin at an early age . Such individuals have 
epithelial tumours about 10 3-10 4 times more frequently than are 
found in normal outdoor workers in tropical areas (Burnet 1978, 
Setlow 1978) . Studies on cultured cells from patients with 
x e roderma pigrnentosum have enabled these patients to be divided 
~nto groups which have differe nt deficiencies in their DNA repair 
mechanisms. Cleaver (1968,· 1969) reported that DNA repair in 
cultivated skin cells from xeroderma pigrnentosum patients was 
defective following exposure to UV-light when compared to normal 
cells. This finding was confirmed by other investigators and was 
attributed to a defect in the excision-repair process (Setlow 
et al . J 1969; Lehmann et al . J 1975). 
Xeroderma pigrnentosum patients have also been found who 
have normal e xcision repair processes'.Robbins et al . J 1974), but 
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the cells of these individuals have a slower rate of DNA synthesis 
compared to cells from normal individuals . In addition, the cells 
of these patients are defective in post-rep lication repair 
(Lehmann et al . ~ 1975, 1977) . It is now thought that such defects 
in the DNA repair processes in xeroderma pigmentosum patients are 
partially responsible for their clinical symptoms and for their 
high incidence of skin tumours . 
The evidence suggests that inJury to DNA is somehow related 
to carcinogenesis . Epstein et al . (1971) suggested that the 
production of skin cancer by UV-light is initiated by the repair 
of DNA which while allowing the cell to surv ive , favours subsequent 
errors in DNA replication which result in mutagenesis and 
subsequently carcinogenesis. Alternatively , it was proposed that 
UV-light induced damage leads to neoplasia by promoting transform-
ation by an oncogenic virus (Cleaver and Bootsma 1975). 
With regard to the role of photosensitizing chemicals in 
carcinogenesis , it is believed that these chemicals result in 
augmentation of the primary reactions that underlie the sunburn 
r esponse of the skin. A large amount of radiant energy is absorbed 
by the skin in the presence of the photosensitizing agents . This 
absorbed energy can cause cell damage directly or by creating 
covalent linkage between the sensitizing molecule and the 
pyrimidines in the cellular DNA. In addition, the photosensitizing 
molecules can transfer the absorbed energy and oronote the 
formation of free radicals which cause damage to the cell membrane 
(Fitzpatrick and Pathak 1977). It is possible that these agents 
act in conjunction with UV-light to cause skin damage. Since skin 
damage and scar formation is often associated with neoplasia, it 
may be that photosensitizing substances act as co-carcinogens by 
increasing the susceptibility of the affected areas to the 
harmful effects of UV-light . 
1 . 6 CLINICAL OBSERVATIONS AND EXPERIMENTAL EVIDENCE SUGGESTIVE OF 
A HOST IMMUNE RESPONSE AGAINST TUMOURS 
17 
One of the functions of the immune system is to recognize 
and respond to foreign materials introduced into the body and to 
develop resistance against that foreign material . In the last 
forty years , evidence has been accumulating suggesting that the 
immune system is involved in controlling tumour growth. Support 
for this view is based on both clinical observations and experimental 
evidence (Baldwin and Price 1976b). The clinical observations 
include the following: (1) The demonstration that many tumours are 
infiltrated by large numbers of inflammatory cells. The presence 
of cellular infiltrates within the tumour is sometimes associated 
with a better prognosis (Black et al . J 1971; Underwood 1974; 
Dipaola et al . J 1977). ( 2 ) The increased reactivity of the regional 
lymph node in some tumour systems, which again is often associated 
with a better prognosis (Black and Speer 1958 ; Tsakraklides et al.J 
1973 , 1974 ; Berlinger et al . J 1976). ( 3) Spontaneous remissions 
are sometimes seen in patients with melanoma, neuroblastoma and 
r e nal cell carcinoma which are suggestive of an involvement of 
immune mechanisms (Sumner ·and Foraker 1960; Smith and Stehlin 
1965; Everson and Cole 1966). (4) There is a well documented 
increase in the incidence of certain types of tumours in people 
with impaired immune reactivity, eg. in people with immuno-
deficiency diseases (Gatti and Good 1971; Waldmann et al .J 1972; 
Penn 1974), in patients undergoing immunosuppressive therapy (Penn 
and Starzl 1972; Penn 1975), and in aged people (Cairns 1975a, 
1975b ; Teasdale et al .~ 1979). 
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Experimental evidence supporting the view that immune 
mechanisms are involved in controlling tumour growth~ was first 
offered by Gross (1943) , when he described the existence of tumour 
specific antigens . The demonstration of s u ch antigens was crucial 
to sustain the concept of immune reactivity to tumours. 
1 .7 TUMOUR ANTIGENS 
The existence of specific antigens on tumour cells induced 
by chemical , physical and viral agents has been established by the 
u se of several different methods . The term tumour antigen has 
been u sed to describe two different classes of molecules · 
(Alexander 1976a); those which are present on the tumour cells and 
can elicit an immunological reaction in the host, and those which 
are associated with the tumour and can be found on normal cells, 
and arc o nly immunoge nic in s p e ci e s othe r than the host. Based 
on their immunogenicity the antigens can define two distinct types 
of tumours; potentially immunogenic and weakly immunogenic tumours. 
1. 7. 1 Pot entially Immunogeni c Tumours 
This category include s : (1) tumours with unique tumour 
specific transplantation antigens (TSTA) arising from chemical 
induction; and (2) tumours which express antigens induced by 
either DNA or RNA oncogenic viruses. These tumours with few 
exceptions , express TSTA that can cause rejection when syngeneic 
animals are immunized with a potentially lethal dose of tumour 
cells. 
19 
A striking characteristic of the TSTA of chemically 
induced tumours of various histologic types , is the existence of 
individually distinct TSTA. Thus immunization with other 
tumours induced by the same chemical is usually ineffective in 
offering protection against subsequent challenge with the first 
tumour (Old et al . ~ 196 2; Klein 1966; Baldwin 1973) . In contrast 
to the diversity of TSTA expressed on chemically induced tumours, 
tumour cells induced by DNA and RNA oncogenic viruses possess 
antigens that cross- react with other tumours induced by the same 
virus . This group specific cross-reactivity extends across the 
species and the histologic type of neoplasms and strongly suggests 
viral induction or coding of TSTA (Habe l 1961, 1962). Most of 
these neoplasms do not contain the replicating virus particles, 
and once the tumour is established , it does not depend upon virus 
proliferation for its continued growth. 
It has been proposed that unique TSTA of chemically induced 
tumours are anomalously expressed H-2 or minor histocompatibility 
antigens. This was based on the finding that mice immunized with 
allbgeneic tissue are sometimes protected against chemically induced 
syngeneic tumours (Invernizzi and Parmiani 1975). Anomalous 
reactions of H-2 antisera with chemically induced tumours have been 
also observed (Garrido et al.~ 1976) . Finally, it has been reported 
that unique TSTA of rat hepatomata resemble the major histocompatibility 
complex (MHC)antigens in molecular weight and amino acid composition 
(Bowen and Baldwin 1975). 
1. 7. 2 Weakly Immunogeni c Tumours 
Thi s category includes tumours with 2 classes of tumour 
associate d antigens; oncofoetal antigens which are normally 
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expressed only by foetal tissue, and differentiation antigens which 
are normally expressed by certain differentiated adult cells. 
Oncofoetal antigens can be found on tumour cell membranes or they 
may represent tumour products secreted into the serum of tumour-
bearing animals . Oncofoetal antigens are expressed by a wide 
range of tumour cells including those induced by chemicals and 
viruses (Baldwin et al. ~ 1974; Evans 1976) . The expression of a 
foetal product by tumours was first demonstrated by Abelev et al . 
(1963) , who showed that chemically induced rat h epatomata synthesize 
a-foetoprotein which is present in the serum of new-born mice but 
not of normal adults. Alpha-foetoproteins were subsequently 
identi·fied in the serum of patients with hepatomat a (Abelev 1971) 
and in those with germ cell tumours such as ovarian and testicular 
teratocarcinomas (Smith and O ' Neill 1971; Abelev 1974). Alpha-
foetoproteins are poorly irnrnunogenic and only a low degree of 
protection has been obtained by immunization with foetal tissues 
(Baldwin et al.~ 1974). 
Another foetal product which was found to be associated with 
malignancy is termed carcinoembryonic antigen (CEA). Carcino-
embryonic antigen was first described by Gold and Freedman 
(1965a , 1965b) as a substance that was present in adenocarcinomata 
of the human digestive tract and in the digestive organs of foetuses 
up to 6 months old , but not in normal adult tissues. These 
investigators suggested that these antigens represent cellular 
constituents which are r epress e d during the course of differentiation 
of the normal digestive system epithelium and reappear in the 
corresponding malignant cell by a process of dedifferentiation. 
It was originally thought that both CEA and a-foetoprotein 
were specific for gastrointestinal and hepatic cell tumours 
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respectively. However, it was subsequently found that elevated 
levels of these tumour-associated products can be detected in other 
malignancies as well as in non-malignant diseases (Abelev 1974; 
Terry et al ., 1974). Accordingly, it is unlikely that the presence 
of these tumour products will be of great value in cancer diagnosis. 
However, monitoring the levels of a-foetoprotein and CEA in patients 
with hepatoma and colon carcinoma may be of clinical value since any 
variation in their concentrations is likely to reflect changes in the 
behaviour of the tumour . 
Another group of tumour-associated antigens include ~ those 
antigens expressed only by certain normal differentiated adult 
cells , and tumour cells. The best example is the thymus leukaemia 
(TL) antigen of mice . TL antigen is structurally and functionally 
homologous to the H-2 antigens (Anundi et al., 1975). In addition, 
tumours of lymphoid origin can express anomalously certain other 
normal cell-surface antigens. Some tumours were found to express 
antigens characteristic of both Band T cells, such as surface 
immunoglobulin and Thy-1 antigen (Schwartz et al. , 1977). 
1.8 THE NATURE OF THE HOST RESPONSE 
The discovery of the existence of tumour specific antigens 
led to a search for the effector mechanisms involved in the immune 
response to tumours. A wide variety of in vitro assays were 
developed to detect both humoral and cellular immune responsiveness 
directed against tumours. These will be briefly discussed here 
together with their relevance to the bioloqy of the tumour. 
Immune responses to tumours may be antibody-mediated or cellular. 
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1. 8 . 1 Humoral Respon es 
It has been generally held that anti-tumour antibodies play 
little or no role in controlling neoplastic growth. This 
proposition has been based on findings from both experimental and 
human tumour systems . Attempts to transfer passive protection 
against tumours with immune anti-tumour sera have been unsuccessful 
(M~ller 1964; Baldwin and Barker ·1967). Cytotoxic anti-tumour 
antibodies have been detected in some human tumours at an early 
stage of tumour growth and have been eluted from tumour cells of 
various histologic types in vivo (Irie et al . , 1974 ; Gupta and 
Morton 1975). These antibodies apparently have no protective 
effect for the host and consequently their role in controlling 
neoplastic growth has been discounted . 
There are studies, however, that have indicated that 
antibodies may have a role in controlling tumour growth. In a 
murine l e ukaemia system , Old and Boyse (1964) found that the 
injection of immune sera inhibited tumour growth. Immune sera 
were also found to be effective in the treatment of tumours 
induced by Moloney virus (Fefer 1969; 1970). Moreover, in studies 
with induced primary sarcomata in rats, Alexander and co-workers 
(1970) found that the removal of antibodies from animals carrying 
subcutane ous implants increased the formation of metastases , while 
the passive transfer of these antibodies provided good protection 
against an intravenous injection of the tumour cells. 
In some human tumour systems, a positive correlation between 
the presence of anti-tumour antibodies and the clinical course 
of the disease has been well documented. Malignant melanoma has 
attracted considerable interest because of reported instances of 
spontaneous regression (Sumner and Foraker 1960 ; Smith and Stehlin 
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1965) which suggests that immunological control may be involved. 
Studies with malignant melanoma have shown a clear correlation 
between the appearance of antibodies and the clinical course of 
the disease. Lewis et al. ( 1969) - found that anti-melanoma 
antibodies were only detected in patients in which the disease 
was restricted and these antibodies disappeared when the disease 
became disseminated . One interpretation of this finding is that 
antibodies may be responsible fGr controlling the potential of 
tumours to metastasize . Once metastasis occurs, antibodies may 
become absorbed by circulating antigens and consequently are no 
longer detectable . 
Recent studies have indicated that anti-tumour antibodies 
may be involved in protection against cancer , through an antibody-
dependent cellular cytotoxic mechanism (ADCC) . This is a 
cytotoxic reaction mediated by non-immune e·ffector cells in the 
presence of specific antibody (MacLennan 1972 ; Perlmann et al., 
1972) . Some aspects of this reaction have been characterized . 
The relevant antibodies were found to be of the IgG class, 
although IgM has also been shown to mediate ADCC in some situations 
(Lamon et al., 1975). The exact nature of the cell involved is 
less clearly defined. It has been established, however, that the 
effector cell is not a T-lymphocyte (van Boxel et al. , 1972) and 
that it carries the Fe receptor for the immunoglobulin IgG 
(van Boxel et al., 1973). The cytotoxic reaction is not complement 
dependent (van Boxel et a l . . , 1974) and does not involve phagocytosis 
(Greenberg et al.) 1973b). Cells from a variety of sources have 
been shown to be capable of mediating ADCC . These include adherent 
cells (Dennert and Lennox , 1973), and null cells (Greenberg et al., 
1 73a) 
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Indirect evidence which is accumulating both from 
experimental animal models and clinical studies of human cancer 
suggests that ADCC may be an important defence mechanism &n V&VO 
against cancer . The Moloney sarcoma virus system (MSV) has been 
studied most extensively in vivo with regard to ADCC. MSV induces 
tumours which frequently undergo regression (Fefer et al.) 1967). 
Although immune T-cells are generally believed to be responsible 
for mediating the destruction of MSV-induced tumours , cells which 
are not T-cells have also been shown to be able to inhibit tumour 
growth in vitro , especially when obtained from animals in which 
the tumour has regressed (Lamon et al . ) 1973, 1974) . Moreover, 
it has been reported that sera from animals which have previously 
carried a tumour are capable of transferring immunity to MSV 
induced tumours. In general , sera collected from mice in which 
tumours have regressed , were most effective (Pearson et al.) 
1973) . 
It was subsequently shown that sera, collected from mice 
in which tumours had regressed, were able to mediate ADCC 
&n vitro) whereas sera taken from mice in which tumours were 
progressing had no detectable ADCC activity (Harada et al.) 1975). 
This correlation between the amount of tumour present and the 
level of ADCC has been demonstrated in other virus-induced 
tumours. Prather and Lausch (1976) found that with tumours caused 
by PARA-adenovirus in hamsters, ADCC activity was detected in the 
first week after tumour isografting but was no longer detectable 
at three weeks . Following surgical removal of the tumour, ADCC 
levels increased to a maximum at two weeks and persisted at a 
significant level for a month. Similar findings were obtained in 
the Gross lymphoma system in rats, where the appearance of ADCC 
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was closely associated with regression of the tumour (de Landazuri 
et al . ., 1974). 
Due to the extreme sensitivity of the ADCC assay in detecting 
low levels of antibodies (Moller and Svehag 1972; Kiessling and 
Klein 1973) , it has been used extensively in human tumour systems. 
Data obtained so far have indicated that ADCC may be of prognostic 
value. Pearson et al. (1978) and Chan et al. (1979) found a 
correlation between ·ADCC titres to Epstein-Barr'virus (EBV) 
membrane antigens and the rate of survival in patients with' 
nasopharyngeal carcinoma . Patients with high ADCC titres at 
diagnosis survived significantly longer following therapy than 
those with low ADCC titres. Similar findings were obtained in 
patients with Burkitt ' s lymphoma (Granlund et al . ., 1979; Pearson 
et al . ., 1979). Patients with high ADCC titres showed partial or 
complete regression of lymphoma when treated by chemotherapy, while 
the lymphoma grew progressively in those with low titres. Other 
investigators have demonstrated a correlation between ADCC titres 
and the stage of the disease. Faldt and Ankerst (1979) in their 
studies of patients with acute myelogenous leukaemia detected low 
leve ls of ADCC in all patients tested. They found that ADCC 
levels increased after therapy and were highest during clinical 
r emission. 
Although ADCC has been used extensively in detecting tumour 
antigens in a variety of experimental and human tumour systems , 
the validity of this assay in detecting tumour-specific antigens 
is questionable. Studies by different groups of investigators 
have shown that most of the cytotoxicity detected when lymphoid 
cells from cancer patients were cultivated with various tumour 
cell lines was related to ADCC (Pape et al . ., 1977a). However, a 
26 
similar type of cytotoxicity was obtained when lymphocytes from 
healthy donors were cultivated with these tumour cell lines 
(Takasugi et al .~ 1973; Pape et al .~ 1977b). More studies by the 
same research group provided evidence for the existence of 
antibodies capable of mediating ADCC in the serum of both cancer 
patients (disease related antibodies) and healthy controls 
(natural antibodies) (Troye et al . J 1980a, 1980b). Mccredie 
and MacDonald (1980 ) found that ADCC activity was the same in 
healthy individuals as it was in those with benign diseases. It 
was decreased in patients with advanced cancer but also in patients 
with septicaemia 
1. 8. 2 Ce llular Res ponses 
Th e re is a substantial body of evidence which shows that 
lymphoid cells from turnour-bea_ring animals or from cancer patients 
are toxic for tumour cells i n vi t ro . Furthermore, adoptive 
transfer experiments in which various cell populations have been 
shown to offer protection against subsequent challenge with 
specific tumours suggest that the cellular response to a tumour 
is important in controlling its growth. Techniques which identify 
cells according to their surface markers and functional properties 
have implicated a variety of cells of lymphoreticular origin in 
tumour destruction. 
(a ) Th ymu - der ived Lymphocytes (T- ::el ls) 
The role of T-cells in controlling tumour growth has been 
determine d mainly from studie s with virally and chemically induced 
tumours. In tumours induced by Moloney sarcoma virus (MSV) , 
alterations in T-cell reactivities were detected early after 
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infection with the virus, when the tumour was developed and again 
at the time it was regressing (Lamon et al . J 1973). Similarly, 
Leclerc et al . (1973) and Plata and Levy (1974) demonstrated 
T-cell-mediated cytotoxicity against MSV induced tumours. 
Cytotoxicity could be detected early after virus infection; 
cytotoxic activity r eached a peak around tbe time when the tumour had 
begun to regress . In contrast, cytotoxic activity disappeared 
within a few days in younger mice which were unable to reject 
their tumours . The killing of tumour cells by T- lymphocytes has 
also been implicated in plasmacytoma and in EL- 4 leukaemia in the 
mouse (Rouse et al . J 1972 , Wagner and Rollinghoff 1973). Rouse 
et al . (1972) have demonstrated in vivo that cells capable of 
transferring immunity to syngeneic murine plasma cell tumours 
were sensitive to treatment by anti-8 serum and complement. 
In man the role of T-cells in controlling neoplastic growth 
is conjectural. Only a few reports have indicated that the 
cytotoxicity detected against tumour cells in vitro was mediated 
by T-cells. Such reports include observations on melanoma 
(Wybran et al . J 1974), lung cancer (Vose et al.J 1978) and 
bladder carcinoma (Troye et al.J 1980a). However , in some of 
these studies , there was only suggestive evidence that the 
reaction is mediated by T-cells and consequently tumour cell 
death being mediated by natural killer cells (NK) remains a 
possibility. 
Another assay which has been used extensively in studies 
of cellular responses to antigens on transformed human cells is 
the blastogenesis assay. The responsiveness of lymphocytes to 
tumour antigens detected using this assay, has been shown to be 
mediated by T-cells, at least in the mouse system. Positive 
responses were obtained with lymphocytes exposed to Burkitt's 
lymphoma (Stjernsward et al .~ 1970) human leukaemia (Gutterman 
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et al .~ 1972) and other lymphoblastoid cell lines (Svedmyr et al.~ 
1974) . In solid human tumours the significance of the blasto-
genesis assay has been more difficult to assess. Low positive 
responses were obtained with melanoma cells (Nagel et al.~ 1971), 
sarcoma cells (Vanky et al .~ 1971) , cells from breast tumours 
(Stjernsward et al. ~ 1973) and from other cancers (Vanky et al .~ 
1975). The difficulty in demonstrating blastogenic responses with 
solid tumour cells may be a function of the stage of the disease 
at which the test is done. It has been shown by Lamon and co-
workers (1973: 1974), that different cell populations are involved 
in the host ' s response to tumour cells during different stages of 
the disease. Alternatively, the· difficulty in demonstrating 
blastogenesis may be related to the nature of the antigen on the 
tumour cells. 
(b) Macrophage Responses 
Evidence from experimental tumour models has identified 
macrophages as important anti-tumour effector cells . Macrophages 
have been shown to inhibit the growth of tumour cells and also to 
kill th min vitro by a non-phagocytic mechanism that requires 
contact between the macrophages and the tumour cells. Two types 
of effector macrophages have been described , the non-specifically 
"activated" macrophages and the specifically "armed" macrophages. 
The "activated " macrophages were described by Hibbs et al. (1972) 
as a non-specific cytotoxic cell from animals infected with 
parasitic organisms. A number of microbes and microbial products 
have been shown to activate macrophages and although the 
cytotoxicity exhibited by these cells is non-specific in an 
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immunological sense, it is nevertheless selective. Thus 
cytotoxicity is most readily detected against transformed cells, 
but not against normal cel~s (Hibbs 1973; Kaplan et al., 1974; 
Meltzer e t al . , 1975; Mantovani et al .~ 1979). The armed 
macrophages are cells that can participate in immunologically 
specific reactions by acting in co-operation with immune 
lymphocytes (Evans and Alexander 1970). Macrophages can be armed 
by contact with either immune lymphoid cells or with cell-free 
supernatant from cultures of immune T-cells incubated with antigen 
(Evans and Alexander 1972a and b). Macrophages so armed acquire 
the ability to kill the specific target. The difference between 
"activated " and "armed " macrophages li es in the method by which 
they are generated and the specificity of the cytotoxic reaction 
(Krahenbuhl and Remington 1974). The two terms are not mutually 
exclusive , however, since "armed " macrophages, following specific 
interaction with antigen become activated and kill in both a 
specific as well as non-specific way. 
Based on results derived from experimental tumour models, 
it has been suggested that macrophages may play a role not only 
in the regulation of tumour growth but also in controlling its 
metastatic spread (Evans 1972; Zarling and Teveth-ia 1973). A 
clear correlation has been demonstrated between the content of 
macrophages in the primary tumour, the immunogenicity of the tumour 
and its metastatic potential (Eccles and Alexander 1974). In 
these studies with a chemically-induced fibrosarcoma in rats, 
Eccles and Alexander (1974) found that tumours with a high content 
of macrophages were highly immunogenic ·and showed little tendency 
to metastasize. Similarly Wood and Gillespie (1975) found that 
when macrophages were depleted from tumour inocula, this resulted 
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in an incre a se in the me tastatic potential of these tumours and 
the recipie nt animals had lowe r rates of survival. In addition 
the administration of activated macrophages has been reported to 
prolong the survival of mice inoculated with tumour (van Loveren 
and den Otter 1974). 
The me chanism(s) by which "armed" or "activated" macrop hage s 
inhibit tumour growth and kill tumour _cells is not clear. 
Although Granger and Weiser (1966) demonstrated large amounts 
of irnrnunoglobulins on the surface of cytotoxic macrophages 
this finding provide s no conclusive evidence for the involvement 
of cytophilic antibodies in the cytotoxic process since inhibition 
of tumour growth was found to be unaffected by anti-Ig antiserum 
(Evans and Alexander 1972c) . Recently, Currie (1978) reported 
that activated macrophages exe rt their effect on tumour growth 
through the release of arginase which cleaves the essential 
amino acid arginine . 
Macrophages appear therefore to play an important part in 
the body ' s defence against n e oplastic growth . The fact that 
"activate d" macrophages have selective toxicity against transformed 
c e lls in vitro sugge sts that they may be important in providing 
an early surve illance me chanism which p r e cedes or parallels immune 
r e cognition (Hibbs 1974; Alexander 197 6b) . 
( c ) Nalu11al Killer Cell Responoes ( NK ) 
Natural kille r c e ll s are lymp hoid ce lls which are 
spontane ously c y totoxic in vitro to a wide variety of cultivate d 
tumour c e ll lines . As th e y occur naturally in animals which have 
not b ee n p r e vious ly se n s itized and b ecause the y have the ability 
to kill trans forme d c e lls s e l ective ly, it has b e en postulated that 
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these cells act &n V&VO as a mechanism of surveillance against 
potentially neoplastic cells (Haller et aZ .J 1977; Kiessling and 
Wigzell 1979). Evidence to support this proposition comes mainly 
from observations in mice. A positive correlation has been 
observed between NK cell activity in vitro and tumour resistance 
in vivo (Zarling et aZ . J 1975; Minato et aZ .J 1979); eg.mouse 
strains with a high incidence of leukaemia have been found to 
express little or no NK activity. Also , mice genetically 
deficient in NK activity tBeige mice -), have poor resistance to the 
growth of small doses of a variant of B16 melanoma, and large 
numbers of metastases form following the inoculation of tumour 
cells (Talmadge et aZ .J 1980). Furthermore , mice which have low 
levels of NK cells can be made resistant to tumours by the transfer 
of bone-marrow cells from strains that have high levels of NK 
cells (Haller et aZ . J 1977) . 
Several extraneous agents including bacterial adjuvants 
(Wolfe et aZ . J 1976) and viruses (Welsh and Zinkernagel 1977) 
produce increased NK activity in V&VO and at the same time this 
increases resistance to the growth of transplantable tumours. 
Since several of these agents are also known to induce the 
production of Interferon , the possibility has been raised that 
Interferon may be the mediator or regulator by which NK a~tivity 
is expressed and this leads, in turn, to an increased resistance 
to tumours . Support for this idea rests on results of experiments 
in mice which showed that, after the injection of substances 
which induce the production of Interferon, similar kinetics were 
demonstrated for the appearance of both NK cells and Interferon. 
Also the injection of mice with anti-Interferon globulin inhibited 
the increase in NK activity in vi o that usually follows the 
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injection of Tilorone (an inducer of Interferon). The injection 
of mouse Interferon preparations has also been shown to cause an 
increase in NK activity in vivo (Gidlund et al.~ 1978). 
Interferon not only regulates the activity of lymphoid 
cells but it is also produced by these cells . Trinchieri et al . 
(1977) have shown that incubation of human lymphocytes with 
various established cell lines, resulted in the production of 
Interferon, and this , in turn, produced a concomitant increase 
in NK activity . These findings were confirmed by Saksela et al. 
(1979) who showed furthermore, that any increase in the production 
of NK cells can be prevented by treatment with sheep anti-
Interferon antiserum. 
The mechanism by which Interferon acts to produce an 
increase in NK activity is not clear . Experiments using both 
human and mouse cells suggest that it may act by inducing pre-NK 
cells to differentiate into mature killer cells. Timonen et al. 
(1979a, 1979b) u sed an absorption-elution procedure to isolate 
and identify human NK cells from a population of lymphoid cells. 
They found that NK cytotoxic activity in the adherent fraction 
could not be augmented either by Interferon or by incubating 
these cells with the appropriate tumour cell line. However, NK 
cell activity could be increased in the other non-adherent cell 
fraction by adding Interferon to it. These findings were similar 
to those described in the rat by Oehler and Herberman (1978) who 
were abl to e liminate mature NK cells by various procedures 
and to show also that inducers of I nterferon production were able 
to restore NK activity in the remaining cell population in a few 
hours. These investigators suggested that Interferon is able to 
transform a non-cytotoxic pre NK-cell population to a cytotoxic 
one . 
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Despite the fact that there has been an extensive effort 
to characterize NK cells , their precise nature remains uncertain. 
Evidence from mice indicates that these cells arise de nova in 
the bone marrow (Haller and Wigzell 1977) , tnat they develop 
independent of thymic influence (Herberman et aZ . 3 l975a) and 
that they lack the characteristics of mature macrophages , B-cells 
or T-cells (Herberman et al . 3 1975b) . Most r eports agree that 
the majority of NK cells possess Fe receptor (Herberman et aZ. 3 
1977 ; Kay et al . ~ 1977) . 
1 . 9 MECHANISMS OF TUMOUR ESCAPE 
Despite the existence of all these anti-tumour mechanisms 
detected by various in vitro and in vivo assays , tumours often 
grow and kill their hosts . The efficacy of the cellular immune 
response in vivo may be diminished by the presence of humoral 
factors which interfere with existing host immuni t y and 
consequently provide the tumour with an escape route from host 
immunological control . This concept was originally developed by 
the Hellstroms (1974) to explain their finding that sera from 
animals with a growing tumour can prevent immune lymphocytes 
from killing tumour cells with the same TSTA. A strong correlation 
was found between the presence of blocking factors in the serum 
of patients and the clinical course of the disease . Patients 
who had progressive disease mor e frequently had blocking factors 
in their sera than did patients who were tumour free at the 
time of testing . 
The ability of sera from tumour-bearing patients to block cell 
mediated cytotoxicity to tumours was attributed originally to 
34 
blocking antibodies. It was thought that these antibodies enhance 
tumour growth by coating the antigenic sites on the tumour cells, 
thus protecting them from attack by immune lymphoid cells . Later 
findings by Sjogren et al . (1971; 1972) however , suggested that 
the blocking effect was due to antigen-antibody complexes , rather 
than antibody alone . These complexes can vary in their ratio of 
antigen to antibody and may have either antibody excess (Baldwin 
et al .~ 1972) or antigen excess (Thomson et al .~ 1973). 
A different type of interference to the cytotoxic activity 
of lymphoid cells , termed "inhibition ", has also been described . 
This type of blocking is due to circulating tumour antigens, 
which can interact with antigen~specific receptors on immune 
·1ymphocytes and render the cells non-cytotoxic. Baldwin and co-
workers found that the blocking effect of tumour extracts on 
cell-mediated cytotoxicity in vitro occurs when the extracts 
were added either to the effector cells prior to the assay and 
then removed or when the extracts were left with the effector 
and target cells for the duration of the assay .(Baldwin and Price 
1976a) . Currie and Basham (1972) reported that lymphocyte-bound, 
~ 
tumour-associated antigens were detected in cancer patients. 
When these antigens were eluted from the surface of lymphocytes, 
the cytotoxicity of these cells against the tumour cells was 
augment d. 
The host-tumour interaction is complicated further by the 
discovery of scrum factors that can neutralize the effect of 
blocking factors. Hellstrom r l al . (1971) found that sera from 
patients free of disease rarely had any blocking activity. 
Moreover , when these sera were mixed with sera that manifested 
blocking activity the blockins effect was no longer detected . 
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Such sera were termed "unblocking" sera. Similar findings on this 
unblocking effect of sera have been demonstrated in other tumour 
systems (Robins and Baldwin 1974; Prather and Lausch 1977) . 
Although the blocking theory provides an explanation of how 
established tumours can escape destruction by the immune system, 
it is inadequate to explain why the host ' s immune system fails 
to destroy a nascent tumour. A number of possible mechanisms 
have been advanced to account for the "early " escape of tumours. 
Old and Boyse (1964) proposed that a nascent tumour may not 
initially stimulate the immune response (sneaking through) and by 
the time sufficient tumour is present to cause stimulation of the 
host ' s immune system , the established tumour may grow at a rate 
beyond host control. The concept of immunological enhancement 
provides an alternative hypothesis to explain why the immune 
system fails to destroy tumours, (Kaliss 1962). According to this 
concept, low levels of circulating antibodies,which are specific 
for the tumour , enhance tumour growth by binding to the antigenic 
sites on the tumour cell and thus preventing attack by immune 
cells. Finally , it has been proposed by Prehn (1971; 1977) that 
the immune system may play a dual role in the control of tumours. A 
weak immune response against tumour-specific antigens will 
stimulate tumour growth whereas a strong immune response could 
lead to tumour rejection . According to this proposal, nascent 
tumours stimulate a weak response which results in enhancing 
their growth. 
It is apparent from the previous discussion on the 
involvement of the immune response in defence against cancer 
that the tumour-host relationship is extremely complex. A wide 
range of lymphoid cells and their products are involved in the 
1 . 10 
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body ' s reaction to tumours and each population of cells may mediate 
its anti-tumour effect through a different mechanism . The relative 
importance of each cell type in any host- tumour interaction is 
greatly influenced by the nature of the antigen on the tumour 
cell , the clinical behaviour of the tumour (Miller and Heppner 
1979) , its mode of interaction with the host ' s immune system 
and finally the stage of tumour growth and differentiation . 
SCOPE OF THE THESIS 
The experiments described in this thesis were designed to 
elucidate certain aspects of the immunobio logy of an ovine 
squamous cell carcinoma. The approach taken was to exa mine 
certain characteristics of the tumour cell populations as well 
as the host's response to its own tumour . 
Methods were first established for the successful 
cultivation of pure populations of epithelial tumour cells &n 
vitro . These cells were then examined by both light and electron 
microscopy and their morphological characteristics described. 
The growth rates of the various cultivated tumour cell lines 
were measured in vitro , and the ability of these cultivated 
tumour cells to form tumours in immunosuppressed hosts was 
examined. Furth r characterization of the tumour cells was done 
by examining their interaction with allogeneic lymphocytes both 
&n vitro and &n V&VO and the capacity of the tumour cell lines 
to stimulate and suppress an allogeneic response was investigated. 
Finally , studies were done to examine the immune response 
of a tumour-bearing sheep to autochthonous tumour cells using a 
cannulated isolated lymph node technique . This was done while 
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the primary tumour r e maine d in situ and following resection of 
the tumour. A comparison between the immune response of the 
regional and a distant lymph node to challenge with autochthonous 
tumour cells was also carried out and the responses in these two 
sites compared . 
CHAPTER 2 
MATERIALS AND METHODS 
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2 . 1 EXPERIMENTAL ANIMALS AND SURGICAL PROCEDURES 
2. 1 . 1 Experimental Animals 
Merino sheep were used for all the allogeneic experiments. 
Tumour-bearing sheep , either Merino or Merino-Border Leicester 
cross , were collected from private properties in the district of 
Goondiwindi, Queensland. All sheep were kept indoors or in small 
paddocks for most of the time . They were transferred to 
metabolism cages a few days before the operation. This was done 
to accustom the sheep to the conditions in which the subsequent 
experiment would take place. While in metabolism cages, the 
sheep were fed lucerne chaff and grainoats and given water 
ad libitum. Sheep were deprived of food and water 24 hours 
before s urgery. 
The nude mice which were used were either BALB/c or 
CBA/H-BALB/c Fl (regular). Mice were bred and maintained in a 
pathogen-free environment in the John Curtin School of Medical 
Research Animal Breeding Establishment (ABE) . 
2. 1 . 2 Anaesthesia 
For induction of anaesthes ia in sheep,thiopentone sodium 
(Intraval Sodium) was injected intravenously at a dose of 
15 - 25mg/kg of body weight for normal sheep. For tumour-bearing 
sheep thi s dose was decreased to 10-18mg/kg of body weight 
because they were often in poor health. After the induction 
of anaesthesia> a Magill's tube was inserted into the trachea 
and inflated. The sheep was then transferred to the operating 
table and connected to a Boyle's closed circuit anaesthetic 
apparatus. Anaesthesia was maintained during the operation with 
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Halothane (Fluothane, ICI Ltd) and oxygen . 
2 . 1 . .3 Cannulation of lymphatic vesse_ls 
(a) Cannulation of the afferent lymphatic of the popliteal lymph 
node 
The afferent lymphatics draining to the popliteal lymph node 
are disposed on the anterior and posterior aspects of the 
saphenous vein . There are usually 3 or 4 lymphatics in the 
fascia close to the vein on each side . An incision was made in 
the skin over the vein just below the hock and the edges of the 
incision retracted . The fascia was separated from the vein on 
each side and the afferent lymphatics identified. A loose 
thread was passed around the fascia embracing all the lymphatics. 
The thread was tied loosely and the leg massaged to cause the 
lymphatics to swell. The largest and most appropriate lymphatic 
was sele cted and cleane d of adherent connective tissue for about 
1 cm. The cannulation site was chosen about 2 cm below the 
occluding tie . A fine thre ad was passed around the lymphatic 
and tied to allow tension to be applied to the lymphatic and 
stretch it . A second fine tie was passed provisionally around 
the lymphatic and left loose. The lymphatic was cut with fine 
scissors and a bevelled p lastic tube passed into the lymphatic 
and carried forward to the embracing tie. This tie was then 
loose ned and the tube passed further along the duct towards 
the node . When the best position for the tube was established 
it was tied into the duct and secured by one or two stay 
sutures. The wound was dusted with penicillin and the skin 
incision closed with silk sutures. 
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(b ) Cannulati on of t he e ffer ent l ymphatic of the poplitea l l ymph 
node 
The efferent lymph duct from the popliteal node was 
approached through a skin incision that extended for about 8-10 cm 
vertically 4 cm below the sciatic tuber. The incision was carried 
through the intermuscular sheaths of the biceps and semimembranosus 
muscles. These two muscles were retracted and the posterior 
femoral blood vessels ligated and severed. The fascia around the 
femoral v e in was examined and the popliteal lymphatic identified 
and tied off. The lymphatic was cleaned of adherent connective 
tissue along a length of about 3 cm and an occluding tie passed 
around the duct cranially. The ligated duct soon became swollen 
and a further non-occluding tie of fine silk was passed around it. 
Tension was applied to the duct with the cranial tie and the duct 
opened up with fine scissors. A plastic tube of the appropriate 
diameter was passed into the duct against the direction of lymph 
flow and adjusted to lie along the direction of the duct. Care 
was taken to ensure that the tip of the cannula was clear of any 
valves in the duct and that the iymph flow was unobstructed. The 
tubing was led out through a stab wound in the skin below the 
sciatic tube r and a silk purse-string suture inserted around the 
tubing where it emerged through the skin. 
(c) Cannulation of the afferent and e f fe r ent lymphati cs of t he 
cervical lymph nodes and the r egional node s associated wi t h 
t umours . 
Tumours located on the ears and on the face and nose drain 
to regional nodes such as the parotid , the cranial cervical and 
the s ub-mandibular node s. Th e a pprop riate nodes were identified 
by the injection of a solution of T-1824 into the tumour and the 
draining lymphatics and the r eg ional lymp h node ide ntified. The 
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appropriate affe r e nt and e ff e rent lymphatics were cleaned and cann-
ulated by the techniques d e scribed for the popliteal lymphatics. 
The deep cervical lymph duct was cannulated in some sheep. 
This is a large lymphatic that runs in the fascial sheath 
incorporating the sympathetic nerve trunk and the carotid artery. 
This duct was cannulated against the direction of lymph flow . 
Lymp h was collected into plastic bottles which were attached 
to plastic bottle holders suture d to the skin of the sheep at a 
site adjacent to where the tubing was led out of the skin. 
2. 1 . 4 Lymphadenectomy 
Lymph node s were removed by surgical excision . Popliteal 
nodes and cervical nodes which had received injections of 
cultivate d tumour cells or which may have retained metastatic 
tumour cells were located and removed for fixation and histological 
study . In some case s the nodes were macerated to obtain cells. 
2 . 2 PHYSIOLOGICAL SOLUTIONS, BUFFERS, FIXATIVES AND OTHER SOLuTIONS_ 
2. 2. 1 Phy siological Solutions 
NaCl soluti on (Normal sali ne ) 
One litre of this solution containe d 9.0 g of NaCl. The 
solution was ster ilized by autocl~ving for 20 min. 
Hanks ' balanced alt solution (HESS ) 
A litre of this s olutio n contained 8.0 g NaCl, 0.84 g KCl, 
0.1 g MgS0 4.7H 20, 0 .1 g MgC l 2 .6 H20, 0.14 g CaCl2, 0 . 06 g 
Na 2HP0 4 , 0. 06 g KH 2P04 , 1. 0 g glucos e , 20 mg phenol red. 'The 
solution was sterilize d by autoclaving at 112°c for 20 min. Th e 
p H was ad jus t d t o 7.4 with 5 .0~ NaHC0 3 solution. 
Bovine serum albwnin (BSA ) 1%) 
This solution was prepared by dissolving 1.0 g of bovine 
serum albumin (BSA) in 100 ml of Hanks' solution . The pH was 
adjusted to 7.4 with 5% NaHCO 3 solution . 
Dulbecco 's modified Eagle medium (H-16) 
10 g of the powdered medium (Cat. H-16, Grand Island 
Biological Company, Grand Island, N.Y ., USA) was dissolved in 
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926 ml of double distilled water and 74 ml of 5% NaHCO3 was added 
to the solution . The pH of the solution was adjusted to 7.4 using 
CO 2 and the solution was sterilized by membrane filtration 
(Millipore filter , . 22 µmembrane). Two ml of antibiotics 
(penicillin 100 u/ml, streptomycin 100 µg/ml, neomycin 100 µg/ml, 
PSN) was added to the medium which was then transferred to 150 ml 
0 bottles and stored at 4 C. 
2. 2. 2 Buffer Solutions 
Hepes buffer (1 . 0MJ pH r . 4 ) 
Stock solution (1 M) of this buffer was prepared by 
dissolving 23.8 g of Hepes (Sigma Chemical Company, USA) in 
80 ml of distilled water . The pH was adjusted to 7.4 with 
6N NaOH and the solution was made up to 100 ml. The solution 
was sterilized by autoclaving at 121°c for 20 min. One ml of 
this solution was added to 100 ml of H-16 medium before use. 
A etate buf er ( . 05M rH 5. 0) 
Glacial acetic acid (2.9 ml) was diluted in 800 ml of 
water . The pH was adjusted to 5.0 using 6 M NaOH, and the 
solution was made up to one litre . 
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Pho phate buffered saline (PBS) 
A 10-times concentrated solution was prepared by dissolving 
34.5 g NaH 2PO 4 • 2H20 and 81.8 g NaCl in about 800 ml of water. 
The pH was adjusted to 7.5 with 6M NaOH and t he solution made up 
to one litre . The solution was diluted 10- times before use . 
2. 2. 3 Fixatives 
Buffered formaldehyde solution (4%) 
This solution was prepared by dissolv ing 40 g of para-
formaldehyde in one litre of PBS by boiling. The solution was 
then cooled to room temperature and the pH adjusted to 7 . 5 with 
PBS stock solution . 
Ethyl - ether (1:1) 
This solution was prepared by mixing equal volumes of 95% 
ethyl alcohol and ether . Slides to be stained with Papanicolaou 
stain for keratin (Thompson and Hunt 1966) were fixed for 30 min 
in this so lution b e fore staining. 
2. 2. 4 Stains 
Peroxida e staining solution 
This solution was prepared by dissolving 4 mg of 3-amino-9-
ethyl carbazole in 1 ml of dimet hyl f ormamide. Acetate buffer, 
19 ml , l - 05M , pH 5 . 0) was added to the above solution . Just 
before u se , 3-4 drops of 3% H2O2 were added to the above mixture . 
Leishman ' taining solution (0 . 15%) 
This solution was prepared by dissolving 0 . 15 g of the 
powder in 100 ml of absolute methanol . The solution was filter ed 
and stored at room t empe rature . For staining slides with 
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cytoce ntrifuge preparations of e ff e r e nt lymphocytes, 1 ml of this 
solution wa s adde d to each slide and left for 3 min. Two ml of 
distilled water were added to each slide and left for 10 min. 
Slides we re then rinsed with tap water and left to dry. 
Trypan blue (0 . 5% ) 
The solution was prepared by dissolving 0.5 g of the powder 
in 100 ml of PBS. The solution was filtered and stored at room 
temperatures. Before use the solution was diluted 4 times in PBS. 
The final concentration of the dye was 0.125% . 
2. 2. 5 Other Solutions 
Ficoll-isopaque 
Ficoll solution (8 %) was prepare d by dissolving 8 g of 
ficoll (Ficoll 400, Pharmacia, Fine Chemicals AB, Uppsala, Sweden) 
· in 80 ml of distilled water before making it up to 100 ml. Sodium 
me trizoate , (30 ml of 32.8% W/V) was added to 70 ml of 8% ficoll 
solution. The solution was protected from light with foil 
0 
wrapping and sterilized by autoclaving at 121 C for 20 min. The 
specific gravity of the final solution was 1 . 077 g/ml. 
Heparin solution 
This solution was p r epar e d by dissolving the contents of a 
vial of powdered h eparin (100,000 units) in 66.6 ml of 0.9% NaCl. 
This gave a final concentration of 1500 units/ml. The solution 
was sterilized hy membrane filtration (Millip ore filter, .45µ 
membrane) and was used at a final concentration of 30 units/ml of 
blood . 
Tryp ~n diluent (0 . 5%) 
One litre of this solution contained 8 g NaCl, 4 g KCL, 
3.75 g Na2HP0 4 . 2H 20 , 3 g KHP0 4 • The solution was sterilized by 
autoclaving at 121°c for 20 min . 
Trypsin solution (10%) 
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One litre of this solution contained 8 g NaCl, 0 .4 g KCl, 
0 . 78 g Na 2HP0 4 .2H 20, 0.06 g KH 2P0 4 , 50 g glucose, 100 g trypsin 
(Trypsin 1 : 250 DIFCO Laboratories, Detroit , Michigan, USA). The 
solution was centrifuged at 27 , 578 g for 60 min. The supernatant 
was collected , sterilized _by membrane filtration , dispersed into 
5 ml vials and stored frozen . 
Trypsin solution (0 . 5%) 
This solution was prepared by diluting 5 ml of 10% trypsin 
stock solution with 95 ml of trypsin diluent. The pH was adjusted 
to 7 . 4 with 5% NaHC03. The solution was sterilized by membrane 
filtration and was transferred to 5 ml vials and stored frozen 
until used . The solution was used at a final concentration of 
0 . 25% . 
Versene (EDTA ~ 0 . 2%) 
The solution was prepared by dissolving 0.2g of EDTA 
(Ethylene diarnine tetra-acetic acid disodium salt, AJAX Ch~micals , 
Sydney , Australia) in 100 ml of trypsin diluent. The pH was 
adjusted to 7 . 2 with 5% NaHC0 3 . The solution was sterilized by 
autoclaving at 121°c for 20 min and was stored at 4°c. The 
solution was used at a final concentration of 0 . 1% . 
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2.3 TUMOUR CELL LINES 
2.3. 1 Maintenance 
All established tumour cell lines were maintained in tissue 
culture flasks of either 25 cm2 or 75 cm2 growth area (Falcon 
plastics, Div., Be cton Dickinson and Co . Oxnard, California, USA). 
Tumour c e lls were fed with Dulbecco's modified Eagle medium (H-16, 
Gibco) supplemented with 10 % V/V heat-inactivated foetal calf serum 
(FCS , Gibco, USA) containing PSN _antibiotics (medium containing FCS 
and PSN will be referred to as "complete medium"). Cultures were 
0 
gassed u s ing 10% CO 2 in air and were incubated at 37 C. When the 
cells became confluent, they were subcultured. 
2. 3. 2 Subculture 
Cell monolayers were washed twice with trypsin diluent. 
This procedure removed all the foetal calf serum which inhibits 
trypsin activity. Two ml of trypsin-versene solution (final 
concentrations 0.25% and 0.1% respectively) were added to small 
25 cm2 flasks or 4 ml to large 75 cm 2 flasks. Tissue culture 
flasks were then incubated at 37°c for 10 min after which the 
trypsin was removed and the flasks tappe d to detach the cells 
mechanically. Cells were r esuspended in complete medium, washed 
twice by centrifugation at 300 g for 1 0 min and resuspended in 
complete medium . The viable cells were counted in a haemocytometer 
using Trypan blue and the cell number was adjusted to the required 
conce ntration (10 5 viabl e cells/ml). Five or 15 ml of the cell 
suspension were transferred to 25 cm2 and 75 cm2 tissue culture 
flasks respectively. 
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2. 3.3 Cryopr eservation 
(a) Freezing 
Tumour cells were harvested from tissue culture flasks using 
trypsin-versene solution as described in the previous section. 
Cells were washed twice in complete medium, counted using trypan 
blue and resuspended at a concentration of 2 x 10 6 viable cells/ml 
in H-16 + 30% FCS and kept on ice . An equal v olume of cold H-16 + 
30% FCS + 20% DMSO (Dimethylsulfoxide) wa~ added to the cell 
suspension , and one ml portions of cell suspension were transferred 
into 3 ml glass vials which were placed on dry ice for 30 min. The 
vials were transferred to the nitrogen freezer. The final composit-
ion of the freezing medium was 60% H-16, 30% FCS and 10% DMSO . 
(b) Thawing 
To thaw the cells , the frozen vials were .removed from the 
nitrogen freezer and immersed immediately in a 37°c water bath. 
Just before the cells were comp letely thawed , vials were transferred 
from the water bath and placed on ice for 2 min. The cell 
suspension in the vials was diluted very slowly by the drop-wise 
addition of 1-2 drops of cold H-16 + 30 % FCS every 10 seconds, 
until a volume of 3 ml was reached. Cells were then transferred 
into cold 15 ml centrifuge tubes and one ml of H-16 + 30% FCS was 
added to the suspension which was left on ice for an additional 
5 min. This procedure was repeated until a final volume of 10 ml 
was r eached and at this stage the cells were left on ice for 
15 min . Cel ls we re washed twice in H-16 + 30 % FCS by centrifugation 
at 120 g for 10 min. They were then counted, resuspe nded in comple te 
medium at a concentration of 10 5 viable cells/ml and transferred 
into 25 cm 2 flasks at a cell density of 5 x 10 5 cells/flask. 
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2.4 LYMPHOCYTE PREPARATIONS 
2.4.1 Separation of Peripheral Blood Leucocyt es 
Peripheral blood leu cocytcs were separated from whole blood 
according to the method originally described by Boyum (1976) with 
some modifications. Blood was collected from the jugular vein of 
sheep using a 60 ml syringe fitted with an 18-gauge needle . and 
containing heparin for a concentration of 30 units/ml blood. Blood 
samples were transferred into large 45 ml tubes and were centrifuged 
at 1000 g for 15-20 min at 4°c. The buffy coat formed by this 
centrifugation was collected with a Pasteur pipette and diluted in 
twice its volume with Hanks' solution containing EDTA (final 
concentration of EDTA in Hanks' was .075%) . Seven ml of the diluted 
buffy coat was then layered on 3 ml of ficoll-isopaque solution. 
The tubes were then centrifuged at 600 g for 40 min. The interface 
layer containing mononuclear cells was aspirated with a Pasteur 
pipette and diluted in Hanks1/EDTA solution. Cells were washed 
twice in Hanks1/EDTA by centrifugation at 200 g for 10 min each. 
This was followed by two furth e r washes in Hanks ' solution. After 
the final washing the cells were resuspended in complete medium, 
counted using Trypan blue and the cell number adjusted to the 
required concentration. 
2. 4. 2 Separation of lymph node lymphocytes 
Cell suspensions from lymph nodes were prepared according to 
the method of Lafferty et al . (1974) with some modifications. 
Cervical and popliteal lymph nodes were removed aseptically and 
placed in HBSS containing PSN. Lymph nodes were trimmed of fat, 
cut into several pieces and passed through a 400 stainless steel 
49 
mesh into fresh HBSS. The cell suspension was transferred into a 
centrifuge tube and allowed to settle for 2 min to remove debris 
and cell clumps . The supernatant , consisting of a suspension of 
single cells, was then transferred to another tube and centrifuged 
at 300 g for 10 min. The cell pellet was washed twice in HBSS. 
After the final washing , the cells were resuspended in complete 
medium , counted and the cell number was adjusted to the required 
concentration . 
2 . 5 IRRADIATION OF STIMULATOR CELLS 
Tumour cells were harvested from tissue culture flasks, 
washed twice and resuspended at a concentration of l x 10
6
/ml in 
complete medium. l eukocytes, either efferent lymph cells or 
cells separated from peripheral blood, were washed 3 times and 
resuspended at a concentration of l x 10 7 cells/ml in complete 
medium . Cells were irradiated using a cobalt ( 60 co) source 
(CSIRO , Division of Plant Industry) at a dose of 1200 rads for 
lymphocytes and 7000 rads for tumour cells. 
2 . 6 IN VITRO ASSAYS FOR CELL-MEDIATED IMMUNITY 
2. 6. 1 The Mixed Lymphocyte Culture 
The mixed lymphocyte cultures and the lymphocyte tumour 
cell cultures were set up in sterile disposable plastic tissue 
culture trays using cell concentrations as mentioned in individual 
experiments . For experiments in which only 3H-thymidine uptake 
was to be determined, equal volumes (0 . 1 ml) of the stimulator 
(either tumour cells or lymphocytes) and the responder cell 
suspensio~s were mixed in 6 mm diameter wells in 96 well trays 
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(Linbro Model FB-96-TC Multidish Disposo-trays, Linbro Chemical 
Company, New Haven , Conn ., USA). For experiments in which both 
3H-thymidine uptake and cytotoxic cell generation were to be 
assayed, equal volumes (1.0 ml) of the stimulator and responder cell 
suspensions were mixed in 16 mm diameter wells in 24 well trays 
(Linbro Model FB-16-TC Multidish Disposo-trays, Linbro Chemical Co., 
USA). The control for the mixed lymphocyte culture consisted of 
cultivating together equal concentrations (5 x 10 6 /ml) of responding 
lymphocytes and y-irradiated responding lymphocytes. As a control 
for the lymphocyte-tumour cell interaction, both lymphocytes and 
y-irradiated tumour cells were cultivated separately at the 
appropriate concentration and the uptake of thymidine in these 
cultures was determined. Stimulation was considered to have 
occurred when the mean value for thymidine uptake in cultures 
containing tumour cells in the presence of lymphocytes plus two 
standard errors was higher than the sum of the values for 
thyrnidine uptake obtained from the cultures in which each cell type 
was cultured alone. All cells prepared for the mixed lymphocyte 
cultures were suspended in the compl e te medium containing 10 mM 
-4 Hepes andl0 M2-mercaptoethanol (2ME). All assays were performed 
in triplicate ·wells. Trays were placed in airtight boxes, gassed 
with humidified 10% CO2 , 7% 02 and 83% N2 and maintained at 37°c 
for the required period of time. 
(a) 3 H- t hymidine uptake 
3 H-thyrnidine uptake was assayed at various time intervals 
after the cultures were initiated, in 96 well trays. For cultures 
set up in 24 well trays, 0.2 ml portions were transferred into 
wells of 96 well trays. 3H-thymidine (Methyl 3H-thymidine, S.A. 
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S µCi/mmol, The Radiochemical Centre, Arnersham , U.K.) was diluted 
SO µCi/ml in Hanks' solution and 25 -µl of this solution was added 
to each well . Trays were then returned to gas boxes and incubated 
at 37°c for 5 hr. Following incubation the contents of individual 
wells were harvested onto glass filter strips (Cat. No. 934-AH, 
Reeve Angel , Clifton , New Jersey, USA ) with a Multiple Automated 
Sample Harvester (MASH-II, Microbiological Associates, Bethesda, 
Md., 1 USA ) . Filter strips were dried and discs bearing the 
samples were cut out and placed in scintillation vials containing 
0.5% W/V PPO (2,5-diphenyloxazole, KOCH-Light Laboratories Ltd., 
Colnbrook, Bucks ., England) in toluene. Samples were counted in a 
Packard Liquid Scintillation Spectrometer for one minute each. 
3H-thymidine uptake was expressed as the mean number of counts per 
minute in triplicate sample± the standard error (cpm ±SE) . 
2. 6. 2 The Cytotoxic Assay 
Tumour cell lines to be used in the cytotoxic assay were 
harvested from tissue culture flasks into disposable centrifuge 
tubes . The cells were washed twice in complete medium by 
centrifugation at 300 g for 10 min. After the final washing, 
0 .1 ml portions were removed and the cells counted using Trypan 
blue to indicate the viable cells. Cells were resuspended at a 
concentration of 2 . 5 x 10 6 viable cells/ml in complete medium; 
51 51 200 µCi/ml of Cr (Na Cr04 specific activity 194 mCi/mg, 
Australian Alomic Energy Commission, Commercial Product Unit, 
N. S . W., Australia) was added to the cell suspension. Tubes were 
gassed with 10% CO2, 7% 02, 83% N2, sealed and incubated at 37°c 
for 1 hr . Cells were then washed 3 times by centrifugation at 
120 g for 10 min in complete medium, counted and resuspended at a 
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concentration of 10 5 viable cells/ml in complete medium. 
The cell populations assayed for cytotoxicity consisted 
either of cells pooled from the mixed lymphocyte cultures (set up 
in 24 well Linbro plastic tissue culture trays) or of cells 
collected directly from the efferent lymph of sheep immunized with 
the tumour . In both cases , the cell populations which were used 
were washed twice, counted and resuspended in complete medium at 
the required concentrations described in individual experiments. 
One tenth of a ml of each lymphocyte dilution was added to 4 wells 
of rounded bottom 96 well trays (Cat . No. 76-011- 05 , Linbro, USA ) 
containing 0 . 1 ml target cell suspension . The culture tray was 
d 
. d . o gasse using 10% CO2, 7% 02 an 83% N2 , and incubated at 37 C for 
4 or 24 hr. Spontaneous 51 Cr release was determined . by adding 
0 . 1 ml of complete medium to 4 wells containing 0 . 1 ml of target 
cell suspension. The maximum amount of 
51 Cr that could be 
released was determined by adding 0.1 ml of target cell suspension 
to centrifuge tubes containing 0.9 ml of distilled water. Tubes 
0 
containing the cells lysed by water were incubated at 37 C for 
4 hr. At the end of this incubation period, the tubes were 
subjected to 3 cycles of freezing and thawing after which they 
were centrifuged at 400 g for 10 min. Portions (0.5 ml) of the 
supernatant of the water lysis controls and 0.1 ml of all other 
samples were transferred into small tubes and counted in a Packard 
Gamma Scintillation Spectrometer for one minute each. The 
percentage cytotoxicity of the samples was derived from the formula: 
T - C 
% cytotoxicity = X 100 
M - C 
where Tis 51 cr released in the test sample, C is the spontaneous 
51 1 d d . h . 51 d Cr re ase an Mist e maximum Cr release . 
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2.7 ANTIBODY ASSAYS 
2. ?. 1 Labelling f or Immunoglobulins 
All the anti-serum reagents used in this assay were a gift 
from Dr H.R . P. Miller of the Department of Immunology. The 
antisera were prepared according to the method described by Nawa 
et al. (1978). 
Imrnunoglobulins on sheep lymphocytes were detected according 
to the method described by Stanislawski et al. (1976) . This 
method is known to stain both intracellular and surface 1mrnuno-
globulins• In this method lymphocytes were first reacted with 
rabbit anti-sheep irnmunoglobulin followed by a reaction with goat 
anti-rabbit irnmunoglobulin labelled with horseradish peroxidase. 
Cytocentrifuge smears of sheep efferent lymphocytes were prepared 
in Hanks ' solution containing 1 % bovine serum albumin . Slides were 
allowed to dry for 15 min at room temperature , after which they 
were fixed with 4% paraformaldehyde solution for 15 min. They 
we re then wash ed in 3 changes of PBS for 10 min each and then placed 
in a moist chambe r . Smears were covered with rabbit anti-sheep 
imrnunoglobulin (50 ~g/ml) and l e ft undi s turbed in the humid chamber 
for 3 hr at room tempe rature. The slides were then rinsed 3 times 
for 5 min each in PBS and the n returned to the moist chamber. The 
sme ars we re covere d with 50 ~ l of goat anti-rabbit irnmunoglobulin 
labelled with horseradish peroxidase and were left for 45 min at 
room t emperatur e . Th e excess imrnunoglobulin was rinsed off with 
3 change s for 5 min each in PBS. After the final wash, smears 
we re stained for 10 min with 3-arnino-9-ethylcarbazole/hydrogen 
peroxide r eagent (Graham et al .~ 1965), rinsed with distilled 
water and dried . Slides were examined wet using light microscopy 
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and the number of irnmunoglobulin-bearing cells were counted 
in each smear . 
2. 7.2 Binding Assay 
(a) The radioiodination of proteins 
All the reagents used for the radioiodination of proteins 
were precooled , and the entire reaction was performed on ice in 
low absorption 4 ml plastic tubes. 25 µl of Na 125 I (Sodium Iodide, 
S.A . 16.6 mCj/µg. The Radiochemical Centre, Arnersharn, U.K.) was 
mixed with 40 µl of rabbit anti-sheep IgG (.25 mg/ml) and 50 µl 
of Chloramine -T (4 mg/ml, diluted 1/500, British Drug House 
Laboratory Reagents, Ltd., England) was added, mixed immediately 
and the reagents were left to react for 60 min. At the end of 
this period, 50 µl of sodium metabisulphate (6.5 mg/ml, diluted 
1/1000, AJAX Chemicals, Sydney, Australia ) was added and mixed. 
This was followed by the addition of 50 µl of 0.1 M KI and the 
r e age nts were left on ice for 5 min, after which 0.8 ml of PBS 
containing 1 % bovine serum albumin (BSA) was added. The contents 
of the small tube were transfe rred to a small dialysis bag, the 
tube was rinsed with PBS+ 1 % BSA and the rinsings transferred to 
the dialysis bag giving a final volume of 1.25 ml. The bag was 
dialysed in 3 changes of 60 ml of PBS containing 0.1% sodium 
azide , for 1 2 hr e ach. The sample was then diluted with 3.75 ml 
of PBS+ 1% BS~ making the final volume of the solution 5 ml and 
the final concentration of the IgG,2 µg /ml. The protein solution 
0 
was stored at 4 C. 
(b) Quantitation of binding antibodies 
A 2 fold serial dilution of a lymph sample in Hanks' solution 
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containing 1% bovine serum albumin was prepared before the assay 
was set up . The assay was performed in 96 well microtitre plates 
(Microtitre , Mic-2000, Cooke Laboratory Products, Alexandria, 
Virginia , USA ) as follows: 50 Wl of the serial dilutions of the 
lymph was dispensed in each well (6 wells for each lymph dilution) 
and 100 Wl of the tumour cell suspension in Hanks ' + 1% BSA (10
4 
cells) was added to these wells , mixed gently and incubated on ice 
for 75 min . At the end of this period , 50 µl of Hanks+ 1% BSA 
was added to each well , mixed and centrifuged at 120 g for 7 min 
0 
at 5 C. The wells were emptied by inverting them once into the 
sink . The cells were resuspe nded without adding medium and 150 Wl 
of Hanks ' + 1 % BSA was added to the cell r es idue, mixed and centrifuged 
0 
at 120 g for 7 min at 5 C. This washing process was repeated 
twice after which 100 Wl of 125 I-labelled rabbit anti-sheep IgG 
was adde d to the cell residue , mixed and left on ice for 75 min. 
The plates were centrifuged at 120 g for 7 min and the supernatant 
was removed with a Pasteur pipette . The cells were resuspended 
and washe d 3 time s as d e scribe d above . After the final washing the 
supernatants from the individual wells were removed, the bases of 
the p late were cut and placed into small tubes and counted in a 
Packard Gamma Scintillation Spe ctrometer for one min each . Controls 
in the experiment consisted of a row of cells incubated with 
labelled antiserum and a row of c e lls incubated in the presence of 
both normal serum and labe lled antiserum. For specificity control, 
anothe r tumour cell line was included in the assay . 
2.? . 3 Cytotoxic Assay 
For the d etermination of compleme nt-dependent cytotoxic 
antibodies , all lymph and serum samples were heat inactivated at 
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56°c for 45 min. Five fold serial dilutions of each sample 
were prepared using complete medium. Tumour cells to be used in 
the assay were harvested from tissue culture flasks and labelled 
with Na 51 cro 4 as described in Section 2.6.2. The assay was 
performed in 96 well Linbro tissue culture plates (Linbro, USA 
as follows; 50 ~l of the complete medium was dispensed into each 
of the wells, and was followed by the addition of 100 ~l of the 
labelled tumour cell suspension (10 5 /ml). A 25 µl volume of the 
serial dilution of each of the lymph or serum samples was added 
to 4 wells, followed by the addition of 25 µl of undiluted rabbit 
complement. The plates were placed in air-tight boxes, gassed with 
10% CO2, 7% 02 and 83% N2 and incubated at 37°c for 4 hr . 
Spontaneous and maximum 51 Cr releaseweredetermined as described 
previously in Section 2.6.2. As a control for the non-specific 
cytotoxic effect of rabbit complement, 25 µl of rabbit complement 
was added to 4 wells containing a target cell suspension plus 
complete medium. At the end of the incubation period, 0.05 ml 
portions of the supernatants from the water lysis controls and 
0 .1 ml of all other samples were transferred to small tubes and 
counted in a Packard Gamma Scintillation Spectrometer for one 
minute each . The percentage cytotoxicity of the samples were 
determined from the formula : 
' T - c 
% cytotoxicity = X 100 
' M - c 
where Tis the 51 cr released in the test samples, c is the 
spontaneous 51 cr release in the presence of complement and Mis 
the maximum 51 Cr release. 
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2.8 IN VIVO CHALLENGE 
2. 8. 1 Explants 
Tumour tissue, to be transferred to recipients was 
washed 4 times in Hanks' solution containing antibiotics (PSN, 
4 times the normal concentration) and cut into fragments measuring 
approximately 5 x 5 mm. The tumour pieces were implanted by 
making an incision in the skin with a scalpel, a subcutaneous 
pouch was then formed, into which the tumour fragment was placed. 
Antibiotics were added to the wound before the skin was closed 
using a suture or autoclips. Care was taken during the implantation 
procedure to avoid any contamination of the wound . 
2. 8. 2 Single ce ll suspens&ons 
Tumour cells to be used for challenge were harvested from 
tissue culture flasks as described earlier and washed 3 times in 
medium without serum. Before the final washing 0 . 1 ml portions 
of cell suspensions were removed for counting in Trypan blue and 
the cells were resuspended at a concentration of 10 7 viable cells/ 
0 . 5 ml of medium without serum. 
Before challenge , 0 . 2 ml of normal saline was infused into 
the afferent lymphatic cannula followed by the infusion of 0 . 1 ml 
of 0.5% Tl824 blue dye. The promptappearance of the dye in 
the efferent lymph indicated that the lymphatic circuit was intact. 
Following the appearance of the dye in the efferent lymph, cells 
were infused slowly into the node followed by an infusion of 
0 . 5 ml of saline to ensure that all the cells were delivered to 
the node. 
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2 . 9 ELECTRON MICROSCOPY 
2. 9.1 Reagent 
Cacodylate buf f er (0 . 2M) 
4.28 g of Na cacodylate.3H 20 (British Drug Houses, LR , U. K.) 
was dissolved in 10 ml of distilled water. The pH of the solution 
was adjuste d to 7.2-7 . 4 with O.lN HCl. The solution was made up 
to 100 ml with double distill ed water. 
Co l lidi ne buffer solution (0. 2M) 
This solution was prepared by adding 2.67 ml of 2,4,6 -
Trimethylpyridine (2 , 4 , 6-collidine, British Drug Houses,LR, U.K.) 
to 30 ml of double distilled water . The pH was adj~sted to 7.4 
with approximately 9 ml of lN HCl. The solution was made up to 
100 ml using double distilled water. 
Gl utara ldehyde i n cacody l ate bu ffer (4% ) 
This solution was prep ared by mixing 10 ml of 10% glutaral-
d e hyde solution (Ladd Re search Industries , Burlington, Vermont, 
U.S . A.) with 15 ml of 0 . 2M Na cacodylate . The pH of the solution 
was adjusted to 7.2-7.4 with O.lN NaOH. 
0 miwn- collidine f ixative 
Thi s solution was p r epare d by mixing 2 parts of 2.0 % 
aque ous solution of Os0 4 (osmium tetroxide, Johnson Matthey 
Chemicals , Lo ndo n) wi th one p art of 2 ,4, 6-collidine buffe r. One 
drop of 1.0% s olution of Ca Cl 2 wa s adde d to each 10 ml of the 
fixative . 
Epon 812 re in 
Th e resin was p r epared by mi x ing 2 solutions A & B (1:2). 
Mi xture A c onta ine d 62 ml of Epon 812 (Ladd Re s e arch Indus trie s, 
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Burlington, Vermont, U.S.A.) and 100 ml of the hardener DDSA 
(Dodecenyl Succinic Anhydride, Ladd Research Industries, USA, ) . 
Mixture B contained 100 ml of Epon 812 (Ladd Research Industries, 
USA ) and 89 ml of NMA (Nadic Methyl Anhydride, Ladd Research 
Industries, U.S . A.). 
Epon and accelerator 
This solution was prepared by thoroughly mixing one part 
of Mixture A with 2 parts of Mixture B for 5 min. Then 0.15 ml 
of accelerator 964 (Fluka Komponente C, Buchs , Switzerland) was 
added to each 10 ml of the above mixture. The mixture was stirred 
for 10 min and then left for 30 min to allow any air bubbles to 
escape before using the mixture for embedding. 
2. 9. 2 Processing of Cells 
Cultured cells were harvested with trypsin solution. Cells 
were washed twice in HBSS after which they were · fixed in a pellet 
form for 4-6 hr at room temperature in 4% cacodylate buffered 
glutaraldehyde. The cell pellet was rinsed several times in O.lM 
Na cacodylate buffer and stored overnight in the refrigerator. 
The cell pellet was postfixed in osmium-collidine for 2 hr at 4°c. 
This was followed by dehydration in graded concentrations of 2 
changes of alcohol for 15-20 min each . The pellet was then 
dehydrated in 2 changes of acetone dried with CaCl2 for 20 min 
each . The cells were infiltrated with propylene oxide - Epon 812 
resin (1:1 mixture) for 60 min. This was followed by infiltration 
with propylene oxide Epon 812 resin (1:2 mixture) and the samples 
incubated overnight. Cells were further infiltrated with Epon 
and accelerator for 4-6 hr at room temperature and then embedded 
in fresh Epon 812 + accelerator and incubated at 60°c for 2-3 
2 . 10 
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days to harden . Thin sections were cut from the embedded material 
using a diamond knife and an LKB microtome . The sections were 
stained with uranyl acetate and Millonig ' s lead stain (Millonig 
1961) and examined with a Philips EMU electronmicroscope. 
CELL COUNTS 
The concentration of cells in suspensions was determined 
by one or both of the following methods. 
2. 10 . 1 Trypan Blue Exclusion 
The Trypan blue dye exclusion test was u sed to determine 
viable cell concentrations in all experiments which inv olved 
setting up cultures of either tumour cells or lymphocytes . 
0 . 1 ml of cell suspension was mixed with 0 .1 ml of 0 . 125% Trypan 
blue in PBS , and counted in a haemocytometer to determine the 
total cell count and the percentage of viable cells. A minimum of 
100 cells 'was counted. 
2. 10.2 Coulter Counter 
This method of cell counting was used for monitoring the 
response in the efferent lymph collected from stimulated nodes. 
0 . 1 ml of the cell suspension was diluted in 20 ml of PBS and 
counted using an electronic cell counter (Coulter Model B) with 
the lower threshold set to exclude red blood cells. Total white 
cell counts or Jarge cell counts could be obtained by altering 
the threshold. 
Differential cell counts were done on Leishman stained 
cytocentrifuge smears prepared from efferent lymph from stimulated 
nodes . 
2 . 11 
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HISTOLOGY 
Tissues were removed and fixed immediately in 4% formaldehyde 
at room temperature for a few days . Tissues were dehydrated, 
embedded in paraffin and cut into 7µm sections. Tissue sections 
were stained with Mayer's haematoxylin and eosin. 
CHAPTER 3 
THE ESTABLISHMENT AND CHARACTERIZATION OF THE 
TUMOUR CELL LINES IN VITRO AND IN THE NUDE MOUSE 
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3.1 INTRODUCTION 
The technique of growing neoplastic cells in short-term or 
established cultures has opened up many new opportunities for 
studying the neoplastic process. Comparisons can be made between 
neoplastic cells and their normal counterparts both morphologically 
and biochemically. From an immunological viewpoint neoplastic 
cells can be examined for the presence of antigens not found on 
normal cells. Moreover the cultivated cells may be used in vitro 
as antigens to enable the cellular and hurnoral immune reactivities 
of patients from which the tumour cells were derived to be 
measured. 
Similarly,there is an increasing interest in studying the 
growth of human tumours in immunologically defective animals. 
Human tumours were first grown in immunologically privileged sites 
such as the anterior chamber of the eye (Greene 1952), the brain 
(Gr eene 1951) and the hamster cheek pouch (Lemon et al ., 1952). 
However>because of the difficulties of using these sites for 
transplantation studies, attempts were made to grow human tumours 
in normal animals which had been irnmunosuppressed by irradiation 
(Toolan 1951), by cortisone treatment or by both methods (Toolan 
1954). More recently, thymectomy (Osoba & Auersperg 1966), 
and/or treatment with anti-lymphocyte serum (Phillips & Gazet 
1967; Cobb 1972) have been used to promote the growth of trans-
planted tumours. The discovery of the congenitally athymic nude 
mouse (Flanagan 1966; Pantelouris 1968) provided an excellent 
opportunity for the use of these animals as a practical system 
for the study of human tumours in heterologous hosts. Studies 
have been done on the biology of transplanted tumours, on their 
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sensitivity to radiotherapy, chemotherapy and immunotherapy as 
well as other aspects of cancer therapy. Human tumours and their 
cultivated cell lines have been transplanted serially in the nude 
mouse (Povlsen and Rygaard 1972; Giovanella et al., 1974) where 
these tumours have been shown to maintain many of the original 
characteristics displayed by the primary tumour. 
As no reports have been published on the growth of sheep 
tumours in the nude mouse, attempts were made to establish a 
number of these tumours as xenografts in this host. Moreover, as 
a prerequisite to the immunological studies in the present 
experimental system, it was necessary to attempt to establish 
cultures of a number of naturally occurring sheep tumours. 
The present chapter describes in detail the techniques and 
procedures used to establish tumour cell lines from clinical 
cases of epithelial tumours in sheep both in vitro and in the 
nude mouse. Some results are presented on the culture character-
istics of these tumour cell lines. These include description of 
the morphology, ultrastructure and growth rates of the tumour 
cells in vitro and the ir growth in nude mice. The macroscopic 
and microscopic morphology of the xenografted tumours was also 
studied in the nude mouse and compared with the original tumour. 
3 . 2 METHODSOF TISSUE CULTURE 
Dulbccco ' s n~dified Eagle ~edium, supplemented with 1 0% 
FCS and containing antibiotics (penicillin 100 u/ml, 
streptomycin 100 µg/ml and neomycin 100 µg/ml), was used for 
cultivating tumour tissues. 
Tissue samples were collected from the sheep into cold 
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sterile Hanks1 solution (HESS) containing 4 times the normal 
concentration of antibiotics. Care was taken during biopsy to 
avoid necrotic or contaminated tissue. Hard tissues were also 
avoided since it was found after some early experiences that 
culture of such tissues led mainly to fibroblastic growth. 
Tissues were transferred to a sterile hood in which they were 
processed for cultivation. 
Because of the high degree of bacterial contamination found 
within the tumour, it was necessary to wash the tissue fragments 
extensively in HESS containing antibiotics (4 times the 
normal concentration), trim them of any necrotic and contaminated 
material, and wash them again twice in HESS and PSN. Tissue 
pieces were then cut into 1 cm 3 fragments which were kept on ice 
for 30 min in HBSS and PSN. 
The tissue fragments were cut into 2-3 mm cubes using 
opposed scalpels . Sharp clean cuts were found to be best for 
allowing subsequent cell growth . Cells failed to migrate from 
irregular cut surfaces and no growth was observed in these 
conditions. After the tissue was cut up, fragments were washed 
3 times in HESS and PSN and then processed for tissue culture 
either by enzymatic digestion using collagenase (Owens et al. ., 
1976) or the pieces were cultivate d as explants without any 
further treatment (Moore et al .~ 1975). 
For cultures prepared by enzymatic digestion, the minced 
fragments were transferred to 75 cm 2 tissue culture flasks 
(Falcon plastics , Los Angeles , California, U.S.A.) and dispersed 
in 15 ml of complete medium containing l mg collagenase/ml. The 
flasks were gassed with 10% CO2, 7% 02 and 83% N2, sealed and 
. o 1 h incubated at 37 C for 8-24 r. This incubation was followed by 
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gently pipetting the tissues back and forth to break up the cell 
clusters into finer fragments . The flasks were then placed 
upright for 3-5 min to allow the cell cluster s to settle out. 
The medium was removed with a Pasteur pipette and 15 ml of fresh 
medium added to each flask . This washing step was repeated twice 
to remove all the collagenase. Th e vi s ibLe cell clusters left 
after this treatment were redistributed into 25 cm2 tissue culture 
flasks with a Pasteur pipette and then fed with 5 ml of the comple te 
medium , gassed with 10% CO2, 7% 02 and 83% N2 , sealed and 
' ub 0 inc ated at 37 C . 
In cultures prepared by the explant method , 1 2-15 fragments 
of tissue were placed directly into 25 cm2 tissue culture flasks 
with a Pasteur pipette . A drop of complete medium was then placed 
on each fragment and the flasks were gassed gently with 10% CO2 , 
7 . o f l h % 02 and 83% N2 , sealed and incubated at 37 C or -2 r . This 
method of incubation ensured that the fragments adhered to the 
flasks . Once the fragments adhered, the cultures were fed with 
5 ml of complete medium , gassed and incubated at 37~C without 
disturbing the m for 2-3 days. All cultures were fed twice a week 
by discarding the old medium and replacing it with 5 ml/flask of 
fresh comp l e t e me dium. The pH was adjusted carefully at each 
fe e ding with 10 % CO2,7% 02 and 83% N2 . Care was taken during 
f eeding and gassing of the primary cultures to avoid disturbing 
the tissue fragments . 
3. 2. 1 Selection of Epithelial Cells 
Two me thods were employed to obtain a pure population of 
epithelial cells; differential e nzymatic treatment and/or 
mechanical separation. 
(a ) Differential enzymatic dige s tion 
Cultures were washed twice with trypsin diluent and then 
subjected to a series of 1-2 min exposures to a trypsin-
versene solution (final concentrations of trypsin- versene were 
0 . 25% and 0 . 1% respectively) followed by washing in trypsin 
diluent . This procedure resulted in a more rapid detachment of 
the fibroblastic cells than the epithelial ce l ls . The latter 
grew in sheets and consequently took a longer time to detach 
from the flask . By repeating this procedure , most of the 
fibroblasts were removed and epithelial clusters were left to 
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grow. The epithelial islands were rinsed 3 times with the complete 
medium , fed , gassed and incubated at 37°c . This procedure 
sometimes needed to be repeated 2-3 times a week before a pure 
population of epithelial cells was established . 
(b) Mechanical separation 
Fibroblasts were identified first using an inverted 
microscope. These cells were removed mechanically from the 
culture by scraping the flask with a rubber policeman. The mono-
layer of epithelial cells was then washed twice to remove all 
detached cells . Some cultures were separated by enzymatic . 
treatment alone while with others, both enzymatic treatment and 
mechanical separation methods were used . In those cultures with 
a high proportion of fibroblasts, mechanical methods were used 
initially to reduce the numb ers of these cells. This was 
followed by enzymatic treatment. 
3. 2.2 Serial Subculture 
For subculture, the monolayer of cells was washed twice 
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with trypsin diluent and treated with trypsin-versene solution for 
10 min. This 10 min treatment resulted in the cells rounding up 
but they did not become detached completely from the surface of 
the flask. The trypsin solution was removed with a Pasteur 
pipette and the flasks tapped to help detach the cells. The 
cells were then resuspended in complete medium, washed twice and 
redistributed into new 25 cm2 or 75 crn2 tissue culture flasks. 
3. 2. 3 Morphological Observations 
Tumour cells were cultivated on cover slips in 6-well 
tissue culture plates (Linbro model FB-6-TC Multidish Disposo-
trays) in H-16 and 10% FCS . Morphological studies were done 
either on live preparations using phase microscopy (Olympus, 
Tokyo) or on fixed , stained preparations . For electron microscopy, 
cells were harvested from 25 cm 2 tissue flasks according to the 
method described previously. The cell pellet was fixed with 4% 
cacodylate glutaraldehyde fixative, postfixed in osmium-collidine, 
dehydrated in graded concentrations of alcohol and embedded in 
Epon . 
3. 2. 4 E timation of the Growth Rate and the Doubling Time of the 
Tumour Cells 
For the determination of growth rates , 1 x 10 5 cells were 
inoculated into 25 cm2 tissue culture flasks in 5 ml of complete 
medium. The medium was changed every 2 days . At 24 hr intervals, 
3 cultures were harvested using the method described earlier and 
the cells were counted in a haemocytometer. The doubling time 
of the cell population , (the time required for the cell 
population to double in number) , was determined from the growth 
curves (Huh et al . J 1977). Saturation density was taken as the 
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value where 3 successive harves ts showed no increase in cell 
number (Owens et al . ~ 1976) . 
3. 2. 5 Capacity of Cultivated Cells to Produce Tumours ~n Nude Mice 
The ability of cultivated cells to grow in immunosuppr.essed 
hosts was used as a measure of their malignancy (Sincovics et al.~ 
1978) . Cultivated tumour cells were injected intradermally, 
subcutaneously or intraperitoneally into nude mice and their 
subsequent growth was observed . Explants were also taken directly 
from tumour-bearing sheep and transplanted into nude mice (see 
Section 3 . 3 . 6 in this chapter). 
3 . 3 RESULTS 
3. 3. 1 The Establishment of Tumour Cell Lines 
Fifty different tumours werebiopsiedand used for establishment 
of cultivated cell lines. From these 50 tumours , 17 cell lines 
were established ; a success rate of 34%. Table 3.1 shows detailed 
data of the e stablished cell lines in regard to the site of 
tumour , the methods used for the initial establishment of the 
cultures and the methods used for subsequent separation of 
epithelial cells from fibroblasts . 
In the early attempts to es tablish cultures, both enzymatic 
digestion and explant techniques we re used . Only 3 cultures were 
established from 25 tumours, using the enzymatic treatment (12%) 
compared to 7 cultures es tablished by the explant method (28 %). 
Therefore, for subsequent attempts only the explant technique was 
used and the success rate improved to 40% (Table 3 . 2). 
Th e failure to establi sh cultures by enzymatic treatment 
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Table 3 . 1 Method of e tab lishment and isolation &n culture of OV&ne 
* 
# 
0 quamou 0 ee l l carci nomata de1-iived from different biopsy sites 
Cell line 
numb r 
F6 
F 18 
F 40 
F 41 
F 43 
F 47 
F 59 
F 61 
F 31 
F 34 
F 35 
F 39 
F 51 
F 54 
F 57 
F 58 
F 24 
Site of hiopsy 
nose 
II 
II 
II 
II 
II 
II 
II 
ear 
II 
II 
II 
II 
II 
II 
" 
vulva 
Method of 
establishment 
explant 
II 
II 
II 
II 
'' 
II 
II 
# 
enzymatic 
explant 
II 
# enzymatic 
explant 
II 
" 
" 
#enzymatic 
*Method of isolation 
enzymatic treatment 
II 
II 
enzymatic & mechanical 
II 
enzymatic treatment 
mechanical separation 
II 
II 
enzymatic t reatment 
II 
mechanical separation 
enzymatic treatment 
II 
II 
enzymatic & mechanical 
mechanical separation 
Methods used for separating pithelial cells from fibroblasts in the 
initial culture . 
All three cultures prepared by enzymatic treatment were also grown 
succ ssfully by the explant method . 
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was not due to any difficulti es encountered in the establishment 
of the initial culture but to problems arising in the subsequent 
purification of the epithelial cells . This may have been due to 
the fact that in explant culture , cells migrate from the explant 
outwards to form sheets of c lls , whereas in cultures prepared 
by the enzymatic digestion , cells grow in small colonies completely 
surrounded by colonies of fibroblasts. Epithelial cells growing 
in the latter situation seem to be more sensitive to trypsin 
treatment , and they detach at approximately the same time as the 
fibroblasts . For this reason mechanical separation was used to 
separate epithelial cells from fibroblasts in these cultures. 
A correlation between the site of biopsy and the success 
rate in establishing cultures was observed in these experiments. 
The total success rate in cultivating these tumours was 34%. 
Table 3.3 shows that out of 14 attempts to establish cultures 
from tumours on the nose , 8 were successful (57%). With tumours 
from the ear , 8 cultures were established out of 22 attempts 
(3 6% ). Only one culture was establish ed from tumours derived 
from th e vulva out of 13 attempts (7 . 6 %). The reasons for the 
difficulties found in establishing cultures from tumours growing 
on the vulva is not known . However from my own experience, 
difficulties were mainly related to the initial establishment 
of the epithelial growth rather than to any subsequent 
difficulties in the method of isolation . Two other cell lines 
w.ere established from this r e gion, however they were lost 
(degenerated) on subsequent subcultivation (2nd and 3rd). 
3 . 3 . 2 'I'he Mor phology o f E tablis hed Culture s 
In enzymatically prepared cultures, islands of epithelial 
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Table 3 . 2 The ucces rate for the cultivation of ov~ne squamous cell 
carcinomata u ing either the explant or enzymatic digestion 
techniques . 
Method of culture 
Enz ymat ic 
Explant 
Explant 
Number of attempts 
25 
25 
25 
Number of . established 
cultures 
3 (12)* 
# 7 (2 8) 
10 (40) 
Success rate by explant 14/50 (28 %) 
* The numbe r in parenthesis represents the percentage success rate. 
# 
These cultures include the 3 cultures established by both methods. 
Table 3 .3 The relationship between the site of the tumour and the success 
of cultures . 
Site of tumour 
eye 
vulva 
ear 
nose 
otal 
*Numb€r of establi shed 
cultures 
0/1 
1/13 
8/22 
8/14 
17/50 
*Number of established cultures/number of attempts . 
% ·success rate 
0 . 0 
7. 6 
36.4 
57 . 0 
34 . 0 
cells were seen as early as 24-48 hr after the cultures were 
initiated (Fig . 3.1). In explant cultures, the outgrowths of 
epithelial cells from the tissue fragments were observed 72-96 
hr after the cultures were set up (Fig. 3.?.). Of the 17 cell 
lines established , two distinctive morphological types of cel·ls 
were observed. Fig. 3.3 shows one of these cell types. 
Epithelial cells were small in size , densely packed and had a 
regular cobblestone appearance . The nuclei of these cells 
were large relative to the cytoplasm . Cel~s were frequently 
observed in mitosis in these cultures . When the cells became 
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confluent they usually continued to grow, piling up on each 
other . This suggested that these cells were not subjected to any 
contact inhibition (Fig. 3 . 4). 
The other morphologic cell type observed in the established 
cell lines is shown in Fig . 3.Sa. Cells in these cultures were 
irregular in shape and size , and multinucleated giant cells were 
frequently seen (Fig . 3 . Sb) . The nuclei of these cells were 
small in comparison to the cytoplasm which was highly vacuolated. 
Cell division was also frequent in these cultures and abnormal 
mitotic figures were regularly seen . Cellular degeneration 
occurred in some of these cultures when they reached a confluent 
state . Variations were observed in the amount of vacuolation of 
the cytoplasm and in the number of giant cells between the 
different established cultures . 
Cells were tested for the presence of keratin to authenticate 
their epithelial character . Of 8 cell lines tested, 6 stained 
positively for keratin(Fig. 3.6) and these cultures remained 
positive throughout each subculture. 
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3. 3. 3 Ultra tructural Characteristics of Cultivated Twnour Cells 
Five cultivated tumour cell line s were examined in the 
electron microscope after the .cells were removed from the culture 
flasks by trypsinization . Most of the cells were disassociated 
by this treatment but some small aggregates remained intact as 
fragments of the original monolayers . 
The cultivated cells were typical epithelial cells, 
differentiated to varying degrees . Some cel l s were epidermal 
keratinocytes , many with the characteristics of granular cells , 
while others had the characteristics of cells from the basal or 
germinative layer . There were no fibroblasts , Merkel cells or 
Langerhans cells identifiable in any of the es t ablished cell 
lines . 
(a ) Keratinocytes 
Typical examples of these cells are shown in Figures 3.7, 
3.8 and 3 . 9 . The number of keratohyalin bodies and the amount 
of keratin present in these cells varied . The cytoplasm of 
some cells was filled with tonofibrils and associated keratohyalin 
(Fig . 3 . 10 , 3 . 11) while others contained only a few scattered 
keratohyalin bodies . The keratin fibrils and keratohyalin 
bodies we re located p rincipally in and around the Golgi area of 
the cells and in a thin marginal area surrounding the nucleus 
(Fig . 3.7, 3 . 8) . In the cell undergoing mitosis the keratin 
forme d a circumferential ring near to the cell membrane following 
the dissolution of the nucle ar membrane (Fig. 3.12) . Many of 
these cells had a highly vacuolated cytoplasm . 
In the more differentiated cells there were large amounts 
of keratin and tonofibril s ; no cells in the cultures developed 
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to the stage of cornification. There was a variety of inclusions 
in the keratinocytes including larnellar granules, melanin and 
lipid granules as well as lysosomes (Fig. 3.10, 3.11, 3.13a, 3 . 12b). 
Almost all these cells had large prominent nucleoli with an open 
reticulated structure comprised of RNA granules. Their cytoplasm 
contained numerous polyribosomes , arranged in clusters and spirals 
(Fig. 3.14) . There was no visible glycogen in the cytoplasm of 
these cells . 
· (b) Basal Cells and Spinous Cells 
There were large numbers of cells in the cultures that 
resembled basal cells and cells with the characteristics of more 
differentiated spinous cells . The cytoplasm of the basal cells 
was filled with glycogen granules arranged singly or in clusters 
(Fig. 3.15). There were very few or no keratohyalin bodies in 
these cells and the tonofibrils were scattered through the 
cytoplasm and not aggregated into distinct bundles (Fig. 3 .16a) . 
Basal cells still associated with one another were joined by 
desmosomes. The desmosomal boundaries were thickened and more 
electron dense than the adjacent plasma membrane (Fig. 3.16b) 
but there was no orientation of the tonofibrils to the desmosomal 
attachments . The cytoplasm of the basal cells contained many 
polysomes but no rough endoplasmic r e ticulum. Basal cells were 
seen in mitosis in the cultures. 
The cells which resembled spinous cells had more tonofibrils 
than the basal cells and also more keratohyalin in their cytoplam 
(Fig. 3.17) . These cells were proliferating rapidly in culture 
and the mitotic figures usually showed dispersed profiles of 
keratohyalin arranged peripherally in the cytoplasm. Some glycogen 
was often present in their cytoplasm. The cytoplasm of the 
basal and spinous cells was significantly less electron-dense 
than that of the more differentiated keratinocytes. 
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There were some cells in the cultures that had a few rough 
endoplasmic reticular profiles in their cytoplasm and cisternae 
filled with secretory products (Fig. 3 . 18a, 3.18b). 
There were also a variety of other cells with highly vacuolated 
cytoplasm and a variety of inclusion bodies. These cells did 
not have any keratin or tonofibrils in their cytoplasm and their 
designation was uncertain. 
3. 3. 4 Growth Rate and Doubling- Time of Cultivated Tumour Cells 
In the primary cultures, epithelial cells had a very slow 
growth rate and took almost one month to reach confluency in 
25 cm 2 flasks. However with subsequent subculture, epithelial 
cells grew at much faster rates and usually reached confluency 
within a week. 
Growth curves were established for different cell lines 
after the same number of subcultures . In general two different 
types of growth curves were obtained . One pattern of growth had 
a lag phase following subculture. This was followed by an increase 
in cell numbers until saturation density was reached. After this 
the cell numbers declined (Fig. 3.19a). A second pattern of 
growth was observed in which there was no lag phase. Cell numbers 
began increasing within 24 hr of subculture until they 
stabilized (Fig. 3.19b) . In the pattern of growth in which there 
was a lag phase , the different cell lines differed in the length 
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of the lag period as well as in the final cell density. In 
some, the final density of cells correlated with confluency, 
while in others, cells ceased to grow even though they had not 
become a confluent monolayer. In the growth pattern with a lag 
phase, there was a slower growth rate and saturation density was 
reached 48-72 hr later than with cells that showed no lag 
period in their growth. 
An increase in the growth rate 
observed following subculture in vitro . 
was 
Fig . 3.20 shows the 
growth rates determined for the cell line F43 at different sub-
culture levels. At the 6th subculture, the doubling-time was 
88 hr, whereas at the 10th and 20th subculture, the doubling-time 
was 54.4 and 26.6 hr respectively . 
3. 3. 5 Xenotransplantation of Cultivated Twnour Cells 
The ability of cultivated tumour cell lines to grow in nude 
mice was assessed by xenogeneic transfer. Tumour cells were 
injected either intradermally, intraperitoneally or subcutaneously 
into nude mice and the subsequent growth of the tumour was 
followed. In all 3 cell lines tested, cells established growth 
following intradermal injection whereas none grew following 
intraperitoneal or subcutaneous injections (Tabl e 3.4). Further 
cell lines that were tested were therefore injected intradermally. 
Table 3.5 -shows the results of injection of 8 different cultivated 
tumour cell lines into nude mice. Four out of the 8 cell lines 
tested gave rise to tumours. With some tumours, small nodules 
appeared at the innoculation site 2-3 days following injection. 
These nodules enlarged over the next 2 ~onths reaching a size of 
between 15 x 15 mm and 25 x 25 mm by approximately 60 days 
Table 3.4 The effect of route of injection on the growth of 
inocula of twnour cells in nude m&ce . 
Cell line Numbe r of inj e ction Tumour size numbe r Route of (mm) Days s ubcultures 
F6 4 Intr ad e rmal 11 X 8 
*rntrape ritone al 
Subcuta neou s 
Fl8 6 I. D. 18 X 17 
I. P . 
s.c. 
F43 · 4 I.D. 8 X 5 
I.P. 
s.c. 
No growth 
. . 106 Number of cells inJected was . 
* animals receiving ip tumour 'cells were sacrificed at the end 
of the observation period, dissected and examined macroscopically 
for the presence of tumours. 
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obs erved 
52 
89 
120 
35 
135 
85 
26 
94 
111 
78 
Table 3 . 5 Tumour production in nude mice following intradermal injection 
of cultivated tumour cell lines 
Cell line Number of Numbers of cell Tumour size 
number subcultures injected ( mm) Days observed 
F6 6 1 X 106 15 X 15 60 
Fl8 8 1 X 106 25 X 25 55 
F43 6 1 X 106 17 X 15 49 
F 40 9 *l X 1 0 7 123 
F 35 5 1 X 107 16 X 18 29 
F 51 5 1 X 107 92 
F 58 7 1 X 107 139 
F 24 3 1 X 107 150 
* Mice were injected with 1 x 107 cultivated tumour cells because in 
earlier attempts, 6 when mice were injected with 1 x 10 tumour cells, 
no growth was observed over a period of 3-5 months . 
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(F6, Fl3 and F43 ) . The other tumour cell line injected into the 
nude mice (F3 5 ) had a latency period of 7-10 days before it 
appeared at the inoculation site as a smal l nodule. After the 
nodule appeared growth was rapid r eaching an average size of 
16 x 18 mm within the n ext 30 days . No regression was observed 
in any of the cell lines which showed initial growth. 
3. 3. 6 Xenotran plantation of Tumour Explants 
All transplantation procedures were done under sterile 
conditions . Tissue samples were collected in sterile cold HBSS 
containing antibiotics (PSN) . Tissues were taken from healthy 
well-vascularized areas at the periphery of the tumour; care was 
taken to avoid necrotic areas. Tissue fragments were divided into 
2 portions ; one portion was fixed for histological examination and 
the other was us ed for implantation. 
A 6-8 mm incision was made in the lateral abdominal wall of 
the mous e and a subcutaneous pouch formed by blunt dissection. A 
piece of tumour tissue measuring app roximately 3 x 3 mm was inserted 
into the p ouch and positioned on th e lateral thoracic wall, at 
l e ast 8 mm away from the inci sion . The incision was then closed 
using autoclips (Clay Adams, Parisppany, N. J . ). After tumour 
implantation , mice were observed daily and the growth of the 
tumour was measured twice~ week with calipers . Tumour volume 
3 
was estimated from the formula (TI /6)d where dis the mean diameter 
of the tumour (Selby et al .) 1980) . 
When the tumours had reached a sufficient size or had 
killed the host, they were dissected free and examined. The 
autopsy was done by dissecting the skin over the tumour site to 
allow for its inspection. Lymph nodes were examined for any 
80 
enlargement, and the thorax and abdomen were opened and internal 
organs examined . For histological studies, tissues were taken 
from the tumour at its first transplantation . Randomly chosen 
tumours which had been grown serially were sampled and prepared 
for microscopic examination. Organs which showed macroscopic 
changes and enlarged lymph nodes were also prepared for histology. 
Twenty five different tumours from various sites on sheep 
were implanted subcutaneously into nude mice (Table 3 . 6). Of 
these tumours 10 tumour lines were established and subjected to 
serial transplantation. Of the remaining 15 t u mours transplanted , 
7 failed to establish any growth, while 5 others grew initially 
and formed small nodules before they eventually regressed . The 
remaining 3 tumours grew progressively for 2-3 months following 
their initial implantation but they were lost in subsequent 
passages. 
Of the primary tumour grafts, 13 (52%) were successful in the 
first transplantation , 10 (40%) of these were subsequently trans-
planted serially. A possible correlation between the site of 
the original tumour growth and success in establishing growth in 
nude mice was observed in this study. Two xenografts were 
established from tumours growin·g on the vulva out of 7 attempts 
(28%) . Three out of 9 tumours transplanted were established 
from tumours derived from the ear (33 %), and 5 out of 9 were 
established from tumours on the nose (56 %) . Thus tumours from the nose 
had the l1ighest rate of establishment when transplanted into 
nude mice followed by those on the ear and vulva. The rate of 
acceptance of tumour grafts in the first transplantation was 
variable and in some cases it was extremely low. However, the 
rate of acceptance of established tumours in serial transplant-
ation varied between 80-100% (Table 3.7). 
Table 3. 6 Details of the history of the pr&mary t ransplantations of 
heep t wnours into nude m&ce 
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Sheep number Tumour site Growth ob served \umbers accepted Passage number 
F 4 v.ulva 0/6 
F 7 II 0/6 
*P 19 II + 1/4 
F 21 II + 6/6 8 
*F 23 II + 2/6 
F 24 II + 1/6 7 
*F .38 II + 6/6 
*F 5 e,ar + 1/6 
F 14 " 0/6 
tF 31 II + 2/6 
F 33 II + 3/6 6 
F 34 II 0/6 
F 35 II + 2/6 7 
tF 36 II + 2/6 
F 37 II + 1/6 9 
F 44 II 0/5 
F 6 n ose + 1/14 15 
F 18 II + 3/6 20 
F 29 II 0/6 
F 40 " + 2/6 6 
F 41 II + 1/6 11 
F 42 " 0/6 
*F 43 11 + 1/6 
tr, 46 II + 1/4 
F 47 II + 1/4 5 
# number of animals accepting the tumour graft/number of ainimals inoculated. 
* tumours r e mained as small nodules throughout the observation period 
(4-5 months) 
t tumours gre w initially but disappe ared on subsequent passages 
+ yes , - no . 
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Table 3.7 Acceptance rates of selected tumours following s erial passage 
Tumour number 
Fl8 
F6 
F35 
Passage number 
1 
2 
7 
1 
2 
5 
1 
2 
7 
*Acceptance rate 
3/6 
5/6 
6/6 
1/14 
12/12 
6/6 
2/6 
8/9 
7/8 
Percentage 
50 
83 
100 
7 
100 
100 
33 
89 
88 
* Number of animals accepting tumour graft/number of animals inoculated. 
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3.3 . ? Tumour Morphology 
The pattern of growth of the different tumours established 
in the nude mice by transplantation of explants was very similar 
to the growth of the primary tumour in the original host. The 
morphologic appearance was uniform and consistent with each 
subsequent transplantation in the nude mouse. Basically two 
distinctive morphologic types of tumours were observed in nude mice. 
(a) Expan ively gro~&ng tumours 
Tumours of this type began to increase in size usually 
between 10-14 days after they were transplanted. In early passages, 
growth was slow until the tumour became established (approx. vol. 
3 1.5 cm); growth then increased rapidly. The tumour attained an 
approximate volume of 12 cm 3 within 2-3 months of transplantation. 
As shown in Fig. 3 . 22 , the tumours had smooth surfaces, were well 
circumscribed and encapsulated . These tumours remained movable 
and did not become attached to either the skin or the chest wall. 
The tumours invariably had a sterile necrotic centre (Fig. 3.24c) 
which was revealed when the tumour was cut. The extent of 
necrosis was proportional to the tumour volume. This type of 
growth was identical to that seen in the host sheep (Fig. 3 . 21). 
Histologically the transplanted tumours were differentiated 
squamous cell carcinomata with s ome areas of keratinization 
(Fig . 3 . 24a) . The boundary b e tween the normal tissue and the 
tumour was well demarcated by a thick layer of connective tissue 
elements (Fig . 3 . 24b) . This histological appearance was retained 
with tumours that had been serially transplanted and resembled 
closely the histological appearance of the primary tumour (Fig. 
3 . 2 3) . In one case (Fl8), the amount of s tromal material within 
the tumour decreased with subsequent passages . Lymph nodes and 
other organs showed no tumour metastases in the nude mouse . 
(b) Invasively grow&ng tumours 
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Tumours of this type grew very slowly in the first 2 months 
after the primary transplantation . Growth was more obvious 
during the 60-90 days following transplantation and the tumours 
r e ached a volume of 2-3 cm 3 by this time. As shown in Fig. 3 . 26 
the tumours were highly vascular with rough surfaces. They were 
not encapsulated but extended into the adjacent tissues. These 
tumours sent out finger-like projections of malignant tissue which 
formed adhesions with the overlying skin and the underlying body 
wall (Fig . 3 . 27) . Ulcerations occurred through the skin with 
this tumour , but there was no internal necrosis. This invasive 
type of growth corresponded closely to the way these particular 
tumours grew in their primary hosts . For example invasion of 
the upper lip and destruction of the cartilageneous elements in 
the nasal septum was observed in sheep carrying these tumours 
(Fig. 3.25). 
The histological appe arance of some of these tumours was 
characterized by the presence of spindle-shaped tumour cells 
separated by large amounts of stromal elements. Few keratinized 
areas were observed scattered throughout the tumour (Fig. 3.29). 
These tumours had a similar histology to the primary tumour 
(Fig . 3 . 28) , and their histological appearance remained unchanged 
on subsequen t passages. The tumours were locally invasive and 
infilt~ated the adjace nt tissues . -In a cross section through the 
muscle layer overlying the thoracic wall, clusters of tumour 
cell s could be seen s urrounding individual muscle cells (Fig. 3.30). 
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In one case a secondary growth of the tumour was found in the 
lung (Fig. 3.31). Tumour tissue had already penetrated the body 
wall by direct extension and was also located on the inside of the 
thorax and extended over the surface of the lung. The histologic 
appearance just described was representative of some infiltrative 
tumours. Other infiltrative tumours had a histologic appearance 
similar to that described for tumours which had an expansive growth. 
No correlation between the histologic appearance of the tumour and 
its growth pattern was observed. 
3.3.8 Growth Rates 
Growth curves (expressed as volume) were plotted for various 
tumour s after varying numbers of transfers. Differences were 
observed in the growth rates of the tumours with subsequent 
passages. Fig. 3.32 shows the growth rates of 2 representative 
tumours (F6 and Fl8) after the first, 7th and 9th passage . Cell 
line F6, which is an example of an invasive tumqur had a latency 
period of 2 months before any growth of the tumour was observed 
at its primary transfer. After this period the tumour increased 
in size and reached a volume of 2 cm 3 by 90 days following 
transplantation. When subsequently transplanted, the latency 
period was shorter (20 days) and the tumour reached a volume of 
2 cm 3 in 50- 60 days. For the other tumour, Fl8, (expansive 
growth), the latency period during which no growth was observed 
was between 10-15 days at the primary transfer; after this time 
there was a dramatic increase in the size of the tumour which 
reached a volume of approximately 5 cm 3 by 55 days after it was 
transplanted . Faster growth rates were observed with subsequent 
3 passages of the tumour and it reached a volume of l2 cm on day 65 
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and day 55 on the 7th and 9th passages respectively. 
3 . 4 DISCUSSION 
These experiments have demonstrated that pure populations 
of cells derived from ovine squamous cell carc inomata can be 
grown su9cessfully in vitro . A number of factors were found to 
influence the success in establishing the cell cultures . These 
included the initial method used for obtaining the cells , and the 
subsequent method used for separating the epi t helia l cells from 
contaminating fibroblasts . The site of the tumour appeared also 
to influence the success of the culture. A high success rate was 
obtained in tumours derived from the nose, s u ccess was less with 
tumours growing on the ear and least with tumours from the vulva. 
The reason for this association between the site of the tumour 
and the success rate in establishing cultures is not known, but 
it does not seem to be related to the histological appearance of 
tl1e tumour. However, it may be related to the malignancy of the 
tumour , since most tumours growing on the nose tended to be 
invasive , infiltrating the nasal cartilage and the adjacent 
tissues of the upper lip. 
Comparative studies were done on the relationship between 
the location of the tumour , its growth pattern (invasive or 
expansive) and the growth rate and morphologic appearance of the 
established ceJl lines in vitro . No association was found 
between the tumour site and the morphologic appearance of the 
tumour or between the growth pattern of the twnour and its 
morphologic appearance. However there seemed to be anassociation 
between the growth pattern of the twnour in the sheep and the 
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growth rates of the cultivated cells ~n vitro . It was found that 
cells from all invasive tumours, except two (F6 and F43), grew 
relatively slowly in vitro when compared with other cell lines 
after the same number of subcultures . 
An increase in the growth rate of the established cell lines 
was observed following in vi tro subculture. This may have been due 
either to the adaptation of the cells to grow in vitro >or, because 
the cell population was heteroge neous, tissue culture may have 
resulted in selection of fast growing cells which subsequently 
predominated in the culture. These results agree with data 
reported by Huang et al . (1980 ) who observed that a tumour cell 
line established from the nasopharynx showed an increase in its 
growth rate following in vitro subculture. However the growth 
rate of this culture stabilized at the 25th subculture. 
Some cultivated cell line s failed to grow when inoculated 
into nude mice. This may be due to the fact that growth is 
dependent on the preservation of the architecture of the tumour 
parenchyma and stroma (Povlsen and Rygaard 1976). However other 
reasons such as an insufficient inoculum size or insufficient 
time elapsing between the time of tumour inoculation and _ the 
death of the nude mouse may exp lain the failure of growth . 
Success ful transplantion of sheep tumours from different 
sites into nude mice was also established in 10 out of 25 attempts. 
As with in vitro culture, there was a correlation between the site 
where the tumour was located and its acceptance as a xenograft. 
Tumours derived from the nose were most readily accepted followed 
by those derived from the ear and vulva respectively. 
Three other tumours were transp lanted into nude mice and 
their growth observed . While these tumours grew on first passage , 
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they failed to grow when transplanted to secondary hosts. This 
may have been due to the fact that these particular tumours 
showed massive central necrosis to the extent that only a thin 
outer rim of tumour tissue was available for transplantation. This 
lack of a sufficiently large inoculum could have been the reason 
behind the failure of these tumours to grow when passaged 
subsequently. 
The other five tumours which remained the same size through-
out the observation period (4-5 months) may have required a longer 
period of time to grow (Povls en and Rygaard , 1976). The life span 
of the nude mouse did not permit these studies to be followed 
except by keeping the mice in germ-free conditions . The inability 
of these tumours to grow could have also been due to other factors 
such as a lack of vascularization or to the depletion of an 
essential factor for tumour growth which is present in sheep but not 
in nude mice. 
The reason for the complete failure of the remaining 7 
tumours to grow is unknown. One possible explanation may be that 
the failure of these tumours to grow is due to their immune 
rejection by the nude mouse. Although the nude mouse lacks a 
thymus , it is not completely incompetent immunologically. It has 
been shown that nude mice have intact humoral immune mechanisms 
(Koene et a l .J 1974 , Adelman et al . J 1980) and they have an 
enhanced activated macrophage response to bacterial infection 
(Reid et al . J 1978) as well as an enhanced NK cell response when 
compared to conventional mice (Holden et al. J 1978) . The increased 
NK cell activity may account for the low incidence of spontaneous 
tumours in the nude mou s e (Outze n et al .J 1975). Since NK cell 
activity is highest at 5-10 weeks of age and since most of the 
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mice used in my experiments fell within this age group (6-8 weeks 
old), it is possible that the lack of growth of some of these 
tumours was due to rejection by NK cells. 
The pattern of growth of the tumours in the nude mice was 
similar to that observed in sheep. Thus the Fl8 tumour was a 
highly vascular tumour in the sheep where it grew expansively and 
showed no tendency to infiltrate or metastasize. F6 was a highly 
infiltrative tumour, invading the surrounding tissues of the 
upper lip and the nose cartilage. This same invasive pattern was 
observed in the nude mice to which the tumour was transplanted. 
This finding is not in accord with the findings of Povlsen and 
Rygaard (1971). They reported a change in the growth pattern of 
human carcinomata of the rectum and colon once these tumours were 
transplanted into nude mice. Although the rectal and colonic 
tumours had an invasive growth in the primary host, they grew 
as local well-circumscribed tumours in nude mice. The reason 
behind this difference is unknown, however it may be related 
either to the site from which the primary tumour was obtained or 
to the sex of the nude mouse. Reid et al . ( 1978) have described 
a prostatic carcinoma which was found to be locally invasive to 
the muscles when transplanted into females. However, this 
prostatic carcinoma grew as a circumscribed encapsulated tumour 
when it was transplanted into male mice. 
The histological appearance of the skin tumours in mice 
resembled that in the primary host , and did not change through 
subsequent passages except in the case of one tumour (Fl8) where 
a decrease in the amount of stromal elements within the tumour 
was observed on serial passage . This may account for the increase 
in the acceptance rate of this tumour as well as the increase in 
its growth rate observed in its later passages. Loss or change 
in the stromal content of some transplanted human . tumours have 
also been reported by other investigators (Povlsen and Rygaard 
1971 , Selby et al .~ 1980). However this loss was attributed to 
the gradual replacement of the fibroblastic elements within the 
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__. . 
primary tumour by fibroblasts of mouse origin (Selby et al .~ 198~ ) 
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Figure 3.1 Epithelial islands growing from an enzymatica~ly prepared 
culture, 48 hr after culture initiation. 
Figure 3.2 Epithelial cells growing from a tissue fragment in explant 
culture , 72 hr after culture initiation . 
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Figure 3.3 Epithelial cells of culture F6 (5 days after the 4th sub~ 
culture) showing a regular cobblestone appearance with large 
nuclei; some cells are seen in mitosis. 
Figure 3.4 The morphologic appearance of the cell line shown in 
Fig. 3.5, take n 9 days after subculture . Note loss of contact 
inhibition with subsequent piling up of cells. 

( '•il'.'.l,;:::/:/:._::J;,-,.· 
~ 
ik if[· 1:~t:·.• 
~.•,,,;•" 
i1.'i..l"1:~ 1 f:: •ill· 
to • ,~' ~ . •, 
f.~ 
~":-
~-
i;· [:::i 
i:1(i 
-:•, .'• J. I~ 
~-!• ·, '. :1 [il:i 
f)!l 
,_.1 
. ~;~ 
;'. . 
r·:~:1: 
1··•1· ,~ -... ~ 
•r_ .. ~< 
!·:·'.. 1::-:: 
I•.• 
n.·. 
~<r} 
1: :·.;·. 
~J. . -(~~ 
-1 • •I• 
:t: ' 
i: 
r 
.,.·· 
I'' l,i. 
i• 
,:]', 
!''." t·.i '('. 
~,·.: . 
l"I ,·; 
f\V: 
r:i .r' 
,,. ,_.'.:.J. 
f'I•·.· • 
c::·::;:•1 
... ... ;r t~· .-:: ~•,~ 
1::;!: 
,, ... ,.,. 
r:rn;: 
f/\'. 
~~/)f 
~~:.~ti 
~({ 
~lli~lt 
~-·,, ,1;1; ' 
~j•)•l•1•' N~<tif~ 
~nm-ir 
y.1•i•l••• 
~/'.:~~/J H, ... ,./, 
~- ,·,.:,:. ij .. ~,::J·, 
~~,.Ji~~-r··• '''' b::;/'.~if 
p-··1,'i-."1-!~ 
~
:,;,;\): 
\i'.J\k 
:(:~Ji· 
~~)j:,;i:' 
n··· .. ·• 
~:'.'.j\l 
[ .· ~ iJ<' 
FUll\ 
[ 1\\1\:: 
r-,,, .. ,. 
~:j::;: 
pc ,;;,, 
r" ' '.'1, •,~; (' 1:,; 
I·. 
r 
r 
t. 
r. . 
F 
• r 
t 
, . 
,r 
~ 
. 1.: 
:,,' 
-
;mi 
Figure 3.5 The morphologic appearance of Culture Fl 8 5 days after the 
4th subculture: 
(a) I rregular growth pattern of cells in t he culture, 
the cytoplasm of each cel l is l arge compared to the 
nucle us and it is highly vacuo l ated . 
(b) Multinucleated giant cells are frequent l y seen in the 
culture. 
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Figure 3.7 Epithelial keratinocytes obtained from cultivated tumour cell 
lines showing a varying degree of differentiation reflected by 
the amount of keratohyalin (Kh) in their cytoplasm. Note the 
distribution and location of keratohyalin (Kh) around the 
nucleus (N). 
r 
nucleolus (N ~ ), microvilli (Mv ), vacuole (V). 
(magnification Xll,000) 
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Figure 3.8 An epithelial keratinocyte showing few keratohyalin (Kh) 
granules distributed around the golgi (G) area and the 
, nucleus (N). A centriole (C) is cut in section close to 
the nucle us (N)., 
nucleolus (NS) . 
(magnifica tion X2 7,000) 
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Figure 3.9 An epithelial keratinocyte showing a nucleus (N) with a 
prominent nucleolus (Ns). The keratohyalin (Kh) is distrib-
uted around the nucleus (N). Some vacuoles (V) are seen in 
the cytoplasm. 
(magnification X35 , 000). 
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Figure 3.10 A more differentiated keratinocyte with the cytoplasm of the 
cell filled with tonofibrils (Tf ) arranged i n bundles. 
Polyribosomes (Pr ) , mitochondria (M) and the nucleus (N). 
(magnification X77,000) 

1 
~: 
j,,: 
:l'· :~,j·'.. F 
~:,;•,··· 
H\l-
~- : . 
~.: 
t;~. 
i:· 
i;·. 
ff: ·. ~: 
ir:t 
•' ;-•-·-
~·-''.:::'1 j~: ~; 2-: ~ 
t:~. ~~;. 
t~: .. ) [ji 
f' .. •,:1 
,, .. , .. , 
h: .··. ,};: 
,~- .. j.! ~ -. . ; , ~ 
!i;i} 
ir-::< 
:.!· ,,. 
f: 
k. 
1: 
j: 
r 
, ..... 
r:: 
:] ... ,'.: ~ 
t• I•,", " 
1·· • 
;:}· 
;;):, 
:~.: 
t1r·;_if• 
~F-t<,,. 
r>r 
"''\1 
~F)1. 
., ... -~ r-· •, .. :, 
,~-- ,-r: 
!::< 
Lili: 
t(l\r 
~: ;-: :~: ;:• 
:r,..::;;•. 
•!'.: t '.'.· ·-~'. 
[:i)} 
t~/ir~: 
~1.;·.~-~i! f}T 
I,· .•• ,.,. 
• ·-•·1•:• 
~illl% 
~j :l~,~~-j~! , 
f::\i~! 
rut 
f'·•·•I•' 
~ii!~\ r~- .·:.i~J~; ~ .. _,.:·,, 
~• -__ , ... i/'.;i 
1J·' .' ·. l}~! t ,._,,, 
LJi:: r • ;.,,!• 
a:J·r:nJ: 
i:<:-il'.'. 
~- .- ~.-. 
a· .. :: j{~·:~: 
I' 
r 
r 
t ,. 
F 
t j-
,, 
. 
,.,.-. ·;,!i 
Figure 3.11 A differentiated epithelial keratinocyte showing the 
presence of large amounts of keratohyalin {Kh) and tonofibrils 
(Tf). Polyribosomes (Pr) are also seen scattered in the cyto-
plasm of the cell. Lipid vacuole (Lv). 
(magnification X48,000) 
Figure 3.12 A differentiated epithelial keratinocyte showing the arrange-
ment of tonofibrils (Tf) in a circumferential ring near to the 
cell me mbrane following the dissolution of the nuclear 
me mbrane (Nm). Melanin granules (Mg) are also seen in the 
cytopla sm of the s e cells. 
(magnification X35,000) 
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Figure 3.13 Examples of epithelial keratinocytes showing lamellar 
(a and b) 
granules (Lg), tonofibrils (Tf) , kerato hyalin (Kh), melanin 
granules (Mg) and lipid vacuoles (Lv ), nucleu s (N), nucleolus 
(Ns) • 
(a) magnifi ca tion X48,000 
(b) magnifi cation X32,000 
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Figure 3.14 Epithelial kerat{nocyte showing ·1arge numbers of polyribosomes 
(Pr) in the cytoplasm arranged in spirals and clusters. A 
nuclear pore (Np) is seen in the nuclear membrane (Nm). 
nucleus (N), nucle olus (Ns). 
(magnification X71,000) 
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Figure 3.15 A basal epithelial cell, showing the presence of large nwnbers 
of glycoge n (Gl) granule c~usters in the cytoplasm. A few 
tonofibrils (Tf) are seen in the cytoplasm . nuclear membrane 
(Nm), nucle u s (N) . 
(magnification X24,000) 
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Figure 3.16a A basal epithelial cel l showing a f e w~tonofibrils scattered 
throughout the cytoplasm . The t onofibrils are not arranged 
in bundles . 
(magnification X40,000) 
Figure 3.16b Two basal epithelial cells joined by a desmo s ome (D). ·The 
desomosomal boundaries are thickened and more electron dense 
tha n the adjacent plasma membrane. 
(magnification X70 , 000) 
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Figure 3.17 A spinous epithelial cell showing more t onofibrils and 
keratohyalin (Kh) in the cytoplasm than the b a sal cells. 
Some glycoge n (Gl) granules and vac uo l es (V) a re seen in the 
cytoplasm of these cells . 
nucleus (N) , nucl e olus (Ns ) , microvilli (Mv). 
(magnification X27,000 ) 
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Figure 3.18 The tumour epithelial cultures contained other cells with 
(a and b) 
profile s of endoplasmic reticulum (Er ) and polyribosomes 
(Pr) in their cytoplasm . The identity of these cells was 
uncertain. : 
microvilli (Mv), nucleus (N). 
(magnification X35 , 000) 
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Growth rates of two different tumour cell line s 
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the pattern of growth which did not have a lag phase and Fl8 
(e - e ) represents the type of growth which h ad a 1 ag phase. 
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Pigure 3 . 20 Variations inthe growth rate of the tumour cell 
line P43 after subcultivation in v?'.t1 10 . Growth rates were 
determin ed at the 6 th (• - • ) , 10th (• - •) and 20th (e - e ) 
s ub cu lture l eve l . 
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Figure 3.21 This figure demonstrates the expansive growth pattern of the 
tumour Fl8 in the original host. 
Figure 3.22 The growth pattern of tumour Fl8 in the nude mouse. As seen, 
the tumour is well circumscribed and can be detached easily 
from the body wall (30 days after transplantation, 2nd passage) . 
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Figure 3.23 The histological appearance of tumour F l 8 i n the primary 
host (sheep). This is a squamous cel l carcinoma with keratin-
ized centres (magnification Xl25) . 
Figur e 3.24 The histologic appearance of tumour Fl8 transp l a nted into the 
nude mouse: 
{a ) The morphology is similar to that seen i n the sheep 
(ma gnification Xl25). 
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(b) Thick layers of stromal elements surrounding the tumour. 
(magnific~tion Xl25 ). 
(c) The presence of necrotic centres within the tumour 
(magnifica tion XS O). 
b 
Figure 3.25 The morphological appearance of t he tumour F6 in the primary 
host. This was a highly invasive tumour. 
Figure 3~26 The growth pattern of tumour F6 in the nude mouse showing a 
highly vascular tumour growing attached to the body wall (60 
days after transplantation, 2nd passage ). 

Figure 3.27 Tumour F6 showing finger-like projections of tumour tissue. 
These processes were found on the part of the tumour adjacent to the 
body wall, and represent extensions of tumour cords which subsequently 
invaded the muscular layer (mouse sacrificed 90 days after transplantation). 
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Figure 3.28 The histological appearance of tumour F6 in the primary host 
(sheep), note the spindle-like appearance of the cells, the 
prese nce of a f e w keratin pearls scattered throughout the 
tumour and the large amounts of fibroblastic tissue 
(magnification XSO). 
Figure 3.29 The histological appearance of the tumour F6 transplanted into 
the nude mouse a s c ompa red to that in sheep showing a similar 
c e ll morp hology, a few k e ratin pearls and large amounts of stromal 
ele me n ts (Magnification XSO). 
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Figure 3.30 A section through tumour F6 showing the invasion of the muscle 
layer at the wall of the thorax by. tumour cells. The individ-
ual · muscle i s completely surrounded by t umour cells (magnifica-
tion Xl25 ) . 
Figure 3.31 Metastasis of tumour F6 into the tissue of the lung of the 
nude mouse (arrow showing tumour cells, magnification X312.5). 
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Pigure 3 . 32 Growth rates in the nude mouse of tumours F6 at passage 
level 1 (• - •), 7 (0 - 0) and 9 (• - •) and Fl8 at the same passage 
levels (closed symbols) . 
CHAPTER 4 
THE IN VITRO STIMULATORY CAPACITY 
OF TUMOUR CELL LINES 
91 
. 1 INTRODUCTION 
The role of the host's immune system in tumour control is 
highly complex . Many effector cells and mechanisms have been 
demonstrated to be involved in the response against tumours and 
more critically, it is now known that the host's immune system can 
occasionally play a role in assisting a tumour to survive. Thus 
although it can be assumed that the host's immune system (if it 
is involved in a response against a tumour) plays mainly a 
defensive role, under certain circumstances its activities can 
lead to an enhancement of the growth of the tumour. 
The host-tumour interaction is further complicated by the 
fact that the tumour cell population is by no me ans uniform. The 
heterogeneity of tumour cell populations with regard to growth 
rates, antigenicity, immunogenicity, metabolic characteristics 
and certain other biochemical features (Fidler 1978; Fidler and 
Kripke 1980) is a well established observation in a variety of 
tumour systems. This heterogeneity is not surprising considering 
that the continued growth of a tumour mass will involve a degree 
of differentiation and metabolic change in the tumour cells. 
Variant cells may arise and these will be subjected to survival 
pressures; only those cells suited for the environment in which 
they find themselves will survive . However with the continuing 
growth of the tumour, subpopulations of surviving cells will be 
more likely Lo possess an enhanced malignancy towards the host. 
, 
It is also possible that as tumour cells evolve they come to 
possess an increased antigenicity relative to the host and 
become more likely to stimulate the host's immune system. 
Protection may also be afforded for the different clones of 
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malignant cells as a result of suppressive effects on the host's 
immune apparatus induced by the main bulk of the tumour. 
Because of the complex nature of both the host's response 
and of the tumour cell population, it is virtually impossible to 
understand the host-tumour interaction by studying one system 
without regard to the other. Therefore, before analyzing the immune 
response of tumour-bearing sheep to their autochthonous tumours, 
studies were first carried out i n an attempt to understand some 
of the native properties of the tumour cells themselves. 
It has been shown by a number of investigators that cells 
will vary in their ability to cause proliferation in lymphocytes 
in vitro when they are mixed together. Strong stimulation is 
observed when allogeneic lymphocytes from genetically diffe rent 
individuals are cultivated together (Bain et al .~ 1964; Bach 
et al .~ 1973). Some, but not all kinds of non-lymphoid tissue 
cells .have also been reported to stimulate lymphocyte proliferation 
in humans, and these include skin cells (Hirschberg et al.> 1973), 
vascular endothelial cells (Hirschberg et al .> 1974) and 
spermatozoa (Levis et al .> 1974, 1976). Studies on tumour cell-
lymphocyte interactions have revealed a somewhat similar picture . 
Hardy and Ling (1969) reported that lymphoma cells are able to 
produce a significant stimulation of allogeneic lymphocytes while 
HeLa cells do not . Anderson et a l . (1972) studied the interaction 
between tumour cells and allogeneic lymphoid cells in 14 different 
types of tumours including melanoma, breast carcinoma, osteogenic 
sarcoma, adenocarcinoma and the HeLa cell line. They observed 
significant stimulation in the lymphoid cell populations when they 
were mixed with all these tumour cell lines; however this 
stimulation was low when cdmpared to the stimulation obtained by 
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cell mitogens or by allogeneic lymphocytes. Thus both normal and 
tumour cells seem to vary in their ability to stimulate alloge neic 
lymphoid cells . 
Experiments described in thi s chapter were aimed at invest-
igating the ability of cultivated epi thelial tumour cells to 
stimulate a proliferativ e r esponse in allogeneic lymphocyte s. 
4 . 2 THE ALLOGENEIC TUMOUR CELL- LYMPHOCYTE INTERACTION 
The allogeneic tumour cell-lymphocyte r eaction was studied 
using a one-way mixe d culture t e chnique. In this assay y -irradiated 
tumour cells were cultivated in th e presence of allogeneic 
lymphocytes and the exte nt to which th e lymphocytes were stimulated 
was determin ed by measuring the amount of thymidine incorporated 
into them. 
In the first series of expe riments a constant number of 
lymphocytes (5 x l OG/ml) collected from the efferent popliteal 
lymph of normal sheep was us ed as th e r esponder population. 
Various concentrations (1 x 10 4 - 5 i 10 6 /ml) of y-irradiated 
cultivated t umour cells were added to this population and the 
cultures harvested after 5 d ays of incubation . Stimulation was 
considered to have occurred if the values for thymidine up take 
in the cultures containing both tumour cells and l ymphocytes ±2SE 
(standard errors ) were higher than the sum of the values of 
thymidine uptake obtained from cultivating e ach cell type alone. 
All cultures were set up in triplicate . Seven different tumour 
cell lines were tested for their ability to stimulate allogeneic 
lymphocytes in 1itro . The r esults of a rep r esentative e xperiment 
with tumour cell line Fl8 are given in Table 4.1 . This tumour 
Table 4 . 1 Ina.bility of twnour cell line FlB to stimulate allogeneic 
efferent lymphocytes in vitro 
Source of 
stimulator 
_l 
Stimulator cell 
concentration/ml 
Thyrnidine uptake* 
cpm ± SE 
825 ± 165 
Tumour (F 18) 2 5 X 10 6 397 + 49 
Tumour (Fl8 ) 3 5 X 106 321 + 25 
1 
2 
II 1 X 106 529 + 61 
II 5 X 10 5 760 + 95 
II 1 X 105 674 + 67 
II 5 X 104 373 + 111 
II 1 X 104 182 + 12 
PBL (F1 8 )4 5 X 10 6 87085 ±9211 
Cultures containingre sponder cells only (efferent lymphocytes, 
6 5 x 10 /ml) . 
6 Cultures containing stimulator cells only (tumour cells,5 x 10 /ml) . 
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3 Cultures of stimulator cells at various concentrations in the presence 
4 
* 
of responder cells (efferent lymp hocytes ). 
Cultures of blood leucocytes from tumour-bearing sheep (Fl8) in the 
presence of responder cells (efferent lymphocytes). 
Cultures terminated after 120 hr of incubation . All cultures in 
triplicate . 
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failed to stimulate a response in allogeneic efferent lymphocytes. 
The uptake of thymidine in the mixed cultures was consistently lower 
than in the control . All 7 tumour cell lines tested behaved 
similarly in that they failed to stimulate allogeneic lymphocytes. 
The inability of the tumour cells to stimulate allogeneic 
lymphocytes in vitro could have been due to a number of reasons, 
including compatibility between the tumour donor and the sheep 
from which the responder cells were obtained . This possibility 
was tested by setting up a mixed lymphocyte reaction (MLR) in 
which lymphocytes were u sed from the tumour-bearing sheep instead 
of the tumour cells. As seen in Table 4 .1, significant stimulation 
was obtained indicating that the lack of stimulation in the tumour 
cell-allogeneic lymphocyte cultures was not due to histo-
compatibility between the sheep from which the responding 
lymphocytes were obtained and the tumour donor, In all subsequent 
experiments , tests for compatibility between the donor tumour-
bearing sheep and the sheep from which the responder cells were 
obtained, were carried out. 
Studies by a number of investigators on the mixed lymphocyte 
reaction (Scollay 1972 , Lafferty et a l., 1974) and on the tissue 
or tumour-lymphocyte interaction (Anderson et al ., 1972; Eurton 
et al ., 1975 ; Pawelec et al . , 1979) have shown that a number of 
variables can affect the outcome of this assay. · Therefore it was 
necessary to test for the effect of these variables on the 
stimulatory ca~acity of the tumour cells. 
In the previous experiments , the concentration of the 
stimulator cells (tumour cells) was varied in the assay. The 
effect of altering the time at which the assay was terminated, 
the source of responder cells and the resporider cell concerttration 
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on the outcome of the assay , was also tested . 
4. 2. 1 Kinetics of the Interaction 
To examine the kinetics of the interaction, cultures were set 
up using a constant number of responder cells (5 x 10 6 /ml, efferent 
lymphocytes) and various concentrations of stimulator cells 
(1 x 10 4 - 5 x 10 6 /ml, tumour cells). Cultures were then 
terminated after 3 , 5 or 7 days of incubation. Fig. 4.1 shows 
that the tumour cell line F40 did not stimulate at any of the time 
periods or at any of the concentrations investigated. Thus the 
lack of capacity of the tumour cells to stimulate could not be 
changed by these manoeuvres. 
4. 2. 2 Variation in the Source of Responder Cells 
In the previous experiments , efferent lymphocytes were used 
as responde r cells. It has been shown by Smith et al. (1970) that 
the efferent lymph in sheep consists mainly of small lymphocytes 
and is devoid of macrophages. Since it has been suggested that 
macrophages are required in the mixed lymphocyte reaction (Wagner 
et al .~ 1972 ; Rode and Gordon 1974) , it was decided to use 
peripheral blood leucocytes as responders in the assay. This was 
done to test whethe r the presence of other white cells, together 
with lymphocytes , had any effect on the stimulatory capacity of 
the tumour cell lines. 
Seven Jlfferent tumour cell lines were tested for their 
capacity to stimulate allogeneic peripheral blood leucocytes. 
Table 4.2 shows the results of one representative experiment which 
demonstrated that tumour cell line F35 did not induce any 
proliferation in allogeneic blood leucocytes. This experiment 
Table 4 . 2 Inability of tumour cell line F35 to stimulate 
allogeneic periphera l blood leucocytes in vitro -
1 
2 
Source of 
stimulator 
_l 
Tumour (F35 ) 2 
Tumour (F35) 3 
II 
II 
II 
II 
PBL (F 35 ) 4 
Stimulator cell 
concentration/ml 
5 X 10 6 
5 X 10 6 
1 X 105 
5 X 105 
1 X 105 
5 X 104 
5 X 106 
Thymidine uptake* 
cpm ± SE 
868 + 95 
233 + 25 
176 + 29 
265 + 35 
37 3 + 19 
216 + 45 
185 + 21 
53794 + 9729 
Cultures containing responder cells only (PBL leucocytes, 
6 
5 x 10 /ml) . 
6 Cultures containing stimulator cells only (tumour cells,5 x 10 /ml). 
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3 Cultures of stimulator cells at various concentrations in the presence 
of responder cells (peripheral blood leucocytes). 
4 Cultures of blood leucocy tes from tumour b earing sheep F35 in the 
presence of r esponder cells (peripheral blood leucocytes). 
* Cultures terminated after 120 hr of incubation. All cultures in triplicate . 
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suggested that the presence of other white blood cells in the 
culture did not alter the inability of the tumour cells to .stimulate 
allogeneic lymphocytes. 
4. 2. 3 Variation &n the Concentration of the Responder Cells 
The final parameter which was investigated was the 
concentration of responder cells in the assay. Since previous 
data did not indicate that any specific concentration of stimulator 
cells was optimal, different concentrations of tumour cells were 
used with varying concentrations of responder cells. Fig. 4.2 
shows the results of one experiment in which 3 selected doses of 
responder cells were used . Tumour cells again failed to stimulate 
a respons e in allogeneic leucocytes irrespective of the dose of 
responde r cells used. 
The results of the tumour cell-lymphocyte interactions 
&n vi lro showed that the tumour cells were unable to stimulate 
allogeneic lymphocytes. This inability of the tumour cells to 
stimulate could b e a tissue culture artefact or could be related 
to certain properties of the cancerous cells such as (1) a high 
antigenic content resulting in a high zone tolerance ; (2) a lack 
of certain alloantige ns which are r e sponsible for causing 
stimulation in the mixe d lymphocyte reaction or (3) suppression 
of lymphocyte proliferation by the tumour cells. The first 
possibility seemed unlike ly since differe nt tumour cell 
concentrations were us e d for s timulation. The 2nd and 3rd could 
be tested directly and the r e fore experiments were designed to see 
whether lack of stimulation was due to a defici e ncy of allo-
antigens on the cells or due to irnrnunosuppressive effects on the 
lymphocytes . 
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4 . 3 DEMONSTRATION OF ALLOANTIGENS ON TUMOUR CELLS 
Detection of alloantigens can be done either serologically 
or by measuring cellular reactivity directed against the respective 
alloantigens. Because of the time involved in the production of 
an alloantiserum against each respective tumour, the cellular 
reactivity against alloantigens was measured . 
Th e mixed lymphocyte reaction (MLR) and a cytotoxic assay 
involving cell-mediated lysis (CML) are the two most extensively 
used in vitr o assays for th ~ analysis of the proliferative and 
effector phases of cellular immunity (Hayry and Defendi 1970) . 
In the MLR the proliferation of the responder cells is measured. 
The cell-me diated cytotoxic assay analyzes the .development of 
cytotoxic cells generated in the mixed lymphocyte cultures. 
Cytotoxicity is me asured by the ability of the cell~ generated in 
MLR to lyse labelled target cells carrying the same antigens or 
other cross-reacting antigens, as the stimulator cell. Thus, the 
MLR and CML we re use d to inve stigate the presence of alloantigens 
on the tumour cells . 
4. 3. 1 Generation of Cytotoxi c Ce l ls ~n vitr o 
Since it has b e en r eporte d by various inve stigators that 
proliferation of cells in MLR is require d for the development of 
cytotoxic cells (Wagne r 1972; Cantor and Jandinski 1974; Hirano 
and Nordin 1976), e xpe rime nts we re se t up to d e fine the optimal 
conditions for c e ll proliferation in the MLR in ythe present system. 
Cultures were prepared with an equal number of stimulator cells 
(sheep p e riph e ral blood l e ucocy t es ) and r esponde r c e lls (sheep 
efferent lymphocytes) s o that the final concentration of cells 
in the culture was either 5 x 10 6 /ml, 7 x 10 6 / ml or 10 7/ml. 
Cultures wer harvested on the fifth day after the cells were 
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mixed and the extent of thyrnidine incorporation into the responding 
cell population was measured. 
Results from these experiments showed that cultures containing 
7 
10 /ml lymphocytes gave the lowest level of stimulation whereas 
cultures containing 5 x 10 6 /ml or 7 x 10 6 /ml lymphocytes gave good 
stimulation . The suppression of thymidine incorporation seen at 
the highest cell concentration (10 7 /rnl) may have been a non-specific 
effect resulting from the exhaustion of the medium at high cell 
densiti es (Kung et al .~ 1977). In order to obtain the maximum 
number .of cells for use in the cytotoxic assay designed to 
demonstrate the presence of alloantigens , a cell concentration of 
7 x 10 6 /ml was chosen for subsequent experiments . 
4. 3. 2 The Cytotoxicity Test 
Peripheral blood leucocytes from tumour-bearing sheep were 
used to stimulate efferent lymphocytes from normal sheep. Cultures 
were harvested at day 5 and were used as effectors against 51 cr 
labelled tumour cell targets from the same blood donor sheep. 
For testing specificity , tumour cells were used from other sheep 
and from the xenogeneic mouse tumour P815 . The results of the 
cytotoxic effect of cells generated in these cultures against the 
respective tumours are given in Table 4.3 . 
Cytotoxicity against tumour cells could be demonstrated in 
6/8 of the tumour cell lines tested, indicating that some 
alloantigens were expressed on 6 of these cell lines . The cytotoxic 
reaction was specific since no cytotoxicity was detected against a 
x nogeneic mouse tumour (P815) or against other allogeneic tumour 
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Table 4 . 3 Demon tration of the presence of alloantigens on twnour cells 
Sensitizing 
cell 
Fl8 
F35 
F51 
F40 
F57 
F58 
F24 
F54 
* 4 hr assay 
l ot detected 
N. T . not tested 
51 % Cr release* from tumours 
Effector cell/ 
target cell ratio 
200 : l 100 : l 
42 25 
33 18 
27 11 
20 13 
19 16 
13 8 
3 . 9 
3.4 2 
Unrelated 
cell 
F6 
P815 
Fl8 
P815 
F6 
P815 
Fl8 
P815 
F6 
P815 
N.T . 
F6 
P815 
FlB 
P815 
F24 and F54 are negative 
Effector cell/ 
target cell ratio 
200:l 
3 . 0 
2 . 5 
1 . 5 
15 
2 . 3 
2.8 
2.2 
N. T . 
2 
3.5 
3 . 0 
100:l 
1 . 6 
1.2 
1 . 2 
3 . 0 
7.6 
3.9 
4 . 0 
4 . 2 
N.T. 
4 . 9 
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cells. In one case, however, cross-reactivity was observed; cells 
sensitized against lymphocytes obtained from the FSl tumour-bearing 
sheep caused significant lysis of the tumour cell line F6. This 
cross-reactivity may have been due to the sharing of some 
alloantigens between the 2 sheep. 
The absence of lysis in 2/8 of the tumour cell lines tested 
may be attributed to the absence of detectable alloantigens on 
these cells. Alternatively,it may have been due to decreased 
sensitivity of these tumour cells to immune lysis. For example, 
variations were observed in the total 51 cr uptake, the maximum 
5 l amount of Cr released following water lysis and the spontaneous 
release of 51 Cr between the different tumour cell lines used as 
targets. Accordingly, since cell lines vary in their susceptibility 
to water lysis , there may also be variations in the resistance of 
different cell lines to immune lysis . Variation in susceptibility 
to lysis may also be a function of the number of times the tumour 
cell lines have been subcultured . It is known that tumour cells 
harvested directly from the tumour material in V&VO and those 
obtained from an early subculture in vitro are sometimes less 
susceptible to immune lysis than cells that have been subcultured 
several times (de Vries et al .~ 1974). In the presentstudy, tumour cell 
lines were used after only a few subcultivations (2nd- 6th) . 
The results presented so far have indicated that the 
inability of the tumour cell lines to stimulate allogeneic 
lymphocytes was not necessarily due to a general lack of allo-
antigens . Moreover, it was shown clearly that sheep have cells 
capable of mediating cellular cytotoxicity in vitro and that most 
tumour cell lines tested can be used as targets in a cytotoxic 
assay. This point needed to be established prior to performing 
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any experiments in the autochthonous . system. 
4 . 4 SUPPRESSION OF THE MIXED LYMPHOCYTE RESPONSES (MLR) BY TUMOUR CELLS 
This section investigates whether the lack of stimulation in 
the tumou+ cell-lymphocyte reaction was due to suppression of the 
~n vitro immune response . 
To test for possible suppressive properties of the tumour 
cell lines , the effect of adding tumour cells to a normal mixed 
lymphocyte reaction was investigated . Mixed lymphocyte cultures 
were set up using optimal concentrations of responder cells 
(efferent lymph lymphocytes , 5 x 10 6 /ml) and stimulator cells 
(peripheral blood leucocytes , 5 x 10 6 /ml) from normal sheep . 
Various concentrations of y-irradiated F6 tumour cells were added 
to these cultures and the effect on the proliferative response in 
the MLR was determined. The results of this experiment are shown 
in Fig . 4 . 3. 
The addition of y-irradiated tumour cells to mixed lymphocyte 
cultures produced a significant reduction in thymidine uptake in 
the responding cells. A suppres sion in 3H-thymidine uptake was 
obvious at tumour cell concentrations of '5 x 10 4 - 5 x 10 6 /ml. 
This suppressive effect was considered unlikely to be due to 
overcrowding since the same number of third party allogeneic 
l e ucocytes added to the cultures did not cause any suppression 
of the mixed lymphocyte response. Suppression of 3H-thymidine 
uptake occurred only in the presence of viable tumour cells 
since th e addition of heat-killed tumour cells at high densities 
had no effect on the respons e (Table 4. 4) . 
In total, seven tumour cell lines (F6, Fl8 , F35, F40, FSl. 
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Table 4.4 The e f fect on mixed lymphocyte response s of adding var &ous 
concentrati ons of dead twnour ce lls 
Tumour c e ll *Thymidine uptake 
conce ntration/ml cpm ± SE 
- t 119 ,-6 62 + 17,532 
5 X 106 127, 545 + 11 , 479 
1 X 10 6 136,335 + 12,817 
5 X 105 114,842 + 10,159 
' 
1 X 105 101,379 + 16', 352 
t The uptake of thymidine in mixe d lymphocyte cultures without the 
addition o f d e ad tumour cells . 
* Cultures t e rminate d afte r 120 hr of incubation . 
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F54 and F57) were tested for their effect on the normal mixed 
lymphocyte reaction and six showed the suppressive effects 
described above . One tumour cell line (F40) had no effect on the 
MLR responses (Fig . 4.4) at any of the concentrations tested . 
This particular tumour also lacked the ability to stimulate allo-
geneic lymphocytes although it could function as a target in 
cell-mediated lysis , indicating that the tumour expressed 
alloantigens . 
4 . 5 DISCUSSION 
Cultivated ovine squamous cell lines consistently failed 
to stimulate a response in normal sheep lymphocytes when mixed 
together in vitro. This lack of in vitro immunogenicity was 
apparent regardless of the concentration of t umour cells used for 
stimulc:ilion , the source of the responding cell (efferent lymphocytes or 
peripheral blood leucocytes) or the duration of the culture . It 
was also shown that the failure of the tumour cells to stimulate 
allogeneic lymphocytes was not due to histocompatibility between 
the sheep which provided the cells since mixed lymphocyte 
cultures between cells from the same two sheep resulted in 
significant responses. 
The failure of the tumour cells to stimulate allogeneic 
lymphocytes in vitro does not reflect a general property of normal 
epithelial skin cells. It has been claimed however , by some 
investigators (Talmage et al . J 1977) that stimulation of 
allogen ic lymphocytes &n vitro is dependent on the type of 
tissue from which the tumour derives . Thus they proposed that 
tumours of lymphoreticular origin stimulate allogeneic lymphocytes 
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&n vitPo whereas tumours of epithelial origin do not. The 
capacity of cells to stimulate could be attributed to their 
expression of Ia antigens which stimulate proliferation in MLR. 
Ia antigens are not expressed by epithelial cells in general but 
only by Langerhan's cells (Rowden 1980). Since in this system 
the tumours used were of epithelial origin this may provide an 
explanation of their inability to cause stimulation in allogeneic 
lymphocytes . This possibility however , seems unlikely because it 
has been reported by Hirschberg et al . (1975) that cultivated 
normal epithelial cells, which do not express Ia antigens, were 
still capable of stimulating a significant response in allogeneic 
lymphocytes . 
Another related explanation comes from the work of Lafferty 
el al . (1978) who have proposed that the allogeneic reaction occurs 
only when a responsive lymphocyte binds antigens through its 
cell-surface receptor (signal 1) and at the same time receives a 
stimulus from a lymphokine (signal 2). It would follow that the 
failure of these tumours to stimulate was due to a lack of either 
the binding reaction between the responder cell and the tumour cell 
antigen or to the failure of the tumour cell to produce a 
lymphokine. 
An alternative explanation may be found in the fact thqt 
the majority of the tumour cell lines tested inhibited a normal 
mixed lymphocyte reaction and as a consequence their inability to 
stimulate might be a reflection of irnmunosuppressive capacity. 
It is we ll docume nted that immunosuppression can accompany tumour 
growth and is manifested in vitPo by a decreased response of the 
lymphocytes of cancer patients to mitogens and in vivo by 
diminished delayed cutan ous hypersensitivity to a variety of 
contact allergens (Stutman 1975; Karno and Friedman, 1977). 
Supernatants of stablished cultures of human neoplasms have 
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been shown to contain factors which can affect the non-specific 
lymphocyte responsiveness to mitogens (Renk et al . ~ 1980) as 
well as specific lymphocyte responses to tumour antigens (Dent 
et al .~ 1978). It has been shown that there exists in the 
supernatant fluid of cultures of melanoma cell lines , certain 
factors which inhibit thymidine uptake by degrading the thymidine 
to a non-utilizable form (Dent et al. ~ 1978). The presence of 
such factors may explain the lack of reactivity observed when 
lymphocytes from melanoma patients are mixed with tumour cells. 
In the present system the requirement forviable tumour cells 
in the culture to inhibit thyrnidine uptake suggests that this 
effect is mediated through a suppressive factor. Alternatively 
it may be that tumour cells cause irnmunosuppression by depleting 
the medium of a metabolite which is necessary for lymphocyte 
proliferation . 
With respect to the tumour cell line F40, no stimulation was 
obtained when the tumour was cultivated with allogeneic lymphocytes. 
Furthermore,it was shown that lack of stimulation was not due to 
irnrnunosuppression. Thus whatever mechanism was responsible for 
suppression of MLR by the other tumour cell lines, it was obviously 
not operative within this particular tumour . It is conceivable 
that the inability of this cell line to stimulate was due to an 
absence of the 2nd signal (Lafferty et al .~ 1978). 
The findings in this chapter illustrate two characteristics 
of the tumour cells ; 1. their inability to stimulate allogeneic 
lymphocytes and, 2. their irnrnunosuppressive properties on 
lymphocyte responses . These two characteristics could be of 
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importance in analyzing the host-tumour interaction in naturally 
occurring tumours . 
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Figure 4 . 2 The effect of the responder cel l concentration on 
the ability of the tumou r cells to stimulate a response in 
allogeneic blood leucocytes. Responde r ce ll concentrations 
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sum of the values of thymidine uptake obtained from cultures 
in which tumour cells and blood leucocytes were cultured alone . 
("") 
·o 
,--
80 
X 
E 
Q. 
u 
, ____ . 
60 • 
w 
z 
0 
~ 
>-
40 
:r: 20 ~ 
/j 
---------,/ ---------
• 
I 
STIMULATOR CELL CONCENTRATION 
Figure 4 . 3 The effect of addition of various concentrations of 
y - irradiated third party tumour cells (F6 (•-• ) or peripheral blood 
leucocytes (•-•) on the level of stimulation obtained in a normal 
mixed lymphocyte reaction . The level of thymidine uptake in the 
mixed lymphocyte cultures without addition of third party cells is 
represented by the dotted line . 
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Figure 4 . 4 The effect of addition of various concentr ations o f 
y - irradiated third party tumour cells F40 (e-e) o r tumour ce l ls 
Fl8 (•-•) on the level of stimulation obtained in a normal mixed 
lymphocyte reaction . The lev 1 of thymidine uptake in the mixed 
lymphocyte cultures without addi-tion of third party cells is 
r presented by the dotted line . 
CHAPTER 5 
THE IN VIVO STIMULATORY CAPACITY OF 
TUMOUR CELL LINES 
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5 . 1 INTRODUCTION 
Results reported in the previous chapter demonstrated that 
the various tumour cell lines were unable to stimulate a 
proliferative response in allogeneic lymphocytes in vitro. It 
was shown that the failure of the tumour cells to stimulate was 
not due to histocompatibility between the donor and responder , 
nor was it due to lack of alloantigens on the tumour cells . 
Further studies revealed that the tumour cells had a non-specific 
immunosuppressive effect on mixed lymphocyte responses in vitro . 
The failure of tumour cell lines to stimulate allogeneic 
lymphocytes may be related to this . Studies a lso showed that 
one .tumour cell line did not suppress 3H- thymidine incorporation 
in in vitro mixed lymphocyte cultures . This cell line also 
failed to stimulate allogeneic lymphocytes in vitro . 
Because of the contrived nature of in vitro systems 
involving cell mixtures , it was not possible to p l ace these 
&n vitro results in the context of ·reactions between cells 
&n V&VO . Experiments were therefore designed to examine 
the ability of selected tumour cells to stimulate a response in 
allogeneic sheep in vivo . Tumour cells were introduced into 
a lymph node of a sheep and the reaction that ensued was monitored 
in the lymph draining from the node . The experimental approach 
that was used is illustrated in Fig . 5 . 1 . 
Both the afferent and efferent lymphatic vessels of the 
popliteal lymph nodes of sheep were cannulated and 10 7 cultivated 
tumour cells were infused into the node through the afferent 
lymphatic cannula . The immune response was confined to the 
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lymph node by quantitatively collecting the lymph drainin9 from 
the node following antigenic challenge. In this way the temporal 
sequence of events that occurred in the node in response to the 
tumour cells could be analyzed (Hall and Morris 1965b). 
The immune response was analyzed · in terms of the changes in 
the rate of lymph flow , the total cell output and the large cell 
output . Both the humoral and cellular reactivities which were 
induced against the tumour cells were measured during the response 
using an in vitro cytotoxic assay . 
Three different cell lines were selected fo r these 
experiments. These cell lines had been characterized in vitro 
with regard to their expression of alloantigens , their ability to 
stimulate a response in allogeneic lymphocytes and their ability 
to suppress a mixed lymphocyte reaction. A summary of the 
characteristics of these cell lines is presented in Table 5.1. 
The three cell lines chosen were similar in that they all 
expressed alloantigens and they all failed to stimulate allogeneic 
lymphocytes in vitro . However , they differed with respect to their 
ability to suppress 3H-thymidine uptake of cells in in vitro mixed 
lymphocyte reactions. Thus while the cell lines F6 and Fl8 were 
found to be highly suppressive in vitro~ the other cell line (F40) 
was not. 
Prior to carrying out the challenge experiments it was 
n ecessary to test the degree of compatibility between the tumour 
donor sheep and the prospective recipient of the tumour cells. 
This was done using a mixed lymphocyte reaction, in which 
peripheral blood leucocytes from the tumour-bearing sheep were 
used to stimulate efferent lymphocytes from the sheep designated 
Table 5 . 1 In vitro lU1racteristics of tumour cell lines selected for 
experiments involving in vivo antigenic challenge 
Cell line 
number 
F6 
Fl8 
F40 
+ Yes 
No 
Expression of 
alloantigens 
+ 
+ 
+ 
Stimulation 
in vitro 
Suppression 
of MLR 
+ 
+ 
111 
112 
to receive the twnour cells . The results presented in Table 5 . 2 
indicate that in each experiment , significant stimulation was 
obtained indicating that the pairs of sheep tested were 
histoincompatible. 
5 . 2 RESULTS 
Two different patterns of reactivity were observed following 
challenge with the different tumour cell lines . The reactivity 
obtained in response to challenge with both F6 and FlB tumour 
cell lines was similar and accordingly , the resul ts from these 
experiments are presented together . 
5. 2. 1 The in vivo Stimulating Capacity of the Tumour Cell Lines F6 
and F18 
The ability of the cell lines F6 and FlB to stimulate a 
response &n V&VO was tested in 4 sheep and 3 sheep respectively. 
The results from a representative experiment with each tumour 
cell line are shown in Fig. 5.2. 
Immediately following challenge there was a sharp decline 
in the cell output in the lymph from the stimulated node. By 
day 3 following challenge, an increase in the lymph flow, the 
total cell output and the output of large cells was observed . 
At the peak of the r e sponse, the total cell output was between 
30-40 x 10 7 cells/hr and the output of large blast cells 
constituted 20-40% of the total white cells leaving the 
stimulated node . These changes in the efferent lymph occurred 
between the 3rd and 7th day following challenge with the peak 
of the response occurring on the 5th and 6th day. By two weeks 
after challenge, the lymph flow , total cell output and large 
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Table 5.2 Mixed lymphocyte r eact ion be tween the tumour cell donors and 
the pro pective t umour ce ll r ecipients 
Tumour donor 1 Tumour recipient2 Thymidine uptake (cpm ± SE) 
Fl8 FN5 56106 + 5489 
Fl8 FN6 27634 + 3316 
Fl8 FN7 38415 + 2689 
F40 FN8 114730 ±12915 
F40 FN9 72923 + 6199 
F40 FNl0 53221 + 7213 
F6 FNl - FN4 N. T. 
1 Peripheral blood leucocytes from tumour-bearing sheep were used as 
stimulator c e lls in MLR. 
2 Efferent lymph lymphocytes from prospective recipients of tumour cells 
were used as responders in MLR; both the stimulating and the responding 
6 cell populations in MLR were used at a concentration of 5 x 10 /ml. 
* Cultures .terminated after 120 hr of incubation. All cultures in triplicate . 
N. T . ~ not tested, no source of peripheral blood leucocytes was available 
because the tumour-be aring donor sheep had died . 
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cell output had returned to their prechallenge levels. Although 
the magnitude of the blast cell response varied in the different 
recipients , the general pattern of events occurring in the 
efferent lymph was similar in all sheep challenged with the two 
tumour cell lines. 
The specific immune response generated d uring challenge with 
the tumour cells was determined by measuring the cytotoxic effect 
of both efferent cells and cell- free lymph against the tumou r 
cells used to stimulate the response . 
(a) Direct cell-mediated cytotoxicity 
The cytotoxic effect of efferent lymph cells against the 
immunizing tumour cells was tested before and at various intervals 
following challenge (Fig. 5 . 3) . Low levels of cell-mediated 
cytotoxicity were first detected at day 4 and this activity 
increased gradually to reach a peak at day 7 before the activity 
declined . Maximal cytotoxicity was detected with an effector-
target cell ratio of 200 : l and 100:l ; low levels of cytotoxicity 
were also detected at ratios of 50:1 . The cytotoxic activity 
displayed by efferent lymphocytes from the stimulated node 1was 
associat ed with the presence of the blast cells in the lymph. 
No cytotoxic activity was detected in the cells in the lymph 
before challenge or at any time after the blast cell response 
had disappeared . 
The cytotoxic activity of the cells was specific for the 
immunizing tumour cells. Table 5.3 shows the result of an 
experiment in which a sheep was challenged with the tumour cell 
line F6 , and the efferent lymph cells were tested for cyto-
toxicity against the immunizing tumour cell (F6), against another 
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· allogeneic tumour cell (Fl8) and against a xenogeneic tumour 
cell (P815). Tests for specificity were carried out on day 5 and 
6 following challenge . As shown in the table, no significant 
cytotoxic activity was demonstrated against the Fl8 tumour cells 
or the P815 cells on either day , whereas the cytotoxic reactivity 
obtained against the immunizing tumour cell F6 was 21% and 49% on 
day 5 and 6 respectively. 
As another test for specificity of the anti-tumour cytotoxic 
effect of lymphoid cells produced in response to an unrelated 
antigen was measured . A sheep was immunized with complete Freund's 
Adjuvant (CFA) and at the peak of the blast cell response (16.9%), 
the efferent lymph cells were tested for their cytotoxicity 
against the tumour cell lines F6 and Fl8. · Table 5.4 shows that 
the addition of lymph cells produced in response to CFA had no 
cytotoxic effect on the tumour cells tested, even when high 
effector cell to target cell ratios were examined and when long 
periodsof incubation were used for the assay. 
The initial experiments which were done to detect cell-
mediated cytotoxicity involved a 4 hr assay . However, it was 
found subsequently that the sensitivity of the assay could be 
rais_ed by increasing the period of incubation to 24 hr . A much 
greater amount of the 51 cr was released in assays in which the 
test was extended to 24 hr and this caused samples that were 
negative in the 4 hr test to become positive in the 24 hr test 
(Figure 5 .4). Usually in this type of cytotoxic assay incubation 
for longer periods of time results in high spontaneous release 
of 5 1 ' . Cr from the target cells and consequently interpretation 
of the significance of the data obtained is difficult. However, 
in the system used in the prese nt experiments , incubation 
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Table 5 . 3 The cytotoxic effect of efferent lymphocytes obtained from 
sheep irrrmunized with the twnour cell line F6 against the 
immunizing tumour and against unrelated tumours 
Days after 
challenge 
with F6 
5 
6 
% large 
cells in 
lymph 
13 . 5 
18 
* 24 hr assay 
Not detected 
Tumour cells 
51 
*% Cr release from tumour cells 
used in assay Effector:target cell ratio 
----------:::.---------
F6 
Fl8 
P815 
Fl8 
P815 
200:1 
21 
49 
100:1 
11.0 
3.4 
2.0 
24.0 
50:l 
5.0 
15.0 
Table 5 .4 The cytotoxic activity of sheep efferent lymphocytes against 
tumour cells following challenge of the popliteal node with 
w1-1?e lated an ti gen# 
Cell line 
tested 
51 T % Cr release from tumour cells 
Incubated with medium Incubated with immune cells* 
# 
* 
t 
F6 
Fl8 
26 . 9 
28.0 
29 
31 
sheep were challenged with CFA; the efferent lymph contained 16 . 9% 
large cells at the time of test. 
effector cell/target cell ratio, 200 : l 
24 hr assay 
was p ossible for 24 hr because the spontaneous release of 51 cr 
from the tumour c e ll lines did not exceed 30% of the total 
r e leasable 51 cr during the 24 hr period (Table 5.5). 
(b) Antibody complement -dependent cytotoxicity 
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Compleme nt-depe ndent cytotoxic antibodies were first detected 
in the cell-free efferent lymph on the 4th day following challenge 
and coincided with the appearance of blast cells in the lymph. 
The level of cytotoxic antibodies increased to reach a peak titre 
of 1/625 around th e 7th - 8th day of the response. The antibody 
titre in the lymph declined only marginally after the blast cell 
response had disappeared from the lymph and the titre persisted 
at a high l e ve l for at least 15 days after challenge (Table 5.6). 
It was c e rtain that in these e xperiments a significant amount of 
antibody was produced by cells which remained in the lymph node 
and neve r appeare d in th e lymph as free-floating cells. In 
the se experiments no cytotoxicity was detected in the efferent 
lymph against P815 or anothe r allogeneic tumour cell line. 
5. 2. 2 The Stimulatory Capacity of the Tumour Cell Line F40 
The ability of F40 tumour cells to stimulate an allogeneic 
response in vivo was next investigated . Tests for histo-
compatibility between the tumour cell donor and the prospective 
tumour cell r e cipie nt s were carried out using mixed lymphocyte 
r eactions . These r esults are p r esented in Table 5.2 . 
The poplitea l lymph nodes of 3 sheep we re challenged with 
F40 tumour cells; the results of one of these experiments showing 
the total and large cell output in the e ff e rent lymph at various 
inte rval s following challenge are presented in Fig. 5 .5. The 
Table 5.5 51 Spontaneous Cr release by tumour cell following 
51 
51 
different periods of incubation 
51 % Spontaneous Cr release from tumour cells 
Target used 
4 hr 8 hr 24 hr 
F6 
Fl8 
8.9 
9 . 7 
11 
14 
Cr released following water lysis of F6 = 8467 + 596 = 100%. 
Cr released following water lysis of Fl8 = 6381 + 163 = 100%. 
27 
29 
118 
119 
Table 5 . 6 Cytotoxic antibodies detected &n the efferent lymph follOuJing 
challenge with the tumour cell line F6 
* % specific 51 Cr release from the tumour 
Days after % large cells cells in the presence of lymph at 
challenge in lymph various dilutions 
1/5 1/25 1/125 1/625 
1 4 
3 5 17 10 
4 15 80 80 15 
6 20 76 82 75 15 
7 17 75 74 71 63 
8 13 85 96 83 44 
10 9 80 93 82 16 
11 5 81 79 72 11 
15 3 76 65 42 9 
* 4 hr assay 
- Not detected 
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magnitude of the response obtained following challenge with F40 
c e lls was significantly lower than the responses detected after 
challenge with either F6 or Fl8 cells, although the time course 
of the r esponse was similar in all cases. The total cell output 
at the peak of the response ranged form 5 - 12 x 10 7 cells per hr 
compared to 30 - 40 x 10 7 cells per hr in the responses to F6 or 
Fl8 tumour cells. At the peak of the total cell output , only one of 
the 3 sheep showed a significant increase in the percentage of 
large cells in the lymph (8 %). In the other two sheep challenged 
with this tumour cell line (F40) the percentage of large cells in 
the lymph reached 4% and 5% respectively. 
(a) Cytotoxic mechanisms detected in the lymph following 
challenge with the tumour cell line F40 
The cytotoxic activity of efferent lymphocytes against the 
immunizing F40 tumour cells was measured at various intervals 
following challenge. No cellular cytotoxicity was detected 
following challenge at any of the effector to target cell ratios 
tested using either a 4 hr or 24 hr incubation period . Low 
levels of complement-dependent cytotoxic antibodies were detected 
in only one of 3 sheep tested. 
5.3 DISCUSSION 
The r esponse of the popliteal lymph node of sheep to a 
wide variety of antigens has b een well documented (Morris 1968). 
A number of characteristic changes occur in the efferent lymph 
when the node is stimulated antigenically . These changes may 
include an increase in the rate of lymph flow, and an increase 
in both the total cell output and in the percentage of large 
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cells in the lymph. These changes in the efferent lymph occur 
regardless of the nature of the antigen although the magnitude 
and the duration (timing) of the response may vary with different 
antigens. Thus Hall (1964) found that the percentage of blast 
cells appearing in the lymph following an antigenic challenge 
with 6 x 10 8 chicken red cells reached a peak of 9% whereas in 
the response to 5 x 10 7 human red cells the percentage of the 
blast cells in the lymph at the peak of the response reached 
12.5% (Hall e t al. , 1967). Yamashita et al . (1970) showed that 
in responses to boiled Salmone lla muenchen organisms the blast 
cells in the lymph often reached 50% of the total cells on the 
3rd-4th day following challenge while Smith and Morris (1970) 
found that the response to 10,000 haemagglutinating units of 
Swine influenza virus lasted up to ·10 days with the blast cells 
reaching· a peak of 26% at day 6 . In:imune responses to live 
allogeneic lymphocytes are very vigorous and protracted~ 
Grant and Cameron (1975) found tha:t al though the magnitude 
of the blast cell response in the popliteal lymph was similar for 
both allogeneic or xenogeneic cells, the response to xenogeneic 
cells occurred earlier ; changes in the efferent lymph were 
detected 3-4 days following challenge with xenogeneic cells 
whereas those detected in response to challenge with allogeneic 
cells occurred 2 days later . 
In the present experiments significant cellular responses 
were detected in the efferent lymp~ following challenge with 2 
of the 3 tumour cell lines tested . The blast cell responses were 
associated with the detection of both cellular and humoral 
cytotoxic reactivities directed against the immunizing tumour 
cells . The cytotoxic activity of the lymphocytes in the efferent 
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lymph was specific for the immunizing cell and was detected only 
during the blast cell response . From the results it seemed clear 
that it was the transformed, activated lymphocytes that were 
responsible for the reaction . No cytotoxicity against the tumour 
cells was observed following incubation of the tumour cells with 
blast cells obtained from animals immunized with unrelated antigens 
or with other tumour cells . 
While the mechanism of the cytotoxic reaction and the precise 
nature of the cytotoxic cell in the efferent l ymph are not known 
the cytotoxic reaction could be either antibody dependent or be 
mediated directly by cells . If the reaction was antibody 
dependent , then it could be mediated either by "K" cells , 
representing an antibody-dependent cellular cytotoxicity (ADCC) 
mechanism of killing, or it could be complement dependent (Grant 
and Cameron , 1975). The ADCC is unlikely to be the mechanism 
whereby the tumour cells were killed in the present system for 
two reasons. First , it has been shown by other investigators 
(Grant et al., 1975) that cells capable of mediating ADCC in the 
sheep (K-cells) are not ·present in the efferent lymph although 
they are found in the blood and have characteristics in common 
with those of blood monocytes . Secondly , I have shown that 
efferent lymphocytes obtained from sheep immunized with one 
particular tumour cell line (F18) were incapable of mediating 
cytotoxicity against another tumour cell line in the presence of 
antibodies specific for the latter (data not shown) . 
It has been suggested by other investigators (Grant et al.~ 
1970 , 1971) that the blast cells in the efferent lymph of sheep 
can synthesize complement . Accordingly Grant et al. (1970, 1971) 
attributed the cytotoxic reaction observed during the blast cell 
response to an antibody complement-dependent mechanism. This 
explanation would seem unlikely, because if blast cells can 
synthesize and release complement, it would be expected that 
cyto·toxicity would be detected when these cells were added to 
cultures containing antibodies specific for the target cells. 
The cytotoxic reaction could be cellular in nature and 
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mediated by either NK cells, macrophages or T cells. NK cells 
are excluded from being the effector cells in this sytern because 
by definitio~ these cells do not require previous sensitization 
to mediate their killing effect and no cellular cytotoxicity 
was detected in the efferent lymph before challenge. 
The possibility that macrophages could be the mediators of 
the cytotoxicity either in a specific or non~specific sense also 
seems unlikely as it has been shown by other investigatqrs 
(Smith et al., 1970) that the efferent lymph of the sheep is devoid 
of macrophages. There are,however,some circumstances in which 
macrophages may enter efferent lymph following antigenic challenge 
although their appearance is usually evanescent. 
It is possible that the cytotoxic reaction was mediated by 
T-cells similar to those cells which are present in mice. 
Although T-cells. in sheep can be detected by certain surface 
markers, no isolation procedures for T-cells were done in the present 
experiments and consequently it is difficult to come to definite 
conclusions about the nature of the cytotoxic cell. 
Direct cell-mediated cytotoxicity which could be attributed 
to T-cells has been reported in the sheep by Grant and Cameron (1975). More recently Pearson et 'al. (1979) reported a T-cell-
mediated cytotoxic mechanism detected in cattle infected with the Theileria parva parasite. The T-cell nature of the cytotoxic 
.. 
I 
.1 
I 
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cells wa s confirmed by a rosetting technique and by the absence 
of surface imrnunoglobulin on the cells (Eme ry, Personal Comm. 
1981). 
The results presented here raise the question as to why 
t~e tumours F6 and Fl8,which failed to stimulate an allogeneic 
response &n vitro , can stimulate in vivo . Lack of correlation 
between the results obtained in vitro and &n V&VO has been 
reported by many investigators. Baldwin and Embleton (1974) 
found that lymphoid cells from rats .with spontaneous or chemically 
induced tumours were sensitized against the tumour cells when 
tested in vitro . These tumours were unable to elicit significant 
tumour transplantation resistance in vivo which suggests that the 
responses detected in vitro oo _not contribute significantly to 
host immunity. Moreover Ilfeld et al . (1973) found that murine 
lymphoid cells sensitized in vitro against either fibroblasts or 
syngeneic tumour cells (3LL Lewis tumour) were equally cytotoxic 
against 3LL tumour target cells. However, in vivo, the lymphoid 
cells sensitized against syngeneic fibroblasts promoted tumour 
growth . In the present experiments two tumour cell lines did 
not behave in vivo as would be expected in terms of the theory 
of allogeneic reactivity proposed by Lafferty et al. (1978). 
Their ability to stimulate in vivo could not be attributed to 
contamination of the tumour cell lines with stimulator cells of 
lymphoid origin because the tumours had been propagated in 
culture for at least 3 generations before they were used for 
challenge and the cell lines contained no cells of lymphoid 
origin. It seems most likely that histocompatibility antigens 
associated with the tumour cells were responsible for the immune 
response and this response was strong and vigorous by any 
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standards . It is obvious that if a suppressive factor was 
responsible for the lack of stimulation obtained in vitro> then 
this factor did not manifest its activity in vivo . Possibly the 
suppressive factor became diluted in vivo where it had no effect 
on the large number of lymphocytes leaving the stimulated node. 
These results stress the importance of conducting both in vitro 
and in vivo studies together before any definite conclusions can 
be made about the relevance of an in vitro phenomenon to real 
life . 
Th e reason behind the observed difference between the 
stimulatory capacity of F6 , Fl8 and F40 is not known . However 
there are many factors that could affect the capacity of cells 
to stimulate other cells and consequently it is not surprising 
that the various tumour cell lines exhibited variable reactivities 
when injected into allogeneic recipients . One important factor 
which seems to influence the stimulatory capacity of cells is 
their metabolic activity which may relate to the rate of turnover 
of specific proteins in the cell membrane (Wagner 1973) . 
Alternatively, the physical properties of the different tumour cells 
may also affect their ability to stimulate . It may be that the 
tumour cell lines differ in their susceptibility to attack by 
allogeneic macrophages. Since the processing and presentation of 
antigen by macrophages is necessary for the stimulation of 
lymphocytes (Brunda and Raffel 1977), differences in the stimulat-
ory capacity of the different cell lines may be reflected in 
differences occurring in the tumour cell-macrophage interaction. 
However, evidence is lacking as to what extent any of these 
factors contribute to the d e v elopment of an immune response 
. . 
-in v-ivo . . 
EFFERENT LYMPHATIC 
AFFERENT LYMPHATICS 
Figure 5 . 1 Experimental protocol for studying in vivo reactions 
to tumour cells. The afferent and efferent lymphatics of sheep 
were canulated and the sheep challenged with al l ogeneic tumour 
cells introduced via the afferent lymphatic. The subsequent 
responses in the popliteal lymph nodes were followed by monitoring 
changes in the efferent lymph . 
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lymph following challenge of the popl iteal lymph node with 107 culti_vated 
tumour cells (F6). 
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Figure 5 . 3 Direct cell - mediated cytotoxicity detected in the 
efferent popliteal l ymph 
following challenge of the popliteal lyrnph node with allogeneic 
tumour cells at effector/target cell ratios of 200:1 , 100:1 and 
50 : l (4 hr assay) . The percentage of blast cells detected in the 
total cell population in the lymph at each time interval is also 
presented (e - e ) . 
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Figure 5 . 4 Direct cell-mediated cytotox icity detected in the 
efferent popliteal lymph following challenge of the popliteal 
lymph node with tumour cells (24 hr assay ) . Effector cell/ 
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following challenge of the popliteal lymph node with 107 cultivated 
tumour cells (F40) . 
CHAPTER 6 
THE IN VIVO REACTIVITY 
AGAINST AUTOCHTHONOUS TUMOUR' 
EXPLANTS AND CELL LINES 
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6 . 1 INTRODUCTION 
There are very few investigations into autochthonous 
tumour immunity in experimental animals when compared to the 
number of studies done in syngeneic animals and even fewer 
investigations with spontaneously- arising tumours in an 
autochthonous system . The main reason for this would seem to be 
that it is usually more expedient and easier to do experiments 
in a syngeneic system where multiple factors can be tested 
simultaneously in a large group of animals . Despite the advantages 
of studying tumour immunity in syngeneic systems , these studies 
are not comparable to investigating the reactions to tumours in 
autochthonous situations . For examp l e , the response of an animal 
bearing a growing tumour of an unknown age , to a further challenge 
with that tumour will undoubtedly be different to the response of 
a naive animal to challenge with a syngeneic tumour. Since the 
question of whether a host can mount an immune response against 
its autochthonous tumour cells is the major question of relevance 
to the human cancer problem, the study of autochthonous tumour 
systems is of capital significance . 
The first direct evidence for the existence of autochthonous 
anti-tumour immunity in an experimental system was reported by 
Klein et al . (1960). An immune resistance was demonstrated 
against methylcholanthrene (MCS)-induced sarcoma in mice whose 
autochthonous tumours we re reimplanted following surgical removal 
of the primary tumour, and a period of inoculation with irradiated 
tumour cells . Mikulska et al . (1966) have shown that reimplant-
ations 0£ autochthonous benzopyrene-induced fibrosarcoma cells 
were rej ected in the original host if the size of the primary 
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tumour was very small or if the primary tumour was resected. If 
the primary tumour was large and was left in situ, the tumour cells 
were accepted . Mikulska et al . (1966) failed to demonstrate any 
reactive lymphocytes in the spleens of animals with large tumours; 
specific anti-tumour reactivities were detected however,, in spleen 
cells 3 weeks after the tumour was removed . In another study, 
using the same tumour-animal model, Alexander and Hall (1970) 
provided further evidence for the existence of tumour immunity in 
tumour-bearing animals after removal of the primary tumour . 
The existence of tumour specific immunity to spontaneously-
arisi~g tumours is not yet accepted by many workers in the field 
of tumour immunology (Hewitt et al .~ 1976 , Hewitt 1978). 
Nevertheless , Morton (1962) reported that the growth of the first 
transplant generation of a spontaneous mammary carcinoma in 
C3H/HEN mice conferred a significant degree of immunity on the 
animals to subsequent transplants of the same tumour . Morton's 
studies were later confirmed by Riggs and Pilch (1964) who were 
able to demonstrate anti -tumour immunity in the primary host 
following removal of the primary tumour. The extent of the 
immunity was related to the time interval between the removal of 
the primary tumour and the introduction of the secondary tumour 
implant. 
Experiments described in this Chapter were aimed at 
investigating whether an animal with a growing tumour can respond 
to a cho..llenge with autochthonous tumour cells . The first 
approach was to implant fresh biopsy material to a site on the 
body distant from the primary tumour, observe the growth of the 
tumour implant and then monitor the immune response in the lymph 
coming from the regional node draining the tumour implant. 
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Subsequent experiments were done using cultivated tumour cells 
as challenge material. These cells were infused directly into the 
lymph node via an afferent lymphatic , and the immune response 
was again monitored in the efferent lymph. 
6 . 2 RESULTS 
6. 2. 1 Challenge with Tumour Autografts 
Early attempts were made to establish the growth of tumours 
in the autochthonous host by implanting tumour tissue into the 
lower part of the hind leg. This area was · chosen because of the 
relative ease with which the efferen t lymphatic of the lymph node 
draining that area (popliteal lymph node) can be cannulated. The 
tumour tissue was implanted 2 days after the p6pliteal efferent 
lymph duct was cannulated as described in Chapter 2. 
Eight tumour-bearing sheep were grafted with tissue fragments 
taken from their own tumour . Table 6.1 shows the location and size 
of the primary tumours from which the tumour grafts were taken. As 
seen in the table, no growth was observed with any of the tumour 
grafts . Moreover, no detectable cellular changes were observed in 
the efferent lymph of the popliteal lymph node draining the site 
of the tumour implant (Table 6.2) . 
There are several possible explanations as to why the 
tumour transplants failed to grow . One reason could be that lack 
of growth of the tumour was due to immunological rejection by the 
host. This possibility , however seems unlikely since none of the 
sheep studied demonstrated any changes in the efferent lymph from 
the regional node indicative of an immune response . This finding 
does not preclude the possibility that the destruction of the 
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Table 6 . 1 The fate of autochthonous tumours transplanted into _the lower 
part of the hind legs of heep 
Sheep 
n umber 
F 3 
F22 
F 5 
F l4 
F 4 
F 9 
F2 1 
F23 
Tumour site 
nose 
II 
ear 
II 
vulva 
II 
II 
II 
Tumour size 
(cm) 
6 X 5 
3 X 3 
7 X 6 
8 X 9 
4 X 5 
12 X 9 
11 X 14 
8 X 7 . 
* 2 - 4 week observation period 
Site of implant 
lower part of 
hind leg 
II II II 
n II II 
II II II 
II II II 
II II , II 
II II II 
II II II 
Growth * 
observed 
none 
none 
none 
none 
none 
none 
none 
none 
Table 6 . 2 Cellular events in the efferent lymph of the popliteal lymph 
node o heep following the implantation of autochthonous 
tumour grafts into the lower part of the leg 
Days after Flow rate 
challenge ml/hr TWC/ml LC/ml TWC/hr 
0 3.75 4.96 .07 18.6 
1 3.3 6.5 
.09 22.0 
2 2.9 4.5 
.07 13.1 
3 4.2 4.0 
.08 16 . 8 
4 5.2 3.9 .10 20.3 
5 4.7 5.3 
.11 24.9 
6 4.5 5.8 .11 26.1 
7 4.3 6.4 .09 27.5 
8 3 .9 5.4 .12 21.1 
9 3.4 4.9 .11 16.7 
10 4.3 4.2 .11 18.1 
12 3.4 3.5 .07 11.9 
14 3.2 4.2 .08 13.4 
TWC/ml total white cell concentration per ml (x 10-6 ) 
LC/ml large cell concentration per ml (x 10-6 ) 
TWC/hr total white cell output per hour (x 10-6 ) 
-6 LC/hr large cell output per hour (x 10 ) 
LC/hr % large 
.26 1.4 
.30 1.4 
.20 1.5 
.34 2.0 
.52 2.6 
.52 2.1 
.. so 1.9 
.39 1.4 
.47 2.2 
.37 2.2 
.47 2.4 
.24 2.0 
.26 1.9 
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tumour graft may occur within the graft itself without causing 
any detectable changes in the draining lymph node. Alternatively 
the failure of the tumours to grow could be related to the size 
of the tumour transplant. Since a tissue graft was used, the 
relative amounts of normal and tumour material in the graft was 
not known. It was possible therefore , that the transplant did 
not contain sufficient tumour material to initiate and/or support 
tumour growth . The failure of the grafts to grow could also have 
been related to the site of transplantation . It has been shown 
by several investigators that the ability of an animal to reject 
or accept a tumour autograft is dependent in part upon the site 
into which the tumour is implanted (Howard 1963; Haskill et al.~ 
1976) 
To test the possibility that there are preferred sites for 
the growth of this particular epithelial tumour, attempts were 
made to graft similar sized pieces of autochthonous tumour to 
various sites on the body. Pieces of tumour tissue were grafted 
subcutaneously into the shoulder , the dorsal chest region , the 
flank and the lower part of the hind leg. The results of these 
experiments are presented in Table 6.3, which shows the location 
and the size of the primary tumour and the site to which pieces 
of the primary tumour were grafted. 
The implantation of tumour tissue subcutaneously into 
several different locations resulted in growth . All grafts placed 
in the shoulder region (3/3), in the dorsal chest region (3/3) or 
in the flank (4/4), grew . Growth was observed in only one graft 
(see Tables 6.1 and 6.3), of a total of 12. grafts placed in the 
lower part of the hind leg. Since all tumour grafts transplanted 
at different sites were similar in size, the results suggested 
Table 6 . 3 The fate of autochthonous tumouY' transplanted into the 
subcutaneous tissue at different sites in the sheep 
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Sheep 
site Tumour size Site of implant *Growth observed number Tumour (cm) 
Fl8 nose 14 X 12 lower p art of hind leg No 
f l ank r egion Yes 
dorsal ches t region Yes 
the shoulder Yes 
F 19 vulva 6 X 6 lower part of hind leg Yes 
flank region Yes 
dorsal chest region Yes 
the shoulder Yes 
F 24 vulva 8 X 6 lowe r part of hind leg No 
flank region Yes 
dorsal chest region Yes 
the shoulder Yes 
F 37 ear 8 X 9 lower part of hind leg No 
flank region Yes 
* 2 - 4 week period of observation 
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that the failure of the tumour grafts to grow in the lower part 
of the hind leg reported in the early experiments was unlikely to 
have been due to the grafts being of an insufficient size. 
Moreover, these observations indicated that there were preferential 
sites for tumour growth to occur . 
The data presented above demonstrated that tumour grafts can 
be grown when transplanted subcutaneously into the flank. This 
area is drained by the prefemoral lymph node . Subsequently, 
experiments were carried out using the flank as a site for 
transplanting tumour grafts and for measuring any immune response 
which occurred in the efferent lymph of the prefemoral node 
draining the transplant site. 
The e fferent lymphatics of the prefemoral lymph nodes were 
cannulated in two tumour-bearing sheep. Two days after cannulation, 
each sheep was given an autograft of tumour tissue subcutaneously 
into the flank and the efferent lymph was then monitored for the 
next 2 weeks. Although the tumour implants grew during the first 
10 days after implantation , no detectable cellular changes were 
observed in the efferent lymph (Table 6 .4). 
The failure of the animal to respond to its own tumour could 
be attributed to a number of factors . One obvious factor was the 
influence of the presence of the primary tumour . It has been 
demonstrated by a number of investigators (Gershon et al .) 1967,~ 
Barski and Youn 1969; Vaage 1971; Deckers et al .) 1973) that 
tumour-bearing animals are able to react to and subsequently reject 
a secondary implant of the same tumour . This condition in which 
a tumour continues to grow progressively despite an immune response 
that prevents a graft of the same tumour frorn growing elsewhere 
in the body is termed concomitant immunity. Concomitant immunity 
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Table 6.4 The cellular events in the eff erent lymph from the prefemoral· 
lymph node foll owing implantation of an autochthonous tumour 
graft in the drainage area 
Days after Flow rate 
TWC/ml TWC/hr challenge ml/hr LC/ml 
0 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
12 
14 
TWC/ml 
LC/ml 
TWC/hr 
LC/hr 
4 . 1 9.6 . 28 39 . 4 
4 . 0 9 . 4 . 23 37 . 8 
4 . 2 9 . 5 . 19 39 . 9 
4 . 1 8.9 . 1 7 36 .5 
4 . 0 7 . 3 . 13 29 . 2 
3 . 9 8 . 2 .12 32 . 0 
3.8 9 . 8 . 18 37 . 2 
3 . 7 8 . 0 .15 29 . 6 
3 . 4 10 . 5 . 24 35 .7 
3 . 9 7 . 9 . 16 30 . 8 
3 . 4 8 . 6 . 2-5 29 . 2 
2 . 9 6 . 4 . 17 18 . 6 
1 . 7 6 .2 . 15 10 . 6 
total white cell concentration per ml (x 10- 6 ) 
large cell concentration per ml (x 10-6 ) 
total white cell output per hour (x 10~6 ) 
-6 large cell outp ut per hour (x 10 ) 
LC/hr % large 
1 . 20 2 . 7 
. 92 2 . 4 
.78 1 . 95 
. 70 1. 9 
. 52 1 . 8 
. 47 1. 5 
. 68 1. 8 
. 56 1 . 9 
.82 2 .'3 
. 62 2 . 0 
. 85 2 . 9 
. 49 2.6 
. 26 2.5 
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declines as the primary tumour increases in size and this 
reduction in anti-tumour immunity coincides· with a reduction in 
the general non-specific responsiveness of a tumour-bearing 
animal ' s lymphocytes. Both specific and non-specific immune 
reactivities are restored when the primary tumour is removed 
(Whitn ey et al .J 1974). The period that elapses before the immune 
reactivity of the host is restored varies depending on the tumour 
system studied . Since all the sheep I have studied had primary 
tumours of an unknown age, it is possible that the presence of 
the primary tumour may have accounted for the lack of responsive-
ness observed in these animals. To test this possibility, the 
effect of removal of the primary tumour on a subsequent challenge 
with autochthonous tumour cells was investigated. It was not 
possible to do these experiments by autografting pieces of tumour 
tissue because once the primary tumour was removed, no tumour 
tissue was available for subsequent autografting. The approach 
chosen therefore was to biopsy the tumour, grow it in culture as 
a pure population of epithelial cells and use these cells for 
challenge . This method had the advantage that tumour material 
was available for challenging the host at any time. Moreover, 
quantitative studies in which a precise number of tumour cells 
were used could be carried out. 
6. 2. 2 Challenge with Cultivated Twnour Cells Before Removal of the 
PrimaPy Twnour 
The sheep chosen for these expe riments, with one exception , 
were those with primary tumours on their ears. These sheep were 
chos n because tumours at this site are easily removed by surgery . 
The tumour challenge was made by infusing tumour cells into the 
popliteal lymph node as described previously in Chapter 5 and 
specific anti-tumour cellular and humoral reactivities were 
determined in the efferent lymph using the established cytotoxic 
assay. 
Prior to challenge, peripheral blood and efferent lymph 
were tested for both cellular and antibody- mediated cytotoxicity 
directed against the tumour. None of the animals tested ~ad any 
detectable cytotoxic reactivity . Animals we r e then challenged 
with 10
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cultured autochthonous tumour cells a nd the changes in 
the efferent lymph were monitored . The resul t s of a representative 
experiment arc presented in Figure 6.1 . 
The total white cell output before challenge was 5 x 10 6 
cells per hr . Immediately following challenge there was a sharp 
decline in the total cell output so that by 4 hr , the total cell 
output had dropped to 1 x 10 6 cells per . hr . This fall in the 
total cell output was transient and was followed by a steady 
increase so that by 24 hr following challenge the total white 
cell output was higher than the prechallenge level. Further 
changes in the efferent lymph which consisted of an increase in 
the total cell output and large cell output were observed by day 
5 , with the peak of the response occurring at day 6-7 . At this 
stage the total cell output was approximately 60 x 10 6 cells per 
hr and the blast cell response constituted 13% of the total. 
Although the extent of the cellular changes in the lymph was less 
between 30-60 x 10 6 cells/hr) than that which occurred in responses 
6 to allogenejc tumour cells (300-400 x 10 cells/hr) , the 
percentage of blast cells in the lymph was high. The . changes 
described above occurred in 5 out of 6 sheep studied, with the 
only differences observed being in the timing and magnitude of 
the response. For example, the blast cell response ranged between 
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11% - 27% of the total cell output among the different sheep 
tested. 
In the remaining sheep (F40), an increase in the total cell 
output was observed following challenge with tumour cells and a 
peak of approximately 45 x 10 6 cells per hour was reached at day 
6 - 7· (Fig. 6 . 2) . This was followed by a gradual decline in the 
cell output from day 8 after challenge. Although the . . increase in 
the total cell output was similar to that observed in other sheep 
tested, there was no significant increase in the large cell output. 
Moreover the characteristic fall in the cellular output which 
occurred immediately following challenge in the other sheep was not 
observed in this animal. 
Both cellular and antibody-mediated complement-dependent 
cytotoxicity against the tumour cells were investigated in the 
lymph . No detectable cellular or humoral cytotoxic reactivities 
were found in any of the sheep tested . Since it has been 
demonstrated by other investigators (Denham et al., 1969, Grant 
and Cameron 1975) that the blast cell response was. always 
accompanied by the appearance of both cellular and humoral 
cytotoxic reactivities, I was surprised that I did not detect 
any positive cytotoxic response . The question arose as to the 
significance of the observed blast cell response. It was possible 
that it may represent a type of non-cytotoxic response which was 
not detected by the cytotoxic assay , and that antibodies were 
being producPd. Experiments we~e carried out to investigate 
whether any ·of the blast cells appearing in the lymph during the 
response were producing immunoglobulin, and whether any tumour-
specific antibodies can be detected in the efferent lymph. The 
presence of lg-positive cells was determined by an indirect 
imrnunoperoxidase method and d etection of tumour specific 
antibodies was done with an 1 25 1 binding assay. 
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Approximately 20 - 25% of the blast cells were found to be 
lg positive. This percentage was similar to that obtained with 
the blast cells produced in responses to allogeneic tumours (Fig . 
6 . 3) . The presence of antibodies specific for the tumour in the 
lymph was confirmed using the binding assay . Results from these 
experiments demonstrated clearly that antibodies which were specific 
for the tumour were produced in the response . These antibodies 
were first detected in lymph at day 5 , and increased to a titre 
of 1/16 at day 8 . They then declined as the blast cell response 
declined but were still detectable in the lymph at the end of 
the experiment (Fig. 6.4). The appearance of these antibodies in 
the lymph was associated closely with the appearance of the blast 
cell response. 
6. 2. 3 Challenge with Cultivated Twnouri Cells after Removal of the 
n1:mariu :J1wnouri 
The effect of removing the primary tumour on the immune 
response of th e host to a subsequent challenge with tumour cells 
was investigated in a series of experiments in tumour-bearing 
sheep which had had a previous challenge with tumour cells in 
the popliteal node. The primary tumour was resected as completely 
as possible and the popliteal lymph node which received the first 
challenge was also removed . This was done to remove any tumour 
material that might be present in the node from the previous 
inoculation. Three weeks following the removal of the tumour and 
the challenged node, the popliteal lymph node on the contralateral 
side was cannulated and challenged with tumour cells as described 
previously (Ch=1.pter 5) . The changes in the efferent lymph were 
monitored and the results of a representative experiment are 
presented in figure 6 . 5. 
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Three weeks after removal of the primary tumour and just 
prior to the secondary challe nge , peripheral blood and efferent 
lymph were tested for any cellular or humoral cytotoxic reactivities 
against the immunizing tumour. None of the animals tested showe d 
any cytotoxic responses either in the blood or in the lymph. In 
general, similar changes to those observed in the primary challenge 
occurred in the lymph following the secondary challenge . These 
included mainly an increase in the total cel l output and the large 
cell outp ut. Howeve r, the secondary challenge was accompanied by 
a significant blast cell response. The percentage of blast cells 
in the lymph was approximately 2 fold higher .than that obtained with 
the challe nge given before r e moval of the primary tumour . Moreover 
changes in the efferent lymph occurred earlier; between days 3 - 5 
following challenge. Thus, the timing and intensity of these 
responses were diffe rentfromthose described for the primary challenge 
and indeed they had the characteristics of a typical secondary immune 
respons e . 
(a) Cyto toxic mechanisms de t ected &n lymph f ollowing secondary 
challenge 
Tests we re carrie d out throughout the experiment to investigate 
the production of cellular and hurnoral cytotoxic responses directed 
against the tumour. Figure 6 .6 shows that significant levels of 
cellular cytotoxicity were first detected 5 days after challenge; 
this reactivity incre as ed to a peak by day 8 and then declined. 
No activity was detectable by day 10. The appearance of this 
cytotoxic activity was associated closely with the appearance of 
blast cells in the lymph and it declined in parallel with th e 
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decline cf these cells. 
Low but persistent leve ls of cytotoxic antibodies were 
present in the lymph during the response (Fig. 6.7). Antibodies 
were first detected at day 4 following challenge and they increased 
in titre to a peak titre of 1/16 at day 7 and persisted at that 
level until the end of the experiment . These cytotoxic antibodies 
also appeared in the lymph in parallel with the blast cell 
response but they persisted after these cells had left the lymph, 
indicating that a component of this population of antibody-
forming cells was restricted to the node. The peak antibody 
titres ranged between 1/8 - 1/32 among the different animals 
tested. 
(b) Specificity of the cytotoxic r eaction 
Both cytotoxic c e lls and cytotoxic antibodies were tested 
against a panel of 2 other allogeneic tumours and against the 
xenogeneic mouse tumour P815. No cytotoxic cells produced 
by any of the sheep t es ted r eacted with any other tumour except 
the immunizing one . Table 6.5 shows the combined results of all 
the specificity t es ting experiments . As seen in the Table, high 
levels of cytotoxicity were always obtained with the immunizing 
c 11, ranging between 27% -75 % as compared to l ess than 5% 
cytotoxicity against the allogene ic tumours (F6 and Fl8) and 
against the xenogen e ic ce ll line (P815). 
The Sf Pcificity of the antibody r esponse was also determined. 
In only one instance did the cytotoxic antibodies react against 
cells of another allogeneic tumour (F6) apart from the immunizing 
cells (F 35 ). 
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Table 6.5 Te t for specificity of the cytotoxic reaction of lymphocytes 
ensitized against autochthonous tumours 
Sheep % large Days after % cytotoxicity* number cells in challenge 
lymph Immunizing cell P815 F6 Fl8 
F35 27 8 75 1.4 
F51 33 5 56 4.5 2.3 1.7 
F54 25 5 32 5 1.4 
F5 7 17 6 27 
F58 2 3 7 31 4.1 2.3 4.9 
* 24 hour assay at effector:target ratio of 200 :l 
- not detected 
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6. 2. 4 Speci icity o lhe Blast Cell Response 
To determine whether the blast cell response obtained was 
due to organ specific skin antigens or tumour associated antigens, 
both popliteal lymph nodes of tumour-bearing sheep were cannulated 
and challenged either with cultivated tumour cells or with an equal 
number of cultivated epithelial cells from the tumour donor . 
Results obtained from this exreriment are presented in Figure 6.8. 
A significant blast cell response was obtained following challenge 
with tumour cells whereas no response was detected in the side 
challenged with normal epithelial cells. These results indicated 
that the blast cell response detected following challenge with 
autochthonous tumour cells was a response to tumour- associated 
antigens rather than skin-specific antigens or histocompatibility 
antigens. 
6 . 3 DISCUSSION 
Autografts of tumour tissue transplanted subcutaneously into 
the lower part of the leg failed to grow whereas successful growth 
was obtained whe n th e autografts were transplanted subcutaneously 
into other sites of the body s uch as the shoulder, the chest or 
the flank. Thes e observations may be e xplained in terms of 
tumours having preferred growth sites or by the more general 
xplanation that the lower l eg may present an inappropriate graft 
bed due to its lack of subcutaneous tissues or to a deficient blood 
supply. It has been shown previously by several investigators that 
the ability of a tumour graft to grow is partly dependent on the 
site of transplantation. Haskill et al . ( 1976) described a murine 
adenocarcinoma that grew progressively when injected subcutaneously 
into the shoulder but failed to grow when injected subcutaneously 
into the abdomen . In another study , Auerbach et al. (1978a) , 
described an antero-posterior gradient of tumour growth along the 
mid dorsal line between the first vertebra and the sacrum in adult 
mice injected intradermally with tumour cells. Faster tumour 
growth was obtained when tumours were injected in the anterior 
part of mice than in the posterior part. This d ifference between 
the anterior and posterior injection sites was a l so manifest 
after a subcutaneous inoculation (Auerbach et al . ~ 1978a) and was 
observed with a wide variety of different types o f tumours. The 
differences in tumour growth between different inoculation sites 
was independent of the sex of the host, or the level of 
immunocompetence and was not related to the immunogenicity of the 
tumour (Vaage 1973 ; Auerbach e t al . , 1978b) . Studies on auto-
transplanted human tumours of different histologic types are also 
in agreement with the above data. Howard (1963) reported that 
the muscular tissue provided a better "soil " for tumour growth 
than did the subcutaneous tissue. Six of the 22 tumour autografts 
transplanted into muscular tissues grew compared with l of 30 
transplanted into subcutaneous tissues. The reasons why tumour 
transplants grow in certain sites and not in others may be 
-related to the vascularity of the transplantation site, as sites 
supporting the growth of tumour transplants have in general a 
mor extensive vascular bed than those where tumours grow less 
readily . Studies by Auerbach et al . (1978a) suggested that tumour 
growth may be regulated by factors which control growth and 
differentiation during embryoge nesis . They proposed that such 
factors may still be operative in the adult, and produce the 
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variations in tumovr growth seen when tumours were transplanted 
to different anatomical locations on the host. 
Although tumours grew when transplanted subcutaneously into 
the flank , they produced no detectable changes indicative of an 
immune response in the e fferent lymph of the prefemoral lymph node 
draining the site where the tumour was growing. The introduction 
of cultivated tumour ce~ls into the lymph node however, resulted 
in a significant increase in the number of blast cells in the 
efferent lymph draining the challenged node. The difference 
between the host response to challenge with cultivated tumour 
cells and a tumour autograft could be attributed to a number of 
factors . First the route of immunization may play a role. The 
cultivated tumour cells were infused directly into the node , and 
in this situation the tumour cells would be more accessible to 
the host's immune system than an autograft placed some distance 
from the node. Secondly , the presence of lymphoid cells and/or 
antibodies within the graft itself may interfere with the 
sensitization of the host. Thus antigenic sites on the tumour 
cells could be masked by antigen-antibody complexes at the graft 
site which would prevent the sensitization of the draining node. 
Failure to detect reactivity in sheep challenged with tumour 
autografts may of course reflect a true unresponsiveness (tolerance) 
of the animal to its own tumour. Thus the reactivity detected in 
sheep challenged with cultivated cells may be due to changes in 
the antigenic structure of these cells induced by tissue culture. 
These changes may have acted to break the tolerant state and 
enable the animal to respond to its own tumour . It is well known 
that tolerance to an antigen can be broken by the introduction of 
the same antigen altered slightly by chemical means (Parish 1971), 
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by h e at aggregation (Azare 1966 ) or by other treatments. 
Following challenge with cultivated tumour cells, a 
significant increase in the output of blast cells occurred in the 
efferent lymph from the challe nged node. This blast cell response 
was not accompanied by any cytotoxic response, either cellular or 
humoral, that could be d e tected in vilro . However, the response 
was accompanied by low levels of antibodies that bound to the 
tumour cells without causing their demise. The failure to detect 
any cytotoxic immune mechanism in vitro which might be of 
protective value to th e host was attributed to the presence of the 
primary tumour which interfered with the host ' s immunity. After 
the primary tumour was r emove d and the sheep rechall enged with 
tumour cells, a secondary type blast cell response occurred in the 
lymph from th e challe nge d nod. This blast cell response was 
accompanie d by both cellular and antibody complement-dependent 
anti-tumour cytotoxic activity . The blast cell response was 
directed specifically against tumour antigens, since no response 
wa s obtaine d whe n normal ep ithe lial cells from the same tumour 
donor sheep we re u sed instead of tumour cells. The cellular 
cytotoxic r eactions detected in vitro following challenge with 
autochthonous tumour ce ll s were also specific for the immunizing 
tumour. No cellular cytotoxicity wa s d e tected against allogeneic 
tumours or against the xenogeneic tumour P815 . Th e se data supported 
the proposition that individually specific tumour antige ns existed 
on the tumour cells. An alte rnative explanation would be that 
the tumours possess cross-reacting antigens which were not revealed 
b e caus e of the r estriction placed on the cytotoxic reaction by the 
histocompatibility complex (MHC) . By way of example, sheep A 
would r ecognize tumour antigens in association with MHC type A and 
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lymphocytes from this animal would not kill tumour cells having 
similar .tumour antigens if they were associated with a different 
MHC type. There is a histocompatibility requirement between the 
effector and target c e ll for cytotoxic T-ccll reactivity to be 
detected (Zinke rnagel and Doherty 1974; Shearer et al .J 1975) . 
This feature of the T cell responses has been described recently 
in humans · (Dickmeiss et a l .J 1977; Goulmy et al .J 1977) and 
possibly in cattle (Emery, personal comm . 1981). 
The absence of any detectable cellular immune reactivity 
in the host whilst the primary tumour persisted could be either a 
non-specific phenomenon due to general debilitation of the immune 
system or a specific depression of immune responsiveness towards 
the tumour antigens . Non-specific depression of cell-mediated 
immunity is frequently demonstrated in patients with cancers of 
various histologic types . In particular many patients suffering 
from squamous cell carcinoma of the head and neck have been shown 
to have a major impairment of their cellular immunity as measured 
by unresponsiveness to antigens such as 2.4-dinitrochlorobenzene 
(DNCB) and by a decreased responsiveness of their blood lymphocytes 
to T-cell mitogens (Catalana et al . J 1973; Eilber e t al., 1974; 
Lundy et al ., 1974; Wanebo et al .J 1975). Similarly, studies on 
sheep with squamous cell tumours have r e vealed a general non--
specific decreas e in cell-mediate d immunity . This was manifest 
by a decre ase in resp onsiveness of the blood lymphocytes of 
tumour-be aring she ep to phytohaemagglutinin (PIIA). The level of 
decreased responsiveness was relate d to the size of the primary 
tumour (Jun et al .J 1979). A specific decrease in the responsive-
ne ss of blood lymphocytes from tumour-bearing sheep to tumour cell 
extracts has bee n d e scribed by Jun et al . (1979) and the extent 
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of the d epr ess ion corre lated with the size of the primary tumour. 
A specific d e er ase in host r esponsivene ss to tumour antigens has 
also been described in various other tumour systems (Stjernsward 
1968 ; Vaage 1971). 
There is considerable evidence which shows that tumour 
antigens , both free and comple xed with antibodies , are capable of 
blocking cell-mediated cytotoxic reactions . The first indication 
that thi s phenomenon existed came from the observation that sera 
taken from tumour-bearing animals can prevent immune lymphocytes 
from killing tumour c e lls carrying the same tumour antigens 
(Hellstrom et al . ~ 1969). After this first description of blocking 
antibodi es , similar effects were found to occur in a variety of 
experimental tumour systems , both spontaneous and induced . These 
blocking e ff e cts , d etec t e d in vitro~ showed some correlation with 
tumour growth &n V&VO (Hellstrom and Hellstrom 1974) and there is 
some evidence that th e reactivity of lymphoid c e lls from tumour-
b e aring animals may be inhibited by serum factors which become 
bound to their s urface . These blocking factors were found to be 
both antige n-antibody complexes and tumour antigens (Baldwin an d 
Price 1976a, 1976b) . 
Th e re is direc t evidence that both circulating tumour 
antigens and antigen-antibody complexes are present in tumour-
bearing animals. In rats inoculated with synge neic tumour c e ll s , 
Baldwin and Price (1 9 76a ) we r e able to d e tect tumour ·antigens in 
the circulation 7 days following inoculation and circulating 
antige n-antibody complexes after 11 days. The presence of 
circulating tumour antigens and antigen-antibody complexes have 
b een al so demonstrated in humans with tumours (H e imer and Kl ein 
1 76 , Samayoa (), f al ., 1977). 
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The mechanism by which either tumour antigens or antigen-
antibody complexes depress or eliminate cell-mediated cytotoxicity 
is not known . However there are several possibilities. Tumour 
antigen~ either alone or complexed with antibodiescouldcause the 
observ~d anergy by binding to and neutralizing the effector 
cells , leaving fewer cells to react against the tumour c e lls 
(Vaage 1971 , Baldwin and Price 1976b) . Alternatively , tumour 
cells can suppress cell-mediated immune responses directly through 
the production of suppressive factors (Jun and Johnson 1979b) . 
Jun and Johnson (1979b) have shown that squamous cell 
carcinomata in sheep produce a heat-stable factor which can inhibit 
the response of blood lymphocytes of tumour-bearing sheep to 
mitogens and to the tumour extracts . The nature of such a factor 
is unknown but it has been shown that this factor increases in 
concentration as the tumour increases in size and disappears 
within 5 weeks following removal of the primary tumour . The 
disappearance of th~ factor coincides with recovery of cell- . 
mediated immunity in the tumour-bearing sheep. Similarly , evidence 
for the existence of suppressive mechanism (s) associated with the 
sheep tumour was provided in Chapter 4. 
The detection of a reactivity in sheep which had the 
characteristics of a secondary immune response, and which was 
apparent following removal of the primary tumour and rechallenge 
with tumour cells , indicated that the sheep were sensitized to 
tumour antigens. Failure to detect such reactivity before r emoval 
of the primary tumour could have been due to suppressive effects 
of the tumour on cell -mediated immunity . The inability to detect 
any cytotoxic mechanisms in tumour-bearing sheep before a secondary 
cell challenge could be attributed to incomplete recovery of these 
animals from the suppressive effect of the primary tumour at the 
time the test was done. Jun and Johnson (1979a) reported that 
complete recovery of cell-mediated immunity of sheep following 
removal of the primary tumour takes 5 weeks. In the present 
experiments the first tests were carried out three weeks after 
the tumours were removed . In the absence of any evidence for 
the presence of blocking factors in the tumour-bearing sheep, 
suppression of cellular immunity directly through the production 
of suppressive factors seems the most likely explanation of the 
immunological defect. 
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Figure 6.3 Lymphoid cells obtained from the efferent lymph of a 
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Figure 6 . 7 The cytotoxic antibody titre in the efferent lymph from the 
popliteal node following challenge with autochthonous tumour cells 3 
weeks after rcmovul of the primary tumour . 
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CHAPTER 7 
THE REACTIVITY OF REGIONAL AND DISTANT 
LYMPH NODES AGAINST AUTOCHTHONOUS TUMOUR CELLS 
iso 
7 . 1 INTRODUCTION 
Historically, the interpretation of the role played by the 
regional lymph node in determining the life-history of a developing 
cancer has been influenced firstly by the concept that lymph nodes 
act as mechanical filters that arrest any tumour cells carried to 
them in the lymph , and secondly that lymph nodes have a role in 
the immunologic rejection of tumours . Fisher and Fisher (1966, 
1967a , 1967b) have shown that regional lymph nodes are not by 
any means effective filters of tumour cells . Thus , tumour cells 
injected intravenously traversed the blood capillary endothelium 
of lymph nodes and entered the lymph as do normal lymphocytes. 
It has also been shown that tumour cells are able to enter the 
blood stream by migrating from the lymphatic vessels directly 
through the walls of the blood capillaries within the substance 
of lymph nodes. This means that at least some cancer cells which 
have been shed from the primary tumour are able to undergo a 
blood-lymphatic circulation in both directions. Much of this 
cell traffic occurs within the substance of lymph nodes in a 
similar way to the normal traffic of lymphocytes. Zeidman and 
Buss (1954) however , demonstrated that lymph nodes of normal 
animals can be effective barriers to the spread of some tumours. 
They injected allogeneic Brown-Pearce or V2 carcinoma cell lines 
into the afferent popliteal lymphatics of rabbits and removed 
the lymph nodes 1 to 42 days after injection . Of a total of 30 
animals inject d, only 2 developed secondary tumours beyond the 
regional lymph node. 
It is unquestionable that the regional lymph node is 
immunologically involved in the host's response to tumours . The 
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evidence for this comes from histological data (Alexander et al.) 
1969; Flannery et al.) l975; Berlinger et al.~ 1976); the fact 
that it is possible to transfer immunity with lymph node cells 
(Delmore and Alexander 1964) 1 and from the demonstrable interactions 
between tumour cells and regional lymph node cells (Fisher 
et al .) 1974). 
The results of some clinical observations (Crile 1965; 1968; 
1969) and experimental data (Fisher and Fisher 1971; 1972) on the 
role of regional lymph nodes in tumour immunity , have led to the 
proposal that it may be important to .retain those regional lymph 
nodes which do not contain metastatic tumour so as to maintain a 
degree of systemic immunity against further growth of cancer. 
Although this concept has a significance for the clinical treatment 
of cancer and for tumour research, the evidence so far available 
for its support is inconclusive and conflicting. Fisher et al.) 
1972 , 1974) have suggested that the regional lymph nodes are 
important in the initiation and maintenance of tumour immunity. 
More specifically, they reported that immune cells from regional 
lymph nodes were more toxic for tumour cells in vitro) than were 
immune cells from other sources. This finding indicated that 
regional lymph node cells may be uniquely important in the host's 
defence against tumours. Accordingly Fisher et al.) (1974) 
suggested that the lack of histologic evidence of a growing tumour 
in the regional lymph node should not be interpreted as evidence 
that lymphatic metastas is has not occurred. Gardner and Rosen 
(1967); Bard et al . ) (1969) and Hammond and Rally (1970) have 
shown that regional lymphadenectomy has no effect on host immunity 
and they proposed that regional lymphadenectomy together with 
resection of the primary tumour should remain standard practice in 
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the treatment of cance r patients. 
Most studies done to evaluate the role of the regional lymph 
node have been carried out on normal animals, which were often 
challenged with an overwhelming dose of tumour cells which 
usually produced death in a short period of time after inoculation. 
The pathogenesis of cancer as it occurs in man is not similar to 
this model since only the early events of the response in the 
r egional lymph node to tumours can be studied (Strauli 1970; 
Fidler 1974). As a result these experiments cannot be seen as 
counterparts of clinical studies which are more concerned with 
the later stages of the disease. Studies on the role of the 
regional lymph node in tumour immunity in large animals with 
spontaneous tumours are more comparable to the human situation. 
The experiments reported in this Chapter were done to 
evaluate the reactivity of lymph nodes draining the site of 
progressively growing tumours and to compare this reactivity with 
that of lymph nodes distant from the site of tumour growth. Two 
different approaches were used to study this question. First, 
the in vitro anti-tumour reactivity of autochthonous lymphocytes 
obtained from the lymph node regional to tumour growth was 
investigated and compared with that of lymphocytes from a distant 
lymph node and with leucocytes from peripheral blood. Secondly, 
the responses occurring in the efferent lymph of both regional 
and distant lymph nodes were studied following challenge with 
autochthonous tumour cells . 
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7.2 RESULTS 
?. 2. 1 The Reactivi ty of the Regional Lymph Node~ a Distant Lymph Node 
and Peripheral Blood Leucocytes Against Autochthonous Tumour 
Cells In Vitro . 
The regional cervical lymph node (RLN) and a distant 
popliteal lymph node (DLN) were surgically removed from 5 sheep 
which had tumours on their ears or their noses. The clincal data 
of the sheep studied are presented in Table 7.1. Lymphocytes 
isolated from these lymph nodes as well as peripheral blood 
leucocytes were tested for their cytotoxic reactivity in vitro 
against autochthonous tumour cells . Table 7.2 shows that no 
cytotoxic reactivity was apparent against autochthonous tumour 
cells in any of the animals, regardless of the source of lymphocytes. 
?. 2. 2 The Responses of the Regional Lymph Node and a Distant Lymph 
Node to Challenge with Autochthonous Tumour Cells 
In the experime nts described here , the in vivo reactivity 
of tumour-bearing sheep to challenge with autochthonous tumour 
cells in the regional lymph node and in a distant lymph node was 
compared. The experimental protocol was similar to that used for the 
experiments described in Chapter 5. The afferent and efferent 
lymphatics of the cervical lymph node (RLN) and the popliteal 
lymph node (DLN) were cannulated and equal numbers (10 7 ) of 
tumour cells were infused into· both nodes simultaneously, and the 
changes i n the efferent lymp h were monitored (Fig. 7.1). 
( a) Challenge o di tant lymph nodes 
Four tumour-bearing sheep were challenged with autochthonous 
tumour cells into an afferent poplite al lymphatic. The clinical 
data of th e sheep studied arc summarized in Tabl e 7.3. The response 
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Table 7 . 1 The clinical data of the tumour bearing sheep studied &n 7.2.1 
Sheep Sex Z\ge Tumour site Tumour size number (yea rs) (cm) RLN DLN 
F31 femal e 7 ea r 8x8 cervical popliteal 
F34 11 6 II 16x9 II II 
F3 9 II 7 II 15xl2 11 II 
F41 11 >7 nose 6x3 II II 
F4 7 II >7 II 6x4 II II 
Table 7.2 The reactivity in vitro of regional lymph node~ distant lymph 
node and peripheral blood lymphocytes to autochthonous tumour cells 
% Cytotoxicity of lymphocytes from various sources 
Sheep numbe r 
+ 
* 
+ RLN 
F31 
F34 1. 9 
F39 
F41 1 . 5 
F47 
Regional lymph node 
Distant lymph node 
peripheral blood lcucocytcs 
not detected 
* DLN 
1 . 3 
1.2 
2 .1 
1.1 
in this distant lymph node was similar to that observed in sheep 
challenged with autochthonous tumour cells. (See Chapter 6 
Section 6 . 2 . 2). 
Significant stimulation of the lymph nodes was obtained in 
all sheep studied and led to a substantial increase in the 
percent.age of blast cells in the lymph. The changes in the 
efferent lymph consisted of an increase in the flow rate as well 
as an increase in the total and large cell output. There were 
changes detected 3 - 4 days following challenge and the response 
reached a peak on day 5. The total cell output and blast cell 
output remained at a high level up to day 12 after which the 
response declined . At the peak of the total cell output , the 
blast cells constituted 27% of the total cells in the lymph 
(Fig . 7 . 2) . Differences in the responses were observed among the 
sheep tested, but while the timing and/or the magnitude of the 
r esponse varied, the general pattern of the reaction was consistent 
in each individual sheep . 
(b) Challenge of regional lymph nodes 
The effect of autochthonous · tumour cells on the lymph node 
regional to the developing tumour was investigated in tumour - bearing 
sheep which had been challenged with autochthonous tumour cells 
introduced into a distant lymph node. The lymph coming from the 
node regional to a growing tumour contained a high percentage of 
blast cells (10 % - 14%). This may have been due to continuous 
stimulation of the lymph node by the inevitable bacterial 
contamination that occurs with a natural tumour and/or stimulation 
of the node by the tumour antigens or other products. 
The results of the experiments in which the regional node 
was challenged with autochthonous tumour are presented in Fig. 7.3. 
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Before challenge 7 the total cell output was approximately 60 x 10 6 
cells per hr while the large cell output was approximately 
9 x 10
6 
cells per hr. Following challenge the total cell output 
per hr decreased by 30% during the first 24 hr and then continued 
to decrease steadily throughout the experimental period (12-15 days). 
The large cell output declined in parallel with the total cell 
output and as a consequence the percentage of the large cells in 
the efferent lymph remained constant. It would appear from the 
r~sults that , if an increase in the blast cell response is 
indicative of an immune response then these nodes were quite 
anergic , although the initial decline in the total cell output was 
similar to the " shut down" phenomenon described by Hall and Morris 
(1 965a) in relation to antigenic recognition. 
?. 2. 3 Cytotoxic Activity in the Efferent Lymph of the Regional and 
Distant Lymph Nodes Following Challenge with .Autochthonous Tumour 
Cel ls 
In all the sheep studied, efferent lymphocytes from both the 
RLN and DLN were tested for their cytotoxic prop~rties against 
autochthonous tumour cells before (day 0) and at various intervals 
following challenge . No cellular cytotoxicity was observed in any 
of the cell populations from the sheep tested from either lymph 
node, using a variety of effector to target cell ratios in the 
cytotoxic assay, and periods of incubation up to 24 hr (Table 7.4) . 
Measurements of complement-dependent cytotoxic antibodies 
in the efferent lymph from both nodes were also done and no 
cytotoxic antibodies were detected at any time. This was consistent 
for all sheep studied. 
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Table 7 . 3 The clinical data of the twnour-bearing sheep studied ~n ?.2 . 2 
Sheep 
number 
FSl 
F43 
FS9 
F61 
Age 
(years ) 
7 
>6 
>7 
7 
Sex 
Female 
Female 
Female 
Female 
Tumour site 
Ear 
Nose 
Nose 
Nose 
Tumour size 
( cm) 
17xl8 
4x3 
7xl0 
6x3 
Method of Challenge 
Ce l ls via afferent 
l ymphatic 
II 
II 
II 
Table 7. 4 Test for cel l -mediated cytotoxicity in the efferent lymph from 
the regional and distant lymph node following challenge with 
autochthonous twnour cells 
Days after Regional lymph node Di s tant lymph 
challenge 
% l arge ce ll s * 0 '6 lysis % large cells 
0 14 1 . 0 2 
2 13 4 
4 13 2 . 5 13 
6 16 18 
8 13 3 . 0 25 
10 10 21 
12 13 2 . 3 10 
14 10 1.1 8 
* 24 hour assay at effector/target cell ratio , 200 : 1 
not detected 
node 
* % lysis 
1 . 9 
2 . 0 
2 . 6 
1 . 5 
3 . 0 
1 . 3 
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?. 2.4 The Speci icity of the Response in the Regional Lymph Node 
In order to determine whether the declining responsiveness 
in the regional lymph node was due specifically to the tumours , 
the distant lymph node (popliteal) of a tumour-bearing sheep was 
chronically stimulated by the subcutaneous injection of complete 
Freund ' s adjuvant into the lower part of the hind leg. Two months 
later , an afferent lymphatic of the popliteal node was cannulated 
and autochthonous tumour cells infused into the node as described 
previously . The response obtained was identical to that observed 
in the regional lymph node following challenge with tumour cells in 
that a decrease in the . total and large cell output was observed. 
This result indicated that the reduced reactivity observed in the 
regional lymph node was a general phenomenon and that a distant 
node was also unable to respond normally to · a ntigenic challenge 
(Fig . 7.4). 
7 . 3 DISCUSSION 
The purpose of the present studies was to examine the anti -
tumour r eactivity of a lymph node draining the site of a growing 
tumour and compare this reactivity with that of a lymph node 
remote in the body from the tumour. The results demonstrated that 
lymphocytes taken from the draining lymph node had no demonstrable 
cytotoxicity against the tumour cells; furthermore , there was no 
cytotoxic reactivity in peripheral blood leucocytes or in 
lymphocytes taken from a distant lymph node. 
The r eactivity of a distant lymph node challenged with 
autochthonous tumour cells suggested that while there were changes 
in the cell population in the efferent lymph which were indicative 
of an immune response these changes were not associated with the 
production of any detectable anti-tumour cytotoxic mechanisms 
in vitro. Moreover the results obtained from the in vivo 
experiments demonstrated quite clearly that the regional lymph 
node did not respond to the tumour cell challenge by way of a 
blast cell response. The significance of the decline in the 
total cell output from the node following challenge with 
autochthonous tumour cells was ambiguous since a similar decrease 
in the c e ll output was observed in a node chronically stimulated by 
an unrelated antigen . These results suggested that the lymph nodes 
of the tumour-bearing sheep were generally debilitated and unable 
to produce normal immune responses . 
This anergy displayed by the regional lymph nodes in tumour-
bearing hosts has been described by other investigators. Clinical 
studies of cancer patients have revealed cases in which the blood 
leucocytcs were cytotoxic for the patient 's tumour cells while 
the regional lymph node cells were unreactive (Nairn et al .J 1971; 
1972; Vanky andStjernsward 1971; Nina et al .J 1973). Studies from 
experimental animal models have revealed some details about the 
kinetic aspects of the development of regional lymph node 
unresponsiveness to tumour growth. Flannery et al .J (1973a, 
1973b) investigated the immunological changes occurring in the 
regional lymph node draining the site of a growing squamous cell 
carcinoma in Wistar rats. They found that cytotoxic activity 
against the tumour was present in cells from the regional lymph 
node 2 weeks after the inoculation of tumour cells. Cytotoxic 
activity was also detectable in cells from intermediate and distant 
lymph nodes and in the spleen, but the appearance of this activity 
was out of phase with that observed in the regional lymph node. 
The intensity of the cytotoxic reactions declined as the tumour 
grew so that eventually the lymphocytes from the regional lymph 
node became totally unresponsive while significant levels of 
cytotoxicity persisted in other lymphoid tissues . Flannery et al.> 
(1973a) suggested that such lymphoid anergy may be a factor in 
allowing the tumour to spread into the regional lymph node . 
In another study with a chemically induced hepatoma (Dl92A) 
in rats , Jones et al . > (1978) reported that anergy of the regional 
lymph node , as demonstrated by cytotoxicity testing , developed 
3 weeks following the implantation of the tumo ur . They found that 
anergy in the regional lymph node correlated with the finding that 
the paracortical (T-cell dependent) responses also declined 
towards the end of the 3rd week after implantation of the tumour. 
The B- cell dependent cortical areas of the cor tex showed active 
lymphoid follicles two weeks after tumour transplantation and 
plasma cells appeared in the medulla . These reactions continued 
until the experiment was terminated 4 weeks after tumour implant-
ation . Similarly, Alexander et al . > (1969) have shown that the 
anergy which develops in the regional lymph node is associated 
with changes in the proportion~ of blast cells and plasma cells 
in the regional lymph node . Thus it seems from these studies 
that the lymphoid anergy of a tumour-bearing animal is dependent 
on the duration and extent of the tumour growth. Moreover the 
anergy seems to be associated with a shift in the pattern of 
response in the node from a T-cell-dependent reaction to one 
which involves the B-cell-dependent response of the node. 
The mechanism responsible for the development of the anergic 
state in the lymph nodes is not known . However , as described in 
Chapter 6, it is possible that tumour antigens or tumour antigen-
antibody complexes could be responsible for the creation of anon-
reactive state in the lymphoid tissues possibl y by binding to effector 
cells and causing their desensitization (Jones et al.J 1978), by 
preventing the differentiation of lymphoid cells into killer cells 
(Flannery et al.J 1975), or by immobilizing effector cells in the 
node and preventing them from being released into the circulation 
(Alexander et al . J 1969) . Alternatively , tumours might cause 
anergy in the regional lymph node by flooding the node with 
suppressive factors which result in impairment of cell-mediated 
immunity either directly or. indirectly through the activation of 
suppressor cells. Most of these possible explanations , however, 
are conjectural and are not supported by any experimental evidence. 
In most of the experimental systems in which the phenomenon 
of lymph node anergy has been studied , the non-reactive state was 
specific for the tumour and its antigens, and the reactivity of 
the regional lymph node to other antigens remained normal. Moreover, 
the lymphoid anergy was geographically restricted to the regional 
lymph node (Alexander et al . J 1969; Flannery et al.J 1973a, 1973b). 
Lymphocytes taken from other sources were still reactive against 
the tumour. The situation was quite different with the naturally 
occurring skin cancer in sheep. Jun et al.J (1979) reported that 
the reactivity of peripheral blood leucocytes against tumour 
antigens and other mitogens was decreased in tumour-bearing sheep, 
suggesting that there was a degree of systemic lymphoid anergy. 
The diminished reactivity also had both specific and non-specific 
components to it. Since it has been shown by several investigators 
that the development of regional lymphoid anergy is associated with 
a shifting pattern of reactivity from cellular to humoral 
responsiveness , (Flannery et al .~ 1973a, 1973b, 1975; Jones et al ., 
1978), it is possible that responses observed in distant lymph 
node~ (antibody response) are a reflection of a changing reactive 
pattern that has already occurred in the regional lymph node. The 
diffe rence in the pattern of response between a regional and a 
distant node may also be due to differences in the extent to which 
each node has been subjected to stimulation . 
The lack of reactivity .of lymphoid cells from the regional 
and distant lymph nodes against the tumour may have some significance 
for the secondary growth of the tumour cells which occurred in them 
following the inoculation of tumour cells. Metastatic tumours were 
detected in 2 out of 9 of the distant nodes inoculated with tumour 
cells 15-20 days previously (Fig. 7.5), and 1 out of 4 of the 
regional nodes . It should not be construed that metastastic growth 
was absent in nodes in which no tumours were found as no attempt 
was made to section the nodes serially. 
Thus it is possible that the regional lymph node may play an 
important role in tumour rejection at an early stage in the develop-
ment of the primary tumour. It has been shown experimentally that 
the barrier function of the regional lymph node for tumour cells 
is affected by the number of tumour cells and the period over 
which they · are being disseminated to the node (Strauli 1970). 
It seems likely that early in the life-history of a tumour 
when it is small and the lymph nodes are not affected, it may be 
detrimental to the development of the host's immunity to the 
tumour to remove the regional nodes. This in itself may increase 
the likelihood of metastasis occurring (Crile 1969) . Late in the 
course of the disease when the nodes become anergic or when they 
contain metastatic tumour they may no longer be important in the 
generation of systemic immunity and their removal may be of less 
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consequence. Many human cancers are diagnosed after the disease 
has been developing for some time and in many cases the regional 
lymph node may already have become anergic . The present findings 
suggest that there is some therapeutic justification for removing 
the regional lymph nodes in the later stages of clinical 
carcinomatosis . 
Figure 7.1 Experimental arrangements for studying in vivo reactions 
to autochthonous tumour cells in the regional and distant lymph 
nodes . The afferent and efferent lymphatics of the regional (cer-
vical) and the distant (popliteal) lymph nodes of tumour-bearing 
sheep were cannulated and the sheep were challenged with autochthon-
ous tumour cells introduced via the afferent lymphatic. The subse-
quent responses in the cervical and popliteal lymph nodes were 
followed by monitoring changes in the efferent lymph. 
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Figure 7. 4 The cellular events occurring in the efferent lymph of a 
di stant l ymph node (popliteal) chronically stimulated with CFA and 
c h allenged with a u tochthonous tumour cells . 
Figure 7.5~ A secondary tumour growth in a distant lymph node 
(popliteal) challenged with autochthonous tumour cells. 
The node was sampled 20 days following the introduction of 
tumour cells into it (magnification Xl25 ). 
Figure 7.Sb The histological appearance of the primary tumour from which 
the inoculated cells were cultivated (magnification Xl25). 

CHAPTER 8 
GENERAL CONCLUSIONS 
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The discovery that neoplastic cells express specific 
antigens which could be recognized by the host ' s immune system has 
opened up a new era in cancer research. This discovery provided a 
theoretical basis for the use of immunotherapy in cancer treatment 
and offered the advantage· of specificity which other conventional 
forms of therapy such as surgery , radiotherapy and chemotherapy, 
do not have . If a specific destructive immune response could be 
generated in a cancer patient it may be possible to eliminate the 
neoplastic cells with very little damage to normal tissues. In 
addition to specificity in the destruction of the tumour, the 
resultant immunological memory may contribute to a continuing 
immune surveillance against any recurrence of the tumour. 
Subsequent to the discovery of the presence of tumour 
specific antigens on neoplastic cells , a variety of tumours were 
induced expe rimentally in laboratory animals and investigations 
were carried out to clarify and understand the interactions that 
occur between the tumour cells and the immune system of the host. 
During the course of these studies a number of anti-tumour 
effector cells and mechanisms were defined . However, it soon 
became obvious that most models of experimentally induced tumours 
were not analogous to naturally occurring human cancers. These 
experimental models were dependent on the use of syngeneic 
animals for the supply of both tumour tissue and sensitized cells 
for adoptive transfer experiments . The responses seen in healthy , 
syngeneic recipients , challenged with a sudden overwhelming dose 
of tumour have no counterpart in the responses mounted by animals 
in which long-standing tumours are growing . Accordingly, there is 
a need for the reappraisal of results obtained from such models 
and for the study of responses to tumours which have a much 
greater similarity to human cancer (Alexander 1976; Bartlett 
el al ., 1976; Hewitt 1978). 
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A problem which emerged during the studies of the host-tumour 
interactions, related to the interpretation of &n vitro 
experimental results in tumour immunology . It is generally 
accepted that some of the interactions taking place between the 
host and the tumour can be interpreted from the results of 
in vitro confrontations between lymphocytes and tumour cells. 
However, results from various laboratories have indicated that 
this assumption may not be true (Ilfeld et al .~ 1973; Baldwin and 
Embleton 1974), and as a consequence there is a need for doing 
both &n vitro and in vivo studies in order to understand fully 
the nature of host-tumour interactions. 
Naturally-occurring squamous cell carcinomata in sheep offer 
a model for studying host-tumour interactions in a situation which 
bears a close resemblance to a common type of human cancer. The 
tumour appears to hove an aetiology which has been attributed to 
ultraviolet irradiation, the main causative factor in the induction 
of skin cancer in humans. Sheep represent an outbred population 
of animals with a relatively long life span and a large body size. 
In addition the tumour-bearing sheep are frequently debilitated, 
all of which are similar to some of the features that are associated 
with human cancer . Furthermore, sheep have the added advantage for 
in vivo studies of immune responsiveness ; in that reactions in 
singJc lymph nndcs can be continuously monitored by establishing 
chronic fistulae in the regional efferent lymphatic ducts. 
The interaction between a tumour and the host 's immune system 
can be studied from the standpoint of the properties of the tumour 
cells as well as the tumour cell interaction with the host. 
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Accordingly, initial studies were done to examine some of the 
properties of the tumour cells themselves by investigating the 
tumour cell-allogeneic lymphocyte interaction in vitro and in vivo. 
Results from the in vitro experiments revealed that none of the 
cell lines tested were able to stimulate a proliferative response 
in allogeneic lymphocytes . This inability to stimulate was not 
due to compatibility between the responding and stimulating cells 
or to lack of alloantigen expression by the tumour cells . In the 
majority of the cell lines tested , the failure to stimulate was 
probably due to an immunosuppressive effect o f the tumour cells . 
Investigations of the capacity of these particular cell 
l ines to stimulate in vivo showed that they produced significant 
stimulation which was manifest by the appearance of both humoral 
and cellular cytotoxic mechanisms directed against the tumour . 
These results indicated that the suppression induced by tumour 
cells in vilro had no effect in vivo. These data again stressed 
the importance of interpreting the in vitro studies with the 
knowledge that they may not predict the behaviour of the tumour 
i,n vi,vo . 
Although no suppressive activity of the tumour cells was 
observed in allogeneic sheep in vi,vo~ this does not rule out the 
importance of such a suppressive mechanism playing a role in the 
tumour-bearing host. In animals debilitated by a long- standing 
tumour , the antigenic disparity between the tumour and the host 
may not be as strong as in an allogeneic healthy sheep. This 
may result in a shifting of the outcome of the response in 
favour of tumour growth which in turn may lead to immunosuppression. 
In light of the differences in the characteristics of the 
various cell lines and with the knowledge of th e limitations 
.. LU I 
these differences may impose on the immune response of a tumour-
bearing host, the host's ability to respond to its own tumour 
was investigated. The results indicated that no cytotoxic 
anti-tumour reactivities, either cellular or humoral were 
detected against the injected tumour cells. However, antibodies 
that could specifically bind to the tumour but were not cytotoxic 
were detected following challenge. The lack of reactivity was 
found to reflect a systemic depression of the immune · response 
against the tumour , since no anti-tumour cytotoxic reactivities 
were detected in the regional lymph node , in the distant lymph 
/ 
node or in the blood. This anergy of the lymphoid tissue may 
account for the artificial metastasis of these tumours seen in 
both the r egional and distant lymph nodes following challenge with 
tumour cells. 
Removal of the primary tumour did not result in any 
restoration of the reactivity of lymphoid cells when tested three 
weeks after the tumour was resected. However , subsequent 
sensitization of the host 3 weeks after removal of the tumour was 
associated with the appearance of both cellular and humoral 
cytotoxic responses directed specifically against the tumour. 
Th e results of these experiments indicated quite clearly 
that these naturally occurring tumours are antigenic and, under 
proper circumstances, they are capable of stimulating an immune 
response in the host. The demonstrable irnmunogenicity of these 
tumours raises again the paradox as to how these recognizably 
antigenic tumours escape immune destruction. 
A wide variety of speculative theories have been put 
forward to e xplain how antige nic tumours evade the host's immune 
defence. Some of th ese theories are supported by experimental 
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evidence, but the importance or even the relevance of any of these 
mechanisms to the life history of a tumour is entirely conjectural. 
One obvious characteristic of the tumour cells which could enable 
them to escape immune destruction by the host is their immuno-
suppressive effect on the host lymphoid apparatus. Studies with 
squamous cell carcinomata in sheep by another group of investigators 
(Jun 1979; Jun et al .~ 1978) have shown that the injection of tumour 
extracts into tumour-bearing sheep caused an increase in the growth 
of the tumour (enhancement) and its metastatic spread. Comparable 
enhancement was also associated with the inoculation of tumour-
bearing sheep with foetal lamb skin . These investigators suggested 
that the nhancement of tumour growth was a result of suppression 
of the immune system of tumour-bearing sheep by · the tumour and 
by foe tal tissue extracts . This led them to suggest that tumour 
growth was associated with the re-expression of some foetal tissue 
product . 
The basic question of tumour biology that requires 
investigation concerns the role of the immune system of the host 
in explaining the clinical behaviour of tumour growth and in 
particular the metastatic potentiality of neoplastic cells. 
Research into this facet of tumour biology should be done with 
the knowledge that immunological reactions of the host and the 
antigenicity of the tumour cells are not the only facets which 
may affect the outcome of a cancer metastasis . A basic understanding 
of other aspects of the biology of tumour cells which enab les them 
to metastasize is central to the problem of tumour growth in the 
host . For the host immune system to be able to play a role in 
controlling tumour spread two criteria must be operative . 
1. the tumour cells must be antigenic , and 2. the host immune 
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system must be able to recognize and destroy these cells by 
immunological means. The variable antigenic properties of neoplastic 
cells makes the control of tumour spread by immunological means a 
limited and a difficult biological task . An understanding of the 
circumstances in which the immune system might contribute to the 
control of malignant processes would offer prospects for cancer 
therapy but there is no certainty in the proposition that immune 
reactions demonstrable in vitro will necessarily be operative 
in vivo in cancer control. Much more needs to be understood about 
. the intricacies of host-tumour interactions &n V&VO~ particularly 
in relation to the chronic evolutionary changes that must 
inevitably occur between an evolving tumour and an evolving 
reaction to it by the host. The naturally-occurring squamous 
cell carcinoma of the sheep provides a model in which these 
interactionscan be studied . 
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